data_1y3k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y3k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.265 0.555 . . . . 3.1699999999999999 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1899999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.8799999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 3.3100000000000001 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 4.4800000000000004 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 2.4199999999999999 105.967 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 3.3999999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 3.77 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 4.0599999999999996 110.155 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 113.852 1.056 . . . . 2.7999999999999998 113.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 3.1600000000000001 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 3.0299999999999998 109.768 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 1.76 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 2.4900000000000002 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 3.4199999999999999 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 4.5999999999999996 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 3.54 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.9399999999999999 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 7.4699999999999998 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 7.4400000000000004 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.26 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 2.3900000000000001 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 3.6299999999999999 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 1.5600000000000001 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 4.0800000000000001 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 4.7300000000000004 112.28 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 2.1299999999999999 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 1.46 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 3.1099999999999999 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 5.0199999999999996 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 4.96 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 1.6200000000000001 106.019 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 3.2999999999999998 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 3.73 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 5.5599999999999996 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 4.3399999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 1.04 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.8600000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 2.8799999999999999 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 2.29 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 4.0999999999999996 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.55 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.28 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 4.3300000000000001 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 2.8799999999999999 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 1.9299999999999999 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 3.7000000000000002 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 2.23 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 5.6600000000000001 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 3.8799999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.53 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 4.2199999999999998 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 1.0900000000000001 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 1.7 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 2.3799999999999999 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 2.4500000000000002 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 4.5 106.669 -179.694 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.543 -0.54 . . . . 2.8799999999999999 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.5699999999999998 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 5.4800000000000004 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.8799999999999999 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 4.1699999999999999 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 2.7400000000000002 107.582 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 3.1899999999999999 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 4.4100000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 3.25 108.784 -177.452 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 5.0700000000000003 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 3.7200000000000002 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 2.2999999999999998 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.6899999999999999 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 3.5800000000000001 109.762 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.5999999999999996 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 3.7799999999999998 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 2.9500000000000002 110.789 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 8.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 7.3499999999999996 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.4199999999999999 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.3200000000000001 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 2.7799999999999998 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 3.5099999999999998 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 2.1099999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.9300000000000002 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 2.77 113.248 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 1.77 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 1.8 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 3.02 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 6.0700000000000003 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.8300000000000001 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 1.04 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.8599999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 2.02 109.924 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 3.3700000000000001 110.046 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 6.4900000000000002 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 3.8399999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 4.1799999999999997 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.99 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 2.1000000000000001 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 2.2799999999999998 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.1899999999999999 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 4.29 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 3.7999999999999998 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 1.78 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 3.98 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 2.04 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 4.5700000000000003 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 2.8900000000000001 112.136 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.95999999999999996 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 4.4100000000000001 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1799999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 1.9199999999999999 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 3.3100000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 1.99 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 4.5199999999999996 106.998 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 111.647 0.24 . . . . 3.1800000000000002 111.647 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 2.3399999999999999 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 5.4199999999999999 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 2.23 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 3.5600000000000001 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 2.9300000000000002 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 3.98 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 3.1400000000000001 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 2.6400000000000001 110.749 -177.167 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.497 0.184 . . . . 2.8500000000000001 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.9399999999999999 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 2.7799999999999998 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 1.75 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.4399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 2.6200000000000001 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.96 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 3.4199999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 3.6899999999999999 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 8.4399999999999995 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 6.5800000000000001 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.78 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 2.8700000000000001 111.552 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 3.5899999999999999 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 2.04 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.8300000000000001 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 4.4800000000000004 112.105 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 1.9299999999999999 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 1.71 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 2.0699999999999998 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 5.4500000000000002 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 2.0800000000000001 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 3.9300000000000002 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 1.6100000000000001 109.944 -169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 2.7000000000000002 108.538 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 4.5499999999999998 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 3.4300000000000002 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 2.2000000000000002 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.3500000000000001 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 2.6000000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 2.21 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 1.0700000000000001 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 1.03 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 3.9900000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 2.96 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 1.9299999999999999 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 3.7000000000000002 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 1.8600000000000001 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 5.0099999999999998 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 2.3199999999999998 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 4.1600000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.95999999999999996 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 1.8600000000000001 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.99 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 1.6100000000000001 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 2.4300000000000002 109.279 177.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 118.141 -0.933 . . . . 3.29 109.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.71 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 4.0099999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 2.5499999999999998 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 3.4900000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 1.76 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 4.7300000000000004 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.8700000000000001 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.9199999999999999 111.663 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.972 -0.751 . . . . 3.1200000000000001 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 4.2300000000000004 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 3.2000000000000002 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 2.0 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.71 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 3.1099999999999999 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 5.0300000000000002 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 3.02 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 2.77 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 7.8700000000000001 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 9.4100000000000001 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.46 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 2.79 110.558 170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 3.7599999999999998 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 1.72 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.7599999999999998 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 4.2800000000000002 110.791 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 1.8999999999999999 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 1.51 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 2.5899999999999999 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 5.5499999999999998 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 1.8 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.8100000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 1.6599999999999999 108.085 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 2.6800000000000002 109.179 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.8899999999999997 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 3.2000000000000002 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 2.27 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.88 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.6699999999999999 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 2.0499999999999998 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 2.5499999999999998 111.199 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 1.05 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 4.4199999999999999 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 3.3100000000000001 111.618 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 1.8700000000000001 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 4.0999999999999996 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 2.2400000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 4.3399999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 2.0499999999999998 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 4.0999999999999996 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.92000000000000004 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 1.48 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 2.3399999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 1.8999999999999999 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 4.0899999999999999 106.262 178.659 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.509 -0.182 . . . . 3.6699999999999999 110.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 3.1699999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.9100000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.8899999999999999 106.488 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 5.1600000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 1.97 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 3.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.8799999999999999 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 4.1200000000000001 110.106 176.551 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.746 -0.835 . . . . 3.73 108.746 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 3.7599999999999998 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 2.8300000000000001 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 2.1299999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.4199999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 3.4700000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 4.5999999999999996 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 3.2599999999999998 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 2.7400000000000002 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 8.1799999999999997 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 6.3700000000000001 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.1599999999999999 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 2.5499999999999998 109.907 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 3.5499999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 1.7 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.8100000000000001 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 3.0499999999999998 113.07 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 1.79 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 1.6200000000000001 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 2.29 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.9299999999999997 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 1.9099999999999999 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81999999999999995 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 6.5999999999999996 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 1.97 109.44 -168.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 2.6400000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 3.4100000000000001 110.135 -170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 2.0600000000000001 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 2.4100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 2.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.91000000000000003 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 5.0800000000000001 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 2.8900000000000001 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 1.73 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 3.3100000000000001 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 1.95 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.8999999999999999 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 2.5099999999999998 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.04 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 4.2699999999999996 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.90000000000000002 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 1.8200000000000001 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 2.4900000000000002 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 1.79 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 2.4300000000000002 109.644 -177.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 3.1800000000000002 116.588 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 2.4100000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 4.7999999999999998 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 2.9199999999999999 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 3.6600000000000001 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 2.0800000000000001 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 3.7799999999999998 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 3.6299999999999999 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.6600000000000001 109.903 -176.679 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 2.0899999999999999 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 3.8799999999999999 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 1.71 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 2.3500000000000001 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 2.8799999999999999 109.622 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.8399999999999999 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 3.7200000000000002 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 3.3999999999999999 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 7.5999999999999996 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 7.5499999999999998 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.2999999999999998 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 1.23 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 2.7200000000000002 109.791 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 3.7000000000000002 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 1.96 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 4.1699999999999999 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 2.75 111.767 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 2.2000000000000002 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 1.6699999999999999 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 2.6400000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 5.7999999999999998 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 1.6799999999999999 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.81000000000000005 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.6800000000000002 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 1.48 107.157 -168.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.6800000000000002 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 3.52 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.9100000000000001 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 3.5899999999999999 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.5499999999999998 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.8300000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 2.5299999999999998 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 3.1800000000000002 112.689 -157.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 3.71 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 2.1000000000000001 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.6699999999999999 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 4.8899999999999997 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 3.48 111.023 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 2.0 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 3.4900000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 2.1400000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 4.9299999999999997 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 2.2799999999999998 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.92000000000000004 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 3.5499999999999998 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.94999999999999996 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 1.78 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 2.5699999999999998 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 1.6699999999999999 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 4.1500000000000004 106.981 -170.41 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 3.2999999999999998 105.61 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 2.3300000000000001 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 5.9100000000000001 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HG ' ' CD1' ' A' ' 57' ' ' ILE . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.8700000000000001 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 5.1200000000000001 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 2.4300000000000002 105.961 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.7200000000000002 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 4.0700000000000003 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 3.77 109.652 -177.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.947 0.88 . . . . 2.79 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.2400000000000002 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 3.6200000000000001 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 2.1600000000000001 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.52 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 3.0 109.387 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.9900000000000002 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.6899999999999999 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 3.0 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 7.3600000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 10.779999999999999 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.3799999999999999 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 2.5499999999999998 109.899 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 3.7599999999999998 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.75 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 2.7200000000000002 111.076 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 1.6699999999999999 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 1.47 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 2.9500000000000002 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 5.5700000000000003 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 2.1000000000000001 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.8399999999999999 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 1.48 108.614 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 2.5800000000000001 108.777 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 6.0999999999999996 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 3.21 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 2.3999999999999999 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 1.74 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 2.0899999999999999 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 2.48 113.129 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.95999999999999996 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 5.5199999999999996 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 3.1699999999999999 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 1.77 110.994 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 3.4700000000000002 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 1.72 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 3.1899999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 2.6400000000000001 111.512 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 4.2300000000000004 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 1.6599999999999999 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 2.25 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 1.8400000000000001 108.932 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt . . . . . 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 2.3999999999999999 109.504 178.51 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 112.687 0.625 . . . . 3.4500000000000002 112.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 4.0599999999999996 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 4.5599999999999996 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 2.1499999999999999 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 4.4699999999999998 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 2.21 105.631 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 5.0199999999999996 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 4.1299999999999999 108.028 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 3.21 109.65 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.5 114.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 3.5899999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 3.79 110.124 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 2.2200000000000002 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.6100000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 2.8599999999999999 109.435 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 8.7599999999999998 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.9500000000000002 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 3.1299999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 6.6799999999999997 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.8699999999999992 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.8700000000000001 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 2.8500000000000001 110.243 174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 4.1100000000000003 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 3.2400000000000002 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 4.1699999999999999 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 2.7200000000000002 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 1.78 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 1.48 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 2.1400000000000001 110.952 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 4.8200000000000003 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 1.6499999999999999 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.75 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 4.4199999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 1.6499999999999999 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.29 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 2.7599999999999998 108.286 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 4.8499999999999996 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 3.3900000000000001 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.8399999999999999 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.98 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 2.2200000000000002 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 2.3399999999999999 112.173 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 3.0899999999999999 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 1.0900000000000001 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.8199999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 3.2799999999999998 111.453 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 1.99 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 3.7000000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 1.97 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 3.3700000000000001 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 2.0800000000000001 112.53 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.98999999999999999 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 3.9500000000000002 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.81999999999999995 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 1.6200000000000001 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 2.1000000000000001 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 1.8999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 2.5099999999999998 107.964 174.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.664 -0.495 . . . . 3.0499999999999998 109.664 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 3.1200000000000001 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 4.4800000000000004 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 2.1099999999999999 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 4.6600000000000001 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 1.78 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 3.5600000000000001 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 2.9399999999999999 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 2.9500000000000002 111.522 -177.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.711 0.634 . . . . 1.9199999999999999 112.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 3.2599999999999998 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 3.3100000000000001 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 2.1499999999999999 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.6699999999999999 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 2.6699999999999999 109.067 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 4.6200000000000001 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 4.2400000000000002 109.608 172.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 3.0299999999999998 111.455 -165.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 7.6900000000000004 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.9900000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 1.1799999999999999 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 2.8599999999999999 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 3.3300000000000001 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 1.75 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 5.1900000000000004 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 2.9399999999999999 111.745 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 1.7 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 1.52 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 2.21 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 5.6200000000000001 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 2.0499999999999998 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 4.2699999999999996 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 1.45 109.683 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.4500000000000002 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 2.9399999999999999 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 5.7000000000000002 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 3.1299999999999999 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 2.27 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.99 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 2.5499999999999998 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 2.21 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 1.01 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.8100000000000001 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 2.9399999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 1.6899999999999999 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 3.3999999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 1.71 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 5.3200000000000003 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 2.4100000000000001 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 3.6499999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.66000000000000003 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 1.7 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 2.1299999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 1.71 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 2.5299999999999998 108.221 175.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 3.5499999999999998 108.176 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 2.2000000000000002 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 3.7599999999999998 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 2.2799999999999998 107.28 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 3.9700000000000002 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 2.1299999999999999 106.091 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 5.7800000000000002 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 3.7599999999999998 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 3.2999999999999998 110.059 -177.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.311 0.485 . . . . 3.0699999999999998 112.311 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.7599999999999998 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 3.46 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 2.1299999999999999 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.5800000000000001 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 2.6099999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 6.7599999999999998 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 3.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 3.7200000000000002 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 6.7699999999999996 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 9.6600000000000001 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 1.1699999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 2.79 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 4.4800000000000004 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 2.27 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.8999999999999999 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 3.1299999999999999 112.929 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 1.76 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 1.6699999999999999 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 2.9500000000000002 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 5.46 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 2.4199999999999999 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.21 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 3.54 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 1.6599999999999999 108.158 -169.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 3.1200000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 2.54 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 4.9000000000000004 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 3.1899999999999999 110.793 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.9100000000000001 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 2.1699999999999999 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 2.5 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 2.4100000000000001 112.192 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 1.04 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 4.2999999999999998 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 3.23 111.538 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 2.0499999999999998 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 3.75 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 2.0299999999999998 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 3.0899999999999999 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 2.27 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 4.0300000000000002 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.92000000000000004 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 1.45 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 2.3599999999999999 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 1.77 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 2.6000000000000001 108.225 -173.318 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 4.0099999999999998 107.161 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 3.2000000000000002 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.9300000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 2.5299999999999998 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 4.5800000000000001 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 1.9199999999999999 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 4.71 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 2.9300000000000002 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 2.8999999999999999 109.144 -178.855 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.447 0.906 . . . . 2.5299999999999998 113.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 3.0800000000000001 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 3.8199999999999998 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 1.6200000000000001 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.3999999999999999 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 3.02 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.8899999999999997 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 4.2400000000000002 107.434 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 3.0600000000000001 114.583 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 9.5600000000000005 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 7.3099999999999996 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 1.2 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 3.3199999999999998 108.057 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 3.8100000000000001 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 1.6399999999999999 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 4.1100000000000003 112.132 -174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.9700000000000002 111.842 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 1.99 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 1.8100000000000001 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 2.3100000000000001 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 5.2999999999999998 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 1.5900000000000001 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.73999999999999999 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 3.6400000000000001 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 1.5 109.72 -163.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 2.75 109.435 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 4.8700000000000001 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 3.0899999999999999 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 3.9700000000000002 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.3200000000000001 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 2.1800000000000002 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 2.7200000000000002 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 2.9700000000000002 110.539 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 1.1200000000000001 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 5.4100000000000001 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 2.9500000000000002 111.056 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 1.95 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 3.4900000000000002 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 2.0499999999999998 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 4.0599999999999996 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 2.6600000000000001 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.88 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 4.2300000000000004 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.1699999999999999 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 1.8100000000000001 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 3.79 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 1.98 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 2.3100000000000001 111.221 -178.283 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 3.0099999999999998 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.6499999999999999 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 4.7999999999999998 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 2.04 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 4.0199999999999996 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 1.96 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 3.3199999999999998 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 3.4300000000000002 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 3.21 109.274 178.523 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.159 0.8 . . . . 2.0899999999999999 113.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.75 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 2.8399999999999999 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 2.3999999999999999 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.6699999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 2.9700000000000002 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 7.71 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.6000000000000001 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 3.6499999999999999 113.408 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 7.1399999999999997 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 6.0999999999999996 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 1.1299999999999999 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 2.6400000000000001 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 3.4700000000000002 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.6599999999999999 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 6.9800000000000004 111.664 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 2.7799999999999998 112.027 -163.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 2.0099999999999998 110.841 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 4.5599999999999996 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 2.0 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 4.0499999999999998 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 1.77 111.329 -168.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 3.1600000000000001 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 3.6099999999999999 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 4.0 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 3.2000000000000002 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 2.3999999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.6799999999999999 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 2.1400000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 2.2599999999999998 112.238 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.3300000000000001 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.46 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 4.2300000000000004 111.666 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 1.6499999999999999 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 3.54 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 1.96 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 3.1400000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 2.27 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 3.48 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 1.6399999999999999 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 3.3199999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 2.0299999999999998 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 2.8700000000000001 108.312 176.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 119.208 -0.425 . . . . 2.5499999999999998 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 2.3900000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 3.7599999999999998 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 2.6000000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 4.7699999999999996 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 1.9099999999999999 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 3.6699999999999999 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 3.9199999999999999 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 3.7999999999999998 110.468 -177.745 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.745 0.783 . . . . 3.0 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 3.8500000000000001 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 2.8799999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 1.8899999999999999 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 4.04 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 4.3899999999999997 110.363 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 7.5 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 3.27 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 2.6899999999999999 111.244 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 8.9000000000000004 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.9299999999999997 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.4199999999999999 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 1.1299999999999999 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 2.5899999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 3.3199999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 1.5900000000000001 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 4.1699999999999999 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 4.46 110.72 170.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 1.9199999999999999 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 1.49 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 3.2200000000000002 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 5.0199999999999996 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 2.27 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 1.0 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 5.6600000000000001 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 1.55 109.06 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.3199999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 3.5099999999999998 108.856 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 4.5199999999999996 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 3.98 110.312 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 2.4700000000000002 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 2.5600000000000001 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 2.46 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 2.3500000000000001 113.658 -166.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.9399999999999999 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.4299999999999999 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.3899999999999999 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 4.1799999999999997 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 3.4199999999999999 111.954 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 1.54 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 3.5899999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 1.8100000000000001 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 4.5599999999999996 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 3.3700000000000001 113.184 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.80000000000000004 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 4.25 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.73999999999999999 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 2.6499999999999999 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 1.9299999999999999 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 3.6099999999999999 108.623 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.7599999999999998 109.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 2.3900000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 7.2699999999999996 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 3.1000000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 3.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 1.8500000000000001 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 3.8300000000000001 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 3.6400000000000001 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 3.1800000000000002 109.588 178.286 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 113.894 1.072 . . . . 2.25 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 3.1899999999999999 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 3.2000000000000002 111.164 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6899999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 3.2000000000000002 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 6.0300000000000002 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 3.4100000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 3.8399999999999999 113.433 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 9.3200000000000003 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 10.210000000000001 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.8100000000000001 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 2.8799999999999999 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 3.6800000000000002 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 1.77 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 4.0999999999999996 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 2.5600000000000001 111.473 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 2.0899999999999999 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 1.55 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 3.1400000000000001 109.889 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 4.4500000000000002 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.8999999999999999 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 3.21 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 1.49 109.13 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 3.1099999999999999 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 3.7000000000000002 108.199 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.8899999999999997 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 3.8100000000000001 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 3.6200000000000001 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 2.8300000000000001 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 4.1900000000000004 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 4.6799999999999997 108.065 -172.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.53 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 3.23 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 3.5 111.015 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 2.6899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 3.5099999999999998 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 2.5 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 3.96 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 2.3999999999999999 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.85999999999999999 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 3.9199999999999999 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.79000000000000004 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 1.6299999999999999 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 2.21 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 1.9399999999999999 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 2.8799999999999999 108.305 -173.46 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 113.085 0.772 . . . . 4.0300000000000002 113.085 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 2.4500000000000002 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 4.04 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 2.0600000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 3.75 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 1.77 107.337 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 3.6800000000000002 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 3.0299999999999998 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 3.1299999999999999 110.322 -178.46 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.555 0.576 . . . . 2.4500000000000002 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 3.5499999999999998 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 3.1499999999999999 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 1.72 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.49 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 2.7999999999999998 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 7.3099999999999996 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.75 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 3.6899999999999999 111.882 -172.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 8.0 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.8399999999999999 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 1.1299999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 3.0099999999999998 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 3.8300000000000001 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 1.96 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 6.4699999999999998 110.142 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 2.8599999999999999 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 2.0699999999999998 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 1.7 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 3.5099999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 6.3300000000000001 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 2.3700000000000001 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.82999999999999996 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 4.2199999999999998 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 1.55 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 2.6000000000000001 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 5.5700000000000003 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 3.0600000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 2.2599999999999998 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 2.1600000000000001 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 2.1600000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 2.21 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.91000000000000003 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.9700000000000002 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 3.0099999999999998 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 2.1899999999999999 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 3.2999999999999998 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 1.8999999999999999 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 3.1600000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 2.2000000000000002 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 3.9300000000000002 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 1.8999999999999999 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 2.1200000000000001 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 1.8500000000000001 108.283 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 3.6200000000000001 108.299 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 3.3599999999999999 108.738 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.9900000000000002 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 4.0199999999999996 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.48 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 5.0700000000000003 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 2.0299999999999998 106.519 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 5.0899999999999999 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 3.6600000000000001 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 2.6600000000000001 109.5 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.764 0.283 . . . . 2.1800000000000002 111.764 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 3.1299999999999999 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 3.04 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 2.0299999999999998 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.52 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 2.5299999999999998 109.073 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 6.3300000000000001 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 4.0300000000000002 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 3.9700000000000002 110.457 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 6.4800000000000004 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 7.3799999999999999 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 1.1100000000000001 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 2.4500000000000002 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 4.0 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 1.5900000000000001 109.833 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 4.29 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 2.7000000000000002 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 1.96 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 1.7 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 2.79 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 6.5800000000000001 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 1.9299999999999999 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.79 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 1.5600000000000001 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 3.71 109.702 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 4.4900000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 3.2400000000000002 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 2.3100000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 1.79 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 2.2200000000000002 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 2.4100000000000001 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 3.0299999999999998 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.49 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.49 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 3.5800000000000001 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 3.3700000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 1.78 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 3.75 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 2.9399999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 3.5899999999999999 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 2.0099999999999998 111.443 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 7.8700000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 2.27 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 2.3700000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 1.95 106.446 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 2.6600000000000001 107.938 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 114.322 1.23 . . . . 3.4100000000000001 114.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 2.3900000000000001 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 5.4900000000000002 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HG ' ' CD1' ' A' ' 57' ' ' ILE . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 2.5699999999999998 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 4.6699999999999999 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 1.75 105.882 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 3.8599999999999999 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 2.7599999999999998 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 3.6299999999999999 109.265 176.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 112.39 0.515 . . . . 1.8600000000000001 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.96 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 2.73 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 1.73 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.75 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 4.6600000000000001 111.458 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 6.3499999999999996 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.7999999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 4.1799999999999997 112.231 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 9.9600000000000009 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 10.49 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.48 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 2.7000000000000002 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 3.5699999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.53 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 5.6600000000000001 111.717 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 2.7999999999999998 112.901 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 1.8400000000000001 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 1.4299999999999999 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 2.6699999999999999 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 5.3300000000000001 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 2.25 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 4.0899999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 1.6699999999999999 108.896 -168.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 3.29 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 2.6299999999999999 109.421 -173.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 4.6600000000000001 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 3.3100000000000001 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 2.3100000000000001 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 2.52 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 2.5699999999999998 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 2.25 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 1.0900000000000001 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 1.1100000000000001 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 5.2300000000000004 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 2.8999999999999999 112.203 176.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 1.73 111.759 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 3.73 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 1.8700000000000001 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 4.2800000000000002 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 2.0800000000000001 111.474 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.81999999999999995 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 3.5099999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.79000000000000004 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 1.46 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 2.25 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 2.0600000000000001 108.453 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 2.7200000000000002 109.983 179.39 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 112.225 0.454 . . . . 2.98 112.225 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 2.7400000000000002 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 3.6499999999999999 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 2.5099999999999998 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 3.6200000000000001 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 1.8500000000000001 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 3.27 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 3.1000000000000001 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 3.6200000000000001 109.148 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 120.995 0.426 . . . . 3.2200000000000002 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.8500000000000001 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 3.1699999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 2.1899999999999999 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.72 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 3.0800000000000001 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 4.6399999999999997 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 3.54 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 3.2000000000000002 110.316 -173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 9.3599999999999994 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 7.1299999999999999 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.49 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 2.79 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 3.2999999999999998 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 1.8899999999999999 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 6.6699999999999999 112.248 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 2.7999999999999998 112.346 -169.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 1.98 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 1.3700000000000001 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 2.4500000000000002 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 5.0 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.9099999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.03 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 6.7800000000000002 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 1.79 107.653 -174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.8700000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 3.6400000000000001 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.9400000000000004 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 3.3900000000000001 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 4.2699999999999996 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.8799999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 2.1400000000000001 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 2.1800000000000002 112.779 -165.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.5900000000000001 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 4.4100000000000001 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 4.3799999999999999 111.685 171.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 1.6899999999999999 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 3.3900000000000001 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 1.8600000000000001 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 3.3399999999999999 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 2.2400000000000002 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.73999999999999999 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 4.0 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 1.49 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 2.5899999999999999 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 1.8600000000000001 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 2.8399999999999999 108.807 177.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.575 -0.898 . . . . 3.6800000000000002 108.575 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 2.4199999999999999 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.417 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 3.5099999999999998 109.179 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 3.7999999999999998 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 3.1099999999999999 105.754 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 3.9100000000000001 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.9900000000000002 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 2.71 110.037 -176.464 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 110.309 -0.256 . . . . 2.8700000000000001 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 3.6099999999999999 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 3.02 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 2.0800000000000001 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.52 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 3.3300000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 5.6900000000000004 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.7799999999999998 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 3.1699999999999999 113.975 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 8.9100000000000001 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 7.0700000000000003 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 2.0600000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 3.0499999999999998 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 3.5099999999999998 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 1.8300000000000001 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 4.0 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 3.71 113.745 -168.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 2.0499999999999998 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 1.3500000000000001 108.697 162.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 2.9399999999999999 110.594 174.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 4.9000000000000004 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 1.8300000000000001 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.76000000000000001 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.7400000000000002 107.42 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 1.3300000000000001 109.149 -170.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.21 109.117 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 2.4399999999999999 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 4.5499999999999998 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 3.71 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 3.1400000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 3.04 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 4.5099999999999998 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 4.4800000000000004 109.879 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 2.1000000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.3700000000000001 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 3.7200000000000002 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 3.75 111.567 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 2.0499999999999998 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 3.5800000000000001 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 1.9099999999999999 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 3.54 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.99 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.3300000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 4.0 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.66000000000000003 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 1.4099999999999999 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 2.1899999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 2.27 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 3.2799999999999998 109.21 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.8100000000000001 107.78 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 2.48 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 4.71 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 2.6099999999999999 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 4.6399999999999997 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 2.6699999999999999 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 3.5 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 2.8300000000000001 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 3.6000000000000001 109.277 177.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 119.862 -0.113 . . . . 2.0899999999999999 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.6499999999999999 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 2.8900000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 1.6799999999999999 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.4399999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 3.0699999999999998 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 6.6900000000000004 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.7799999999999998 107.685 172.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 3.1299999999999999 113.635 -170.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 9.6799999999999997 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 8.1699999999999999 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 3.0299999999999998 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 3.7400000000000002 109.638 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 3.6000000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 2.04 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 3.8399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 3.2200000000000002 111.453 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 2.3500000000000001 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 1.8 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 2.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 5.4400000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 2.04 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.80000000000000004 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.9100000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 1.5800000000000001 109.493 -164.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 2.6400000000000001 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 4.6600000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 3.6899999999999999 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 2.29 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.9199999999999999 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 2.4700000000000002 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 2.3700000000000001 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.3399999999999999 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.3 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.1799999999999999 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 4.0099999999999998 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 2.8599999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 2.25 111.159 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 3.9900000000000002 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 1.78 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 3.2599999999999998 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 2.0800000000000001 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.85999999999999999 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 3.9900000000000002 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.63 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 1.3999999999999999 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 3.4100000000000001 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 1.8799999999999999 109.563 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 2.8199999999999998 107.48 -176.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 118.046 -0.978 . . . . 5.1399999999999997 108.901 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 52.77 83.02 0.07 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.825 0.85 . . . . 3.1699999999999999 110.578 -166.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1899999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.8799999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 3.3100000000000001 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 4.4800000000000004 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 2.4199999999999999 105.967 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 3.3999999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 3.77 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p -74.46 73.1 1.9 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 4.0599999999999996 110.155 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.52 25.09 0.05 OUTLIER Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.73 1.634 . . . . 2.3500000000000001 112.293 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.67 -42.5 3.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 7.1299999999999999 112.603 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.08 -19.35 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.662 1.585 . . . . 6.2300000000000004 113.365 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.5 47.02 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.297 0.953 . . . . 3.3399999999999999 111.644 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 18.69 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.467 2.707 . . . . 4.4400000000000004 114.512 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -47.95 -29.43 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.588 1.955 . . . . 2.7999999999999998 113.852 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 3.1600000000000001 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 3.0299999999999998 109.768 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 1.76 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 2.4900000000000002 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 3.4199999999999999 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 4.5999999999999996 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 3.54 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.9399999999999999 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 7.4699999999999998 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 7.4400000000000004 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.26 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 2.3900000000000001 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 3.6299999999999999 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 1.5600000000000001 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 4.0800000000000001 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 4.7300000000000004 112.28 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 2.1299999999999999 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 1.46 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 3.1099999999999999 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 5.0199999999999996 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 4.96 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 1.6200000000000001 106.019 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 3.2999999999999998 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 3.73 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 5.5599999999999996 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 4.3399999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 1.04 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.8600000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 2.8799999999999999 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 2.29 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 4.0999999999999996 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.55 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.28 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 4.3300000000000001 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 2.8799999999999999 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 1.9299999999999999 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 3.7000000000000002 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 2.23 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 5.6600000000000001 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 3.8799999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.53 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 4.2199999999999998 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 1.0900000000000001 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 1.7 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 2.3799999999999999 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 2.4500000000000002 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.64 90.62 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 4.5 106.669 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -67.86 130.7 43.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.554 -1.276 . . . . 6.5800000000000001 107.554 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -84.92 -62.88 1.44 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.802 -0.444 . . . . 6.4199999999999999 109.802 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 tt -176.14 165.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 126.41 1.884 . . . . 6.8099999999999996 106.143 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.62 -2.41 17.04 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.877 1.066 . . . . 6.29 113.877 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.31 115.6 0.33 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.824 -0.91 . . . . 5.46 110.824 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 104.841 -2.281 . . . . 12.800000000000001 104.841 164.037 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.158 -0.682 . . . . 4.0700000000000003 109.158 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -97.54 175.27 6.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.727 1.611 . . . . 2.8799999999999999 109.543 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.5699999999999998 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 5.4800000000000004 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.8799999999999999 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 4.1699999999999999 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 2.7400000000000002 107.582 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 3.1899999999999999 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 4.4100000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -104.44 87.49 2.73 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 3.25 108.784 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.47 80.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 106.319 -2.712 . . . . 2.5699999999999998 106.319 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.7 mtm -49.85 143.48 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.161 -0.681 . . . . 6.8700000000000001 109.161 166.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -19.14 -64.5 0.02 OUTLIER 'General case' 0 C--N 1.339 0.112 0 C-N-CA 127.366 2.266 . . . . 10.81 114.471 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.24 -174.23 0.87 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.235 -1.765 . . . . 3.8799999999999999 106.235 165.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.75 -70.4 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.41 0.624 . . . . 4.1799999999999997 110.487 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -86.62 91.3 8.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 5.0700000000000003 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 3.7200000000000002 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 2.2999999999999998 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.6899999999999999 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 3.5800000000000001 109.762 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.5999999999999996 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 3.7799999999999998 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 2.9500000000000002 110.789 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 8.0 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 7.3499999999999996 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.4199999999999999 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.3200000000000001 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 2.7799999999999998 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 3.5099999999999998 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 2.1099999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.9300000000000002 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 2.77 113.248 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 1.77 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 1.8 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 3.02 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 6.0700000000000003 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.8300000000000001 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 1.04 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.8599999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 2.02 109.924 -166.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 3.3700000000000001 110.046 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 6.4900000000000002 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 3.8399999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 4.1799999999999997 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.99 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 2.1000000000000001 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 2.2799999999999998 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.1899999999999999 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 4.29 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 3.7999999999999998 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 1.78 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 3.98 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 2.04 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 4.5700000000000003 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 2.8900000000000001 112.136 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.95999999999999996 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 4.4100000000000001 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1799999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 1.9199999999999999 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 3.3100000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 1.99 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.26 115.59 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 4.5199999999999996 106.998 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -71.96 158.24 36.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.731 -1.122 . . . . 6.5899999999999999 108.651 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -132.18 159.39 39.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.521 -1.659 . . . . 5.0 106.521 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -51.5 146.11 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 123.588 0.555 . . . . 5.3799999999999999 110.385 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.0 144.69 44.39 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.843 -0.535 . . . . 4.3099999999999996 109.62 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.82 -59.93 0.35 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-O 119.159 -0.801 . . . . 5.8799999999999999 111.135 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.343 -1.313 . . . . 15.74 110.645 -170.531 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 107.674 -1.232 . . . . 3.9100000000000001 107.674 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -85.44 144.59 27.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.752 0.657 . . . . 3.1800000000000002 111.647 -171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 2.3399999999999999 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 5.4199999999999999 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 2.23 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 3.5600000000000001 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 2.9300000000000002 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 3.98 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 3.1400000000000001 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p -86.8 56.79 4.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 2.6400000000000001 110.749 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.28 56.87 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.452 -1.059 . . . . 1.8500000000000001 110.452 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -54.12 15.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.107 0.563 . . . . 6.8099999999999996 109.634 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -70.7 56.91 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.846 2.058 . . . . 6.04 111.413 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 m -113.97 66.47 0.67 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.535 -1.654 . . . . 3.6299999999999999 106.535 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 57.72 -73.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.012 2.125 . . . . 3.1699999999999999 112.76 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p -152.63 25.45 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.471 1.109 . . . . 2.8500000000000001 111.497 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.9399999999999999 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 2.7799999999999998 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 1.75 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.4399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 2.6200000000000001 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.96 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 3.4199999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 3.6899999999999999 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 8.4399999999999995 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 6.5800000000000001 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.78 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 2.8700000000000001 111.552 173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 3.5899999999999999 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 2.04 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.8300000000000001 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 4.4800000000000004 112.105 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 1.9299999999999999 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 1.71 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 2.0699999999999998 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 5.4500000000000002 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 2.0800000000000001 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 3.9300000000000002 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 1.6100000000000001 109.944 -169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 2.7000000000000002 108.538 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 4.5499999999999998 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 3.4300000000000002 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 2.2000000000000002 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.3500000000000001 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 2.6000000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 2.21 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 1.0700000000000001 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 1.03 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 3.9900000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 2.96 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 1.9299999999999999 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 3.7000000000000002 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 1.8600000000000001 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 5.0099999999999998 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 2.3199999999999998 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 4.1600000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.95999999999999996 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 1.8600000000000001 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.99 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 1.6100000000000001 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.74 -173.17 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 2.4300000000000002 109.279 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.51 176.64 11.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.436 1.494 . . . . 5.0899999999999999 107.305 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.42 -47.62 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.796 0.838 . . . . 6.1100000000000003 109.815 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.35 174.63 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.632 1.173 . . . . 7.0099999999999998 108.221 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 169.52 15.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.08 1.352 . . . . 4.7999999999999998 109.428 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.5 53.93 4.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.655 -0.978 . . . . 5.7400000000000002 110.655 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 . . . . . 0 C--O 1.254 1.307 0 N-CA-C 105.527 -2.027 . . . . 10.6 105.527 179.445 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.874 -1.06 . . . . 4.1399999999999997 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p -166.09 127.49 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.418 1.463 . . . . 3.29 109.74 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.71 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 4.0099999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 2.5499999999999998 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 3.4900000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 1.76 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 4.7300000000000004 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.8700000000000001 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -93.31 55.36 2.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.9199999999999999 111.663 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.29 40.53 0.1 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 122.129 -0.357 . . . . 1.75 112.212 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -27.58 63.84 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 122.399 -0.471 . . . . 8.2200000000000006 111.931 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.2 p -63.11 -10.99 16.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.066 0.546 . . . . 6.6100000000000003 111.454 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.2 t -62.15 126.79 28.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.983 0.81 . . . . 4.2400000000000002 111.693 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.61 -32.22 7.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.734 1.214 . . . . 2.9900000000000002 112.547 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m -149.19 111.21 4.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.613 0.765 . . . . 3.1200000000000001 108.972 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 4.2300000000000004 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 3.2000000000000002 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 2.0 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.71 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 3.1099999999999999 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 5.0300000000000002 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 3.02 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 2.77 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 7.8700000000000001 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 9.4100000000000001 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.46 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 2.79 110.558 170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 3.7599999999999998 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 1.72 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.7599999999999998 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 4.2800000000000002 110.791 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 1.8999999999999999 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 1.51 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 2.5899999999999999 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 5.5499999999999998 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 1.8 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.8100000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 1.6599999999999999 108.085 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 2.6800000000000002 109.179 -176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.8899999999999997 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 3.2000000000000002 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 2.27 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.88 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.6699999999999999 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 2.0499999999999998 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 2.5499999999999998 111.199 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 1.05 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 4.4199999999999999 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 3.3100000000000001 111.618 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 1.8700000000000001 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 4.0999999999999996 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 2.2400000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 4.3399999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 2.0499999999999998 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 4.0999999999999996 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.92000000000000004 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 1.48 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 2.3399999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 1.8999999999999999 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.35 130.23 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 4.0899999999999999 106.262 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -51.43 -66.18 0.43 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.93 1.292 . . . . 5.6600000000000001 111.106 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 57.56 85.41 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.218 1.407 . . . . 6.1699999999999999 112.266 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 tt 57.08 177.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.897 1.679 . . . . 5.5199999999999996 111.715 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.11 5.58 16.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.026 0.75 . . . . 4.7699999999999996 113.026 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.55 -47.64 0.84 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.391 -0.684 . . . . 5.8300000000000001 111.391 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 104.635 -2.357 . . . . 12.81 104.635 173.053 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.013 -0.518 . . . . 3.9399999999999999 112.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t 77.74 147.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.607 1.563 . . . . 3.6699999999999999 110.509 -166.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 3.1699999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.9100000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.8899999999999999 106.488 169.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 5.1600000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 1.97 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 3.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.8799999999999999 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -90.75 102.09 14.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 4.1200000000000001 110.106 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 37.91 1.69 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.672 -1.371 . . . . 1.7 109.672 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.0 ptp -75.69 -35.6 60.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 110.223 -0.288 . . . . 6.3799999999999999 110.223 173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -74.63 60.39 0.9 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.366 1.066 . . . . 6.0800000000000001 110.087 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 m -137.57 67.34 1.43 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.681 0.792 . . . . 3.23 109.254 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 71.26 -46.08 0.63 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.241 1.816 . . . . 3.3900000000000001 113.616 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 -89.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.843 0.857 . . . . 3.73 108.746 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 3.7599999999999998 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 2.8300000000000001 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 2.1299999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.4199999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 3.4700000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 4.5999999999999996 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 3.2599999999999998 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 2.7400000000000002 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 8.1799999999999997 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 6.3700000000000001 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.1599999999999999 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 2.5499999999999998 109.907 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 3.5499999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 1.7 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.8100000000000001 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 3.0499999999999998 113.07 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 1.79 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 1.6200000000000001 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 2.29 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.9299999999999997 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 1.9099999999999999 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81999999999999995 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 6.5999999999999996 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 1.97 109.44 -168.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 2.6400000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 3.4100000000000001 110.135 -170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 2.0600000000000001 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 2.4100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 2.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.91000000000000003 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 5.0800000000000001 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 2.8900000000000001 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 1.73 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 3.3100000000000001 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 1.95 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.8999999999999999 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 2.5099999999999998 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.04 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 4.2699999999999996 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.90000000000000002 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 1.8200000000000001 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 2.4900000000000002 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 1.79 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.51 140.18 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 2.4300000000000002 109.644 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.43 156.83 30.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.894 -0.78 . . . . 5.6799999999999997 108.894 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -159.84 111.17 1.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.179 -1.786 . . . . 5.0599999999999996 106.179 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.264 2.4 tt 52.22 -167.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.943 1.297 . . . . 5.3200000000000003 110.953 -176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -141.7 158.89 43.25 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.149 -1.426 . . . . 4.21 107.149 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.63 35.63 91.37 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 123.993 0.806 . . . . 6.0999999999999996 111.508 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? . . . . . 0 C--O 1.254 1.314 0 N-CA-C 103.427 -2.805 . . . . 11.74 103.427 167.336 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 106.867 -1.531 . . . . 5.5999999999999996 106.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 14.97 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 3.1800000000000002 116.588 136.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 2.4100000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 4.7999999999999998 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 2.9199999999999999 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 3.6600000000000001 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 2.0800000000000001 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 3.7799999999999998 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 3.6299999999999999 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -115.12 101.93 9.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.6600000000000001 109.903 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.2 17.13 2.5 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.136 1.35 . . . . 2.1499999999999999 112.191 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.5 ptp -64.32 -24.54 67.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.971 -0.723 . . . . 6.4900000000000002 112.087 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -61.81 -12.23 16.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.265 1.026 . . . . 6.3700000000000001 112.455 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -57.07 145.98 29.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.567 0.621 . . . . 2.6600000000000001 111.771 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -16.28 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 129.615 3.166 . . . . 3.3599999999999999 115.553 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -149.64 47.49 0.95 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 2.0899999999999999 109.219 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 3.8799999999999999 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 1.71 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 2.3500000000000001 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 2.8799999999999999 109.622 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.8399999999999999 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 3.7200000000000002 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 3.3999999999999999 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 7.5999999999999996 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 7.5499999999999998 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.2999999999999998 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 1.23 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 2.7200000000000002 109.791 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 3.7000000000000002 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 1.96 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 4.1699999999999999 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 2.75 111.767 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 2.2000000000000002 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 1.6699999999999999 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 2.6400000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 5.7999999999999998 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 1.6799999999999999 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.81000000000000005 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.6800000000000002 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 1.48 107.157 -168.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.6800000000000002 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 3.52 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.9100000000000001 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 3.5899999999999999 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.5499999999999998 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.8300000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 2.5299999999999998 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 3.1800000000000002 112.689 -157.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 3.71 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 2.1000000000000001 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.6699999999999999 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 4.8899999999999997 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 3.48 111.023 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 2.0 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 3.4900000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 2.1400000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 4.9299999999999997 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 2.2799999999999998 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.92000000000000004 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 3.5499999999999998 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.94999999999999996 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 1.78 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 2.5699999999999998 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 1.6699999999999999 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 131.32 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 4.1500000000000004 106.981 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -58.16 167.82 1.19 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.272 1.829 . . . . 6.0899999999999999 111.668 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.32 154.48 7.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.924 -0.769 . . . . 5.8499999999999996 108.924 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -74.73 178.94 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 124.121 0.888 . . . . 5.1200000000000001 110.902 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.73 150.73 21.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.337 1.455 . . . . 5.5800000000000001 110.606 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.81 64.45 3.03 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.829 -0.623 . . . . 7.0 111.56 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.861 2.064 . . . . 14.300000000000001 111.588 -170.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 106.839 -1.541 . . . . 4.0599999999999996 106.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p 176.35 133.91 0.05 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 3.2999999999999998 105.61 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 2.3300000000000001 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 5.9100000000000001 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HG ' ' CD1' ' A' ' 57' ' ' ILE . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.8700000000000001 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 5.1200000000000001 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 2.4300000000000002 105.961 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.7200000000000002 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 4.0700000000000003 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p -138.64 96.58 3.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 3.77 109.652 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.35 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.809 -2.516 . . . . 2.4700000000000002 106.809 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 mmt -44.36 -53.89 6.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.589 1.156 . . . . 7.1900000000000004 109.998 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.52 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.343 1.857 . . . . 9.8800000000000008 107.301 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -168.2 -158.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.16 -1.422 . . . . 5.7699999999999996 107.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.91 -78.88 0.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.755 1.161 . . . . 5.2300000000000004 110.368 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 78.09 4.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.895 -1.128 . . . . 2.79 110.693 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.2400000000000002 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 3.6200000000000001 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 2.1600000000000001 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.52 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 3.0 109.387 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.9900000000000002 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.6899999999999999 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 3.0 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 7.3600000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 10.779999999999999 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.3799999999999999 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 2.5499999999999998 109.899 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 3.7599999999999998 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 1.54 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.75 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 2.7200000000000002 111.076 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 1.6699999999999999 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 1.47 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 2.9500000000000002 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 5.5700000000000003 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 2.1000000000000001 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.8399999999999999 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 1.48 108.614 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 2.5800000000000001 108.777 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 6.0999999999999996 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 3.21 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 2.3999999999999999 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 1.74 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 2.0899999999999999 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 2.48 113.129 -169.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.95999999999999996 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 5.5199999999999996 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' CD1' ' HG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 3.1699999999999999 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 1.77 110.994 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 3.4700000000000002 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 1.72 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 3.1899999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 2.6400000000000001 111.512 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 4.2300000000000004 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 1.6599999999999999 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 2.25 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 1.8400000000000001 108.932 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt -134.53 160.66 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 2.3999999999999999 109.504 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.9 176.77 5.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.045 2.138 . . . . 5.4199999999999999 107.906 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -155.39 -50.99 0.09 Allowed 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 122.938 0.495 . . . . 5.2199999999999998 109.84 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.81 146.28 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.339 -0.986 . . . . 5.7199999999999998 108.339 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.14 3.29 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.54 1.536 . . . . 5.6699999999999999 111.737 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.94 134.84 7.22 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.141 -2.384 . . . . 7.2400000000000002 107.141 -160.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 105.29 -2.115 . . . . 13.390000000000001 105.29 168.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.843 -0.799 . . . . 6.7999999999999998 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -42.75 129.64 4.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.537 1.535 . . . . 3.4500000000000002 112.687 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 4.0599999999999996 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 4.5599999999999996 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 2.1499999999999999 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 4.4699999999999998 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 2.21 105.631 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 5.0199999999999996 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 4.1299999999999999 108.028 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p -109.42 64.46 0.61 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 3.21 109.65 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.34 43.69 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.701 0.667 . . . . 2.0299999999999998 111.932 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.3 mtm 44.99 -106.41 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.257 1.023 . . . . 8.1300000000000008 110.447 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 t -158.18 30.95 0.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.255 -1.387 . . . . 8.5399999999999991 107.255 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 68.81 -79.8 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.425 -0.797 . . . . 3.23 111.704 -167.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.72 129.6 0.08 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.055 1.342 . . . . 3.5600000000000001 108.876 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m 54.72 16.27 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.5 114.114 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 3.5899999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 3.79 110.124 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 2.2200000000000002 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.6100000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 2.8599999999999999 109.435 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 8.7599999999999998 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.9500000000000002 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 3.1299999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 6.6799999999999997 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.8699999999999992 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.8700000000000001 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 2.8500000000000001 110.243 174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 4.1100000000000003 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 3.2400000000000002 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 4.1699999999999999 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 2.7200000000000002 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 1.78 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 1.48 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 2.1400000000000001 110.952 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 4.8200000000000003 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 1.6499999999999999 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.75 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 4.4199999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 1.6499999999999999 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.29 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 2.7599999999999998 108.286 -177.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 4.8499999999999996 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 3.3900000000000001 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.8399999999999999 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.98 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 2.2200000000000002 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 2.3399999999999999 112.173 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 3.0899999999999999 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 1.0900000000000001 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.8199999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 3.2799999999999998 111.453 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 1.99 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 3.7000000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 1.97 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 3.3700000000000001 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 2.0800000000000001 112.53 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.98999999999999999 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 3.9500000000000002 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.81999999999999995 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 1.6200000000000001 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 2.1000000000000001 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 1.8999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt -145.2 173.19 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 2.5099999999999998 107.964 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -159.09 176.68 11.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.666 -1.605 . . . . 5.5999999999999996 106.666 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.66 111.87 3.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.826 -1.546 . . . . 6.3799999999999999 106.826 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.3 pt 51.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.247 1.419 . . . . 5.4900000000000002 112.063 -172.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -141.84 158.56 43.64 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.967 1.707 . . . . 4.7599999999999998 106.604 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.24 -61.32 0.14 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.205 -0.758 . . . . 5.79 111.205 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 . . . . . 0 C--O 1.256 1.439 0 CA-C-O 115.951 -1.976 . . . . 16.609999999999999 106.356 -179.312 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 104.304 -2.48 . . . . 5.2999999999999998 104.304 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.51 148.05 10.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.939 -0.704 . . . . 3.0499999999999998 109.664 -144.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 3.1200000000000001 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 4.4800000000000004 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 2.1099999999999999 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 4.6600000000000001 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 1.78 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 3.5600000000000001 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 2.9399999999999999 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -85.86 55.82 3.7 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 2.9500000000000002 111.522 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.39 57.99 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 N-CA-C 109.908 -1.277 . . . . 1.71 109.908 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -41.37 73.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.267 0.227 . . . . 8.5 110.615 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.297 1.039 . . . . 6.9500000000000002 109.888 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.53 142.09 51.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.904 1.282 . . . . 3.5600000000000001 109.328 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 90.63 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.351 0.66 . . . . 3.5699999999999998 110.601 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m 64.1 29.72 14.03 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.618 1.167 . . . . 1.9199999999999999 112.711 170.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 3.2599999999999998 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 3.3100000000000001 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 2.1499999999999999 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.6699999999999999 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 2.6699999999999999 109.067 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 4.6200000000000001 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 4.2400000000000002 109.608 172.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 3.0299999999999998 111.455 -165.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 7.6900000000000004 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.9900000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 1.1799999999999999 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 2.8599999999999999 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 3.3300000000000001 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 1.75 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 5.1900000000000004 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 2.9399999999999999 111.745 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 1.7 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 1.52 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 2.21 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 5.6200000000000001 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 2.0499999999999998 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 4.2699999999999996 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 1.45 109.683 -168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.4500000000000002 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 2.9399999999999999 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 5.7000000000000002 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 3.1299999999999999 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 2.27 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.99 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 2.5499999999999998 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 2.21 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 1.01 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.8100000000000001 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 2.9399999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 1.6899999999999999 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 3.3999999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 1.71 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 5.3200000000000003 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 2.4100000000000001 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 3.6499999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.66000000000000003 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 1.7 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 2.1299999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 1.71 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt -135.94 -177.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 2.5299999999999998 108.221 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -169.11 -172.92 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.597 -2.001 . . . . 5.3700000000000001 105.597 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 -58.98 0.16 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.71 0.687 . . . . 6.2699999999999996 109.755 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.3 pt -145.39 146.59 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.05 -1.092 . . . . 5.1699999999999999 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -75.74 147.18 39.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.742 1.217 . . . . 4.5599999999999996 109.37 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.37 55.35 4.38 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.398 -0.681 . . . . 6.0 111.398 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.978 -1.01 . . . . 10.43 108.67 -158.769 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.473 -0.936 . . . . 4.5300000000000002 108.473 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t -77.47 151.02 34.86 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 3.5499999999999998 108.176 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 2.2000000000000002 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 3.7599999999999998 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 2.2799999999999998 107.28 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 3.9700000000000002 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 2.1299999999999999 106.091 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 5.7800000000000002 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 3.7599999999999998 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p -139.11 81.38 1.84 Allowed 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 3.2999999999999998 110.059 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.76 72.85 1.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.334 -2.307 . . . . 2.7000000000000002 107.334 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -48.86 16.01 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.298 1.039 . . . . 8.6099999999999994 110.675 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 177.69 -54.2 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.747 1.619 . . . . 9.5800000000000001 107.253 168.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -167.73 177.49 5.77 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.093 -1.447 . . . . 5.8899999999999997 107.093 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 32.17 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.198 1.799 . . . . 5.6299999999999999 115.002 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p -163.68 11.48 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.521 1.129 . . . . 3.0699999999999998 112.311 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.7599999999999998 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 3.46 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 2.1299999999999999 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.5800000000000001 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 2.6099999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 6.7599999999999998 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 3.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 3.7200000000000002 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 6.7699999999999996 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 9.6600000000000001 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 1.1699999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 2.79 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 4.4800000000000004 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 2.27 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.8999999999999999 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 3.1299999999999999 112.929 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 1.76 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 1.6699999999999999 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 2.9500000000000002 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 5.46 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 2.4199999999999999 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.21 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 3.54 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 1.6599999999999999 108.158 -169.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 3.1200000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 2.54 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 4.9000000000000004 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 3.1899999999999999 110.793 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.9100000000000001 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 2.1699999999999999 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 2.5 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 2.4100000000000001 112.192 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 1.04 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 4.2999999999999998 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 3.23 111.538 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 2.0499999999999998 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 3.75 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 2.0299999999999998 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 3.0899999999999999 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 2.27 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 4.0300000000000002 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.92000000000000004 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 1.45 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 2.3599999999999999 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 1.77 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp -144.79 164.28 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 2.6000000000000001 108.225 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.86 139.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.005 1.322 . . . . 8.5099999999999998 111.728 -176.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.61 45.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.307 0.643 . . . . 8.6099999999999994 109.396 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.19 146.31 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.776 0.83 . . . . 4.96 110.299 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -69.66 166.43 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 4.7800000000000002 109.501 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -71.69 0.74 Allowed Glycine 0 CA--C 1.531 1.038 0 N-CA-C 112.073 -0.411 . . . . 6.7999999999999998 112.073 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.743 1.617 . . . . 11.300000000000001 112.625 -171.649 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 107.119 -1.437 . . . . 4.1699999999999999 107.119 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -143.03 148.83 37.39 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 4.0099999999999998 107.161 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 3.2000000000000002 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.9300000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 2.5299999999999998 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 4.5800000000000001 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 1.9199999999999999 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 4.71 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 2.9300000000000002 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p -115.49 78.39 1.17 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 2.8999999999999999 109.144 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.48 28.09 0.85 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.511 1.053 . . . . 1.55 111.567 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -32.03 73.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.248 0.619 . . . . 5.8300000000000001 111.897 172.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -76.33 60.07 1.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.28 1.032 . . . . 5.9000000000000004 110.257 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -105.36 -85.92 0.48 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.366 0.666 . . . . 3.1000000000000001 109.858 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.47 92.24 0.88 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.811 -1.181 . . . . 3.6600000000000001 107.811 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p 43.18 35.75 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.769 1.628 . . . . 2.5299999999999998 113.447 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 3.0800000000000001 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 3.8199999999999998 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 1.6200000000000001 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.3999999999999999 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 3.02 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.8899999999999997 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 4.2400000000000002 107.434 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 3.0600000000000001 114.583 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 9.5600000000000005 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 7.3099999999999996 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 1.2 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 3.3199999999999998 108.057 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 3.8100000000000001 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 1.6399999999999999 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 4.1100000000000003 112.132 -174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.9700000000000002 111.842 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 1.99 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 1.8100000000000001 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 2.3100000000000001 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 5.2999999999999998 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 1.5900000000000001 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.73999999999999999 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 3.6400000000000001 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 1.5 109.72 -163.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 2.75 109.435 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 4.8700000000000001 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 3.0899999999999999 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 3.9700000000000002 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.3200000000000001 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 2.1800000000000002 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 2.7200000000000002 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 2.9700000000000002 110.539 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 1.1200000000000001 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 5.4100000000000001 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 2.9500000000000002 111.056 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 1.95 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 3.4900000000000002 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 2.0499999999999998 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 4.0599999999999996 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 2.6600000000000001 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.88 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 4.2300000000000004 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.1699999999999999 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 1.8100000000000001 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 3.79 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 1.98 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt -136.97 172.39 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 2.3100000000000001 111.221 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 67.48 -67.17 0.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.209 2.203 . . . . 8.5299999999999994 112.011 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 58.02 23.71 10.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 8.5500000000000007 112.731 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 pt -64.88 133.32 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.783 -0.573 . . . . 6.4800000000000004 112.405 -166.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -90.05 4.24 50.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.922 1.289 . . . . 5.2199999999999998 113.484 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.14 129.59 2.34 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.982 -2.047 . . . . 5.9800000000000004 107.982 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.377 0 N-CA-C 104.888 -2.264 . . . . 13.050000000000001 104.888 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.028 -1.101 . . . . 4.0 108.028 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -170.04 151.14 3.93 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 3.0099999999999998 107.552 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.6499999999999999 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 4.7999999999999998 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 2.04 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 4.0199999999999996 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 1.96 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 3.3199999999999998 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 3.4300000000000002 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -130.98 123.52 28.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 3.21 109.274 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.89 33.7 3.99 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.929 1.252 . . . . 1.5900000000000001 110.017 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -44.66 93.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 117.009 0.405 . . . . 6.6799999999999997 110.517 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m -70.14 59.56 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.347 1.859 . . . . 6.3399999999999999 110.494 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.38 170.4 8.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.333 1.453 . . . . 3.4500000000000002 109.366 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.75 77.22 0.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.743 0.817 . . . . 4.0999999999999996 110.742 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m 70.1 46.71 0.61 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.568 1.547 . . . . 2.0899999999999999 113.159 169.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.75 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 2.8399999999999999 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 2.3999999999999999 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.6699999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 2.9700000000000002 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 7.71 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.6000000000000001 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 3.6499999999999999 113.408 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 7.1399999999999997 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 6.0999999999999996 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 1.1299999999999999 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 2.6400000000000001 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 3.4700000000000002 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.6599999999999999 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 6.9800000000000004 111.664 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 2.7799999999999998 112.027 -163.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 2.0099999999999998 110.841 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 1.3600000000000001 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 2.3199999999999998 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 4.5599999999999996 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 2.0 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 4.0499999999999998 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 1.77 111.329 -168.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 3.1600000000000001 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 3.6099999999999999 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 4.0 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 3.2000000000000002 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 2.3999999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.6799999999999999 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 2.1400000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 2.2599999999999998 112.238 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.3300000000000001 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.46 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 4.2300000000000004 111.666 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 1.6499999999999999 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 3.54 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 1.96 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 3.1400000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 2.27 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 3.48 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 1.6399999999999999 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 3.3199999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 2.0299999999999998 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt -141.6 171.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 2.8700000000000001 108.312 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -142.75 106.43 4.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.014 -1.846 . . . . 6.3399999999999999 106.014 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -74.73 -54.25 7.72 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 109.732 -0.47 . . . . 5.54 109.732 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 pt -149.27 159.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.274 1.83 . . . . 5.5899999999999999 106.237 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.85 167.21 9.92 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.539 1.136 . . . . 4.3200000000000003 109.815 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.44 -67.34 2.54 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.642 0.639 . . . . 6.6399999999999997 111.75 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.361 -1.304 . . . . 11.73 108.912 175.701 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 104.521 -2.4 . . . . 4.5 104.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -48.14 154.41 0.58 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 2.5499999999999998 111.124 142.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 2.3900000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 3.7599999999999998 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 2.6000000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 4.7699999999999996 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 1.9099999999999999 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 3.6699999999999999 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 3.9199999999999999 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -139.78 55.01 1.66 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 3.7999999999999998 110.468 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.8 36.09 0.07 OUTLIER Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.261 -0.881 . . . . 1.6799999999999999 111.389 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -29.13 70.17 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.56 -0.965 . . . . 7.79 111.594 -173.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -51.34 -15.22 0.36 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.037 1.335 . . . . 7.21 112.287 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -40.69 -36.67 0.63 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.174 0.99 . . . . 3.77 113.272 165.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 66.08 87.16 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.44 0.696 . . . . 4.4500000000000002 112.101 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p 79.83 115.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.953 2.101 . . . . 3.0 109.333 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 3.8500000000000001 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 2.8799999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 1.8899999999999999 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 4.04 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 4.3899999999999997 110.363 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 7.5 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 3.27 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 2.6899999999999999 111.244 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 8.9000000000000004 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.9299999999999997 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.4199999999999999 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 1.1299999999999999 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 2.5899999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 3.3199999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 1.5900000000000001 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 4.1699999999999999 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 4.46 110.72 170.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 1.9199999999999999 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 1.49 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 3.2200000000000002 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 5.0199999999999996 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 2.27 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 1.0 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 5.6600000000000001 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 1.55 109.06 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.3199999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 3.5099999999999998 108.856 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 4.5199999999999996 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 3.98 110.312 -171.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 2.4700000000000002 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 2.5600000000000001 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 2.46 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 2.3500000000000001 113.658 -166.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.9399999999999999 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.4299999999999999 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.3899999999999999 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 4.1799999999999997 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 3.4199999999999999 111.954 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 1.54 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 3.5899999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 1.8100000000000001 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 4.5599999999999996 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 3.3700000000000001 113.184 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.80000000000000004 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 4.25 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.73999999999999999 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 2.6499999999999999 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 1.9299999999999999 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.81 147.92 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 3.6099999999999999 108.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -165.25 -168.73 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.086 1.354 . . . . 6.5599999999999996 107.459 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.51 164.42 24.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.945 -1.502 . . . . 6.0999999999999996 106.945 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 pt -61.36 143.9 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.621 -0.511 . . . . 11.66 109.621 173.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.57 176.32 12.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.364 1.466 . . . . 7.1699999999999999 107.231 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.73 46.9 6.14 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.616 -0.547 . . . . 10.369999999999999 111.877 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.603 1.961 . . . . 18.760000000000002 108.844 -173.3 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.161 -0.447 . . . . 5.0800000000000001 110.097 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -72.77 110.85 7.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.7599999999999998 109.092 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 2.3900000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 7.2699999999999996 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 3.1000000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 3.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 1.8500000000000001 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 3.8300000000000001 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 3.6400000000000001 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m -74.3 114.76 13.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 3.1800000000000002 109.588 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.71 41.09 6.93 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.245 -1.142 . . . . 2.46 110.245 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.1 mtt 58.86 -158.45 0.3 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 8.6699999999999999 110.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 t -103.65 35.45 2.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.966 1.707 . . . . 8.6500000000000004 107.953 172.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t 64.19 -68.82 0.09 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.602 1.561 . . . . 3.0099999999999998 113.535 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.48 -124.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.324 1.45 . . . . 3.4900000000000002 107.603 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -71.2 30.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.945 -1.097 . . . . 2.25 113.894 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 3.1899999999999999 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 3.2000000000000002 111.164 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 2.0299999999999998 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6899999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 3.2000000000000002 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 6.0300000000000002 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 3.4100000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 3.8399999999999999 113.433 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 9.3200000000000003 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 10.210000000000001 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.8100000000000001 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 2.8799999999999999 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 3.6800000000000002 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 1.77 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 4.0999999999999996 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 2.5600000000000001 111.473 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 2.0899999999999999 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 1.55 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 3.1400000000000001 109.889 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 4.4500000000000002 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.8999999999999999 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 3.21 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 1.49 109.13 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 3.1099999999999999 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 3.7000000000000002 108.199 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.8899999999999997 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 3.8100000000000001 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 3.6200000000000001 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 2.8300000000000001 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 4.1900000000000004 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 4.6799999999999997 108.065 -172.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.53 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 3.23 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 3.5 111.015 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 2.6899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 3.5099999999999998 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 2.5 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 3.96 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 2.3999999999999999 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.85999999999999999 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 3.9199999999999999 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.79000000000000004 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 1.6299999999999999 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 2.21 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 1.9399999999999999 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.86 -165.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 2.8799999999999999 108.305 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 41.4 73.11 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.175 1.39 . . . . 8.7799999999999994 112.972 171.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.0 72.14 1.0 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.958 1.303 . . . . 8.0 107.96 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.8 mt -106.94 4.53 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 122.54 1.162 . . . . 8.6099999999999994 112.144 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -98.41 121.95 40.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.203 2.201 . . . . 7.7400000000000002 110.325 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.15 73.43 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.446 -1.862 . . . . 9.6799999999999997 108.446 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 . . . . . 0 C--O 1.253 1.266 0 CA-C-O 116.667 -1.635 . . . . 17.640000000000001 110.299 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 107.587 -1.264 . . . . 6.3799999999999999 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m 65.86 56.51 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.197 0.999 . . . . 4.0300000000000002 113.085 171.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 2.4500000000000002 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 4.04 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 2.0600000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 3.75 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 1.77 107.337 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 3.6800000000000002 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 3.0299999999999998 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -73.54 110.11 7.58 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 3.1299999999999999 110.322 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.45 35.08 12.42 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.863 -0.895 . . . . 2.6099999999999999 110.863 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 52.93 -150.53 0.35 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.223 1.009 . . . . 7.9400000000000004 110.197 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -105.32 30.82 5.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.655 0.782 . . . . 8.7100000000000009 109.095 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 56.5 -162.22 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.794 -0.566 . . . . 3.1299999999999999 111.884 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.7 89.85 6.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.088 -1.079 . . . . 3.6699999999999999 108.088 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m 75.95 74.77 0.09 Allowed 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 125.498 1.519 . . . . 2.4500000000000002 112.555 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 3.5499999999999998 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 3.1499999999999999 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 1.72 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.49 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 2.7999999999999998 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 7.3099999999999996 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.75 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 3.6899999999999999 111.882 -172.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 8.0 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.8399999999999999 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 1.1299999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 3.0099999999999998 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 3.8300000000000001 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 1.96 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 6.4699999999999998 110.142 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 2.8599999999999999 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 2.0699999999999998 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 1.7 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 3.5099999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 6.3300000000000001 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 2.3700000000000001 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.82999999999999996 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 4.2199999999999998 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 1.55 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 2.6000000000000001 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 5.5700000000000003 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 3.0600000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 2.2599999999999998 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 2.1600000000000001 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 2.1600000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 2.21 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.91000000000000003 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.9700000000000002 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 3.0099999999999998 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 2.1899999999999999 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 3.2999999999999998 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 1.8999999999999999 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 3.1600000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 2.2000000000000002 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 3.9300000000000002 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 1.8999999999999999 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 2.1200000000000001 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 1.8500000000000001 108.283 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.66 161.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 3.6200000000000001 108.299 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.34 -162.37 0.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.008 1.323 . . . . 6.3399999999999999 109.499 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.37 -85.73 0.05 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.369 -0.832 . . . . 7.0499999999999998 109.284 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.03 10.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 122.499 1.142 . . . . 5.4400000000000004 112.239 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -162.6 176.25 10.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.097 2.159 . . . . 6.5499999999999998 107.595 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.92 91.99 1.41 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.835 -1.706 . . . . 11.65 108.835 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.187 -1.387 . . . . 21.43 109.109 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 108.082 -1.081 . . . . 4.6699999999999999 108.082 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -147.17 133.84 19.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 3.3599999999999999 108.738 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.9900000000000002 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 4.0199999999999996 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.48 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 5.0700000000000003 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 2.0299999999999998 106.519 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 5.0899999999999999 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 3.6600000000000001 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p -104.33 72.55 1.07 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 2.6600000000000001 109.5 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.09 49.05 0.05 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.455 1.026 . . . . 1.5700000000000001 111.884 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -31.76 62.3 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.921 -0.752 . . . . 7.6500000000000004 110.561 176.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 t -73.21 59.11 0.54 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.471 1.108 . . . . 6.1200000000000001 109.803 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.87 171.42 7.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.091 1.356 . . . . 3.0800000000000001 108.325 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 83.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.252 1.021 . . . . 4.0099999999999998 112.409 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m 63.18 29.56 16.04 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.459 1.503 . . . . 2.1800000000000002 111.764 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 3.1299999999999999 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 3.04 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 2.0299999999999998 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.52 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 2.5299999999999998 109.073 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 6.3300000000000001 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 4.0300000000000002 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 3.9700000000000002 110.457 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 6.4800000000000004 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 7.3799999999999999 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 1.1100000000000001 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 2.4500000000000002 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 4.0 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 1.5900000000000001 109.833 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 4.29 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 2.7000000000000002 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 1.96 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 1.7 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 2.79 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 6.5800000000000001 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 1.9299999999999999 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.79 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 1.5600000000000001 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 3.71 109.702 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 4.4900000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 3.2400000000000002 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 2.3100000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 1.79 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 2.2200000000000002 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 2.4100000000000001 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 3.0299999999999998 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.49 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.49 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 3.5800000000000001 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 3.3700000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 1.78 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 3.75 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 2.9399999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 3.5899999999999999 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 2.0099999999999998 111.443 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 7.8700000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 2.27 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 2.3700000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 1.95 106.446 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.12 154.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 2.6600000000000001 107.938 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -103.27 169.64 8.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.404 -0.962 . . . . 5.5 108.404 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.98 -64.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.447 -1.686 . . . . 6.0300000000000002 106.447 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -165.23 178.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.004 -1.48 . . . . 5.5 107.004 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -68.16 169.94 9.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.371 1.068 . . . . 5.4800000000000004 111.319 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.5 -66.45 2.58 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.829 -0.544 . . . . 6.5099999999999998 111.771 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 N-CA-C 103.019 -2.956 . . . . 15.15 103.019 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 115.721 -2.085 . . . . 4.3399999999999999 105.822 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m 80.93 82.55 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 121.234 1.834 . . . . 3.4100000000000001 114.322 167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 2.3900000000000001 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 5.4900000000000002 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HG ' ' CD1' ' A' ' 57' ' ' ILE . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 2.5699999999999998 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 4.6699999999999999 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 1.75 105.882 -176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 3.8599999999999999 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 2.7599999999999998 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -94.85 67.16 3.16 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 3.6299999999999999 109.265 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.13 36.32 0.12 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.44 0.543 . . . . 1.6399999999999999 112.832 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.14 93.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.535 0.668 . . . . 5.6500000000000004 111.054 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -70.63 61.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.747 2.019 . . . . 6.0300000000000002 111.008 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -113.26 -167.99 1.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.963 1.305 . . . . 3.02 108.066 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.2 76.97 0.36 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.983 -1.073 . . . . 3.6299999999999999 110.801 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m 61.67 39.2 14.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.27 1.428 . . . . 1.8600000000000001 112.39 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.96 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 2.73 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 1.73 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.75 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 4.6600000000000001 111.458 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 6.3499999999999996 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.7999999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 4.1799999999999997 112.231 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 9.9600000000000009 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 10.49 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.48 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 2.7000000000000002 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 3.5699999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.53 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 5.6600000000000001 111.717 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 2.7999999999999998 112.901 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 1.8400000000000001 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 1.4299999999999999 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 2.6699999999999999 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 5.3300000000000001 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 2.25 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 4.0899999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 1.6699999999999999 108.896 -168.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 3.29 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 2.6299999999999999 109.421 -173.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 4.6600000000000001 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 3.3100000000000001 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 2.3100000000000001 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 2.52 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 2.5699999999999998 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 2.25 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 1.0900000000000001 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 1.1100000000000001 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 5.2300000000000004 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CD1' ' HG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 2.8999999999999999 112.203 176.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 1.73 111.759 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 3.73 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 1.8700000000000001 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 4.2800000000000002 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 2.0800000000000001 111.474 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.81999999999999995 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 3.5099999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.79000000000000004 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 1.46 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 2.25 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 2.0600000000000001 108.453 -172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.93 159.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 2.7200000000000002 109.983 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.74 168.91 8.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.595 -0.729 . . . . 6.5700000000000003 109.314 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -169.91 -176.68 2.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.634 -1.247 . . . . 6.7400000000000002 107.634 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 pt -52.18 109.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.855 0.36 . . . . 8.3200000000000003 111.525 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -71.28 172.43 9.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.093 0.557 . . . . 5.0499999999999998 110.563 172.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -51.87 -52.19 35.93 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.873 0.749 . . . . 6.4199999999999999 111.377 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.441 -1.742 . . . . 11.289999999999999 109.992 -176.138 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.8 p30 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 117.484 -1.246 . . . . 5.0099999999999998 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -59.28 143.27 49.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.609 1.095 . . . . 2.98 112.225 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 2.7400000000000002 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 3.6499999999999999 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 2.5099999999999998 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 3.6200000000000001 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 1.8500000000000001 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 3.27 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 3.1000000000000001 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -89.23 80.5 6.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 3.6200000000000001 109.148 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.44 56.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.112 -0.795 . . . . 1.74 111.112 172.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.11 -44.09 22.75 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.939 0.496 . . . . 7.2599999999999998 110.323 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -74.83 61.64 1.03 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 6.2199999999999998 110.334 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 m -117.4 151.92 36.03 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.678 1.591 . . . . 3.3900000000000001 108.17 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 77.23 0.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.642 0.777 . . . . 3.9399999999999999 110.926 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 79.6 123.61 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 127.31 2.244 . . . . 3.2200000000000002 110.248 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.8500000000000001 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 3.1699999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 2.1899999999999999 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.72 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 3.0800000000000001 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 4.6399999999999997 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 3.54 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 3.2000000000000002 110.316 -173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 9.3599999999999994 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 7.1299999999999999 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.49 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 2.79 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 3.2999999999999998 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 1.8899999999999999 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 6.6699999999999999 112.248 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 2.7999999999999998 112.346 -169.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 1.98 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 1.3700000000000001 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 2.4500000000000002 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 5.0 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.9099999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.03 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 6.7800000000000002 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 1.79 107.653 -174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.8700000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 3.6400000000000001 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.9400000000000004 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 3.3900000000000001 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 4.2699999999999996 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.8799999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 2.1400000000000001 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 2.1800000000000002 112.779 -165.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.5900000000000001 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 4.4100000000000001 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 4.3799999999999999 111.685 171.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 1.6899999999999999 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 3.3900000000000001 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 1.8600000000000001 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 3.3399999999999999 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 2.2400000000000002 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.73999999999999999 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 4.0 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 1.49 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 2.5899999999999999 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 1.8600000000000001 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt -143.28 159.11 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 2.8399999999999999 108.807 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.14 -68.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.828 -1.545 . . . . 6.1500000000000004 106.828 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.13 31.48 8.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.218 0.533 . . . . 6.5 110.899 172.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.8 pt -149.66 167.7 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 126.85 2.06 . . . . 7.5099999999999998 106.473 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.86 166.84 21.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.156 -0.683 . . . . 7.0700000000000003 109.156 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.93 51.84 0.18 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.562 -1.415 . . . . 9.4100000000000001 109.562 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.428 1.491 . . . . 16.300000000000001 107.385 -179.033 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 117.961 -1.018 . . . . 4.8700000000000001 108.7 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -144.11 149.45 36.57 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.55 1.14 . . . . 3.6800000000000002 108.575 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 2.4199999999999999 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' NZ ' ' OE2' ' A' ' 44' ' ' GLU . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 3.5099999999999998 109.179 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 3.7999999999999998 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 3.1099999999999999 105.754 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 3.9100000000000001 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.9900000000000002 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p -81.56 69.9 8.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 2.71 110.037 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.07 48.74 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.679 1.133 . . . . 1.4099999999999999 111.075 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.403 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -60.95 -36.79 80.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.173 -0.604 . . . . 7.46 112.192 177.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -67.0 25.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.327 1.851 . . . . 6.21 113.256 -175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' MET . 19.7 m -80.75 70.53 7.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.099 -1.001 . . . . 3.5600000000000001 109.563 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.89 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.266 1.827 . . . . 3.3300000000000001 112.579 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -155.01 35.21 0.39 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.847 1.259 . . . . 2.8700000000000001 110.309 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 3.6099999999999999 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 3.02 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 2.0800000000000001 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.52 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 3.3300000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 5.6900000000000004 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.7799999999999998 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 3.1699999999999999 113.975 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 8.9100000000000001 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 7.0700000000000003 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 2.0600000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 3.0499999999999998 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 3.5099999999999998 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 1.8300000000000001 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 4.0 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 3.71 113.745 -168.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 2.0499999999999998 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 1.3500000000000001 108.697 162.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 2.9399999999999999 110.594 174.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 4.9000000000000004 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 1.8300000000000001 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.76000000000000001 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.7400000000000002 107.42 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 1.3300000000000001 109.149 -170.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.21 109.117 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 2.4399999999999999 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 4.5499999999999998 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 3.71 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 3.1400000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 3.04 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 4.5099999999999998 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 4.4800000000000004 109.879 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 2.1000000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.3700000000000001 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 3.7200000000000002 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 3.75 111.567 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 2.0499999999999998 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 3.5800000000000001 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 1.9099999999999999 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 3.54 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.99 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.3300000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 4.0 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.66000000000000003 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 1.4099999999999999 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 2.1899999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 2.27 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.39 168.08 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 3.2799999999999998 109.21 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 54.89 -179.82 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.355 0.597 . . . . 9.6999999999999993 111.056 -167.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 169.56 91.17 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 126.805 2.042 . . . . 7.0599999999999996 107.606 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.36 157.61 34.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.526 0.679 . . . . 6.0300000000000002 109.68 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -73.92 165.81 24.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.566 -0.743 . . . . 6.1799999999999997 109.589 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.62 95.22 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.609 -0.996 . . . . 7.7000000000000002 110.609 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.834 1.254 . . . . 12.41 109.407 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 106.726 -1.583 . . . . 4.4400000000000004 106.726 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -165.28 158.13 16.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.8100000000000001 107.78 -168.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 2.48 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 4.71 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 2.6099999999999999 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 4.6399999999999997 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 2.6699999999999999 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 3.5 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 2.8300000000000001 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -103.4 88.93 3.23 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 3.6000000000000001 109.277 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.63 36.85 0.34 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.104 0.859 . . . . 1.46 112.006 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 tpp -75.03 -37.95 61.59 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.976 -0.72 . . . . 7.2000000000000002 111.004 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -72.4 61.67 0.49 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.709 1.204 . . . . 6.25 110.476 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.18 -58.73 1.85 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.151 0.981 . . . . 3.3900000000000001 110.182 -169.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.13 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.637 1.575 . . . . 3.2200000000000002 107.324 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -131.78 25.28 4.69 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.099 0.96 . . . . 2.0899999999999999 110.865 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.6499999999999999 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 2.8900000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 1.6799999999999999 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.4399999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 3.0699999999999998 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 6.6900000000000004 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.7799999999999998 107.685 172.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 3.1299999999999999 113.635 -170.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 9.6799999999999997 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 8.1699999999999999 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 3.0299999999999998 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 3.7400000000000002 109.638 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 3.6000000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 2.04 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 3.8399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 3.2200000000000002 111.453 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 2.3500000000000001 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 1.8 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 2.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 5.4400000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 2.04 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.80000000000000004 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.9100000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 1.5800000000000001 109.493 -164.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 2.6400000000000001 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 4.6600000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 3.6899999999999999 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 2.29 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.9199999999999999 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 2.4700000000000002 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 2.3700000000000001 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.3399999999999999 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.3 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.1799999999999999 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 4.0099999999999998 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 2.8599999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 2.25 111.159 174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 3.9900000000000002 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 1.78 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 3.2599999999999998 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 2.0800000000000001 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.85999999999999999 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 3.9900000000000002 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.63 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 1.3999999999999999 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 3.4100000000000001 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 1.8799999999999999 109.563 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.96 169.0 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 2.8199999999999998 107.48 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -172.21 -168.54 0.56 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.71 -1.589 . . . . 5.6200000000000001 106.71 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -131.04 -58.87 1.0 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.526 0.73 . . . . 5.5 110.062 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -146.31 156.22 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.781 0.832 . . . . 5.75 109.259 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.72 166.98 14.87 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 6.2300000000000004 110.477 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.23 55.29 4.81 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.404 -1.22 . . . . 6.8200000000000003 113.837 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 128.35 2.66 . . . . 14.130000000000001 115.395 174.245 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.265 0.555 . . . . 2.3300000000000001 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1099999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.1499999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 2.2000000000000002 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 3.04 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 0.95999999999999996 105.967 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 2.4399999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 2.5899999999999999 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 3.3300000000000001 110.155 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 113.852 1.056 . . . . 2.52 113.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 2.4399999999999999 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 35' ' ' LEU . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 2.0299999999999998 109.768 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 0.79000000000000004 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 1.9299999999999999 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 2.3100000000000001 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 3.9100000000000001 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 2.5800000000000001 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.1000000000000001 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 6.4000000000000004 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 6.96 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.05 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 1.4099999999999999 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 2.23 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 0.92000000000000004 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 3.2200000000000002 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 3.54 112.28 175.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 0.92000000000000004 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 0.59999999999999998 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 1.72 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 3.98 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 3.8599999999999999 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 0.47999999999999998 106.019 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 2.8500000000000001 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 2.3500000000000001 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 4.8600000000000003 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 2.8999999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 0.97999999999999998 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.0900000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 1.55 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 1.3999999999999999 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 3.48 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.28 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.21 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 3.29 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 0.66000000000000003 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 2.3399999999999999 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 1.22 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 4.54 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 2.1899999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.21 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 2.8999999999999999 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 0.93999999999999995 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 0.64000000000000001 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 1.3400000000000001 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 1.21 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 3.2999999999999998 106.669 -179.694 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.543 -0.54 . . . . 2.3500000000000001 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.27 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 4.3600000000000003 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.55 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 2.75 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 1.4199999999999999 107.582 -177.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 2.21 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 3.0600000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 2.4199999999999999 108.784 -177.452 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 3.8900000000000001 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 2.5 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 1.28 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.3400000000000001 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 2.2400000000000002 109.762 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.0 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 2.8999999999999999 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 35' ' ' LEU . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 1.95 110.789 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 7.0899999999999999 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 6.6200000000000001 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.3700000000000001 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.0 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 1.8799999999999999 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 2.29 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 1.1699999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.1299999999999999 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 1.76 113.248 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 0.68000000000000005 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 0.5 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 1.53 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 5.1900000000000004 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.05 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 0.91000000000000003 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.0899999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 35' ' ' LEU . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 0.51000000000000001 109.924 -166.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 35' ' ' LEU . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 2.02 110.046 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 5.5099999999999998 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 2.3999999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 3.04 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.3999999999999999 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 1.22 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 1.3799999999999999 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.0 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 3.2799999999999998 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 2.46 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 0.85999999999999999 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 2.5800000000000001 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 0.71999999999999997 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 3.3300000000000001 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 1.5700000000000001 112.136 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.90000000000000002 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 3.1299999999999999 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1599999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 0.79000000000000004 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 2.1400000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 0.96999999999999997 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 3.1800000000000002 106.998 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 111.647 0.24 . . . . 2.7000000000000002 111.647 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 1.77 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 4.3200000000000003 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 1.3600000000000001 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 2.29 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 1.3 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 2.9199999999999999 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 2.2200000000000002 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 1.6799999999999999 110.749 -177.167 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.497 0.184 . . . . 2.29 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.2400000000000002 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 1.8 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 0.66000000000000003 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.1399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 1.73 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.2800000000000002 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 2.8999999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 2.5299999999999998 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 7.2199999999999998 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 5.7999999999999998 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.21 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' A' ' 45' ' ' VAL . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 1.6699999999999999 111.552 173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 2.2999999999999998 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 0.89000000000000001 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.0699999999999998 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 3.3300000000000001 112.105 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 0.65000000000000002 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 0.5 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 1.23 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 4.4100000000000001 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 0.85999999999999999 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 2.9100000000000001 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 0.44 109.944 -169.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.601 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 1.6000000000000001 108.538 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 3.4500000000000002 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 2.0 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 1.8200000000000001 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 1.1599999999999999 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 1.5900000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 1.3600000000000001 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 0.91000000000000003 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 0.93000000000000005 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 2.9300000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 1.95 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 0.71999999999999997 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 2.3199999999999998 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 0.62 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 3.5600000000000001 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 1.1699999999999999 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 2.8100000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.93000000000000005 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 0.77000000000000002 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.24 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 0.56000000000000005 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 1.5800000000000001 109.279 177.752 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 118.141 -0.933 . . . . 2.6299999999999999 109.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.1499999999999999 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 3.2599999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 1.6000000000000001 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 2.2400000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 0.77000000000000002 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 3.3700000000000001 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.0699999999999998 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.3100000000000001 111.663 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.972 -0.751 . . . . 3.1200000000000001 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 3.6000000000000001 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 1.96 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 0.88 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.27 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 1.99 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 4.4000000000000004 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 2.3199999999999998 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 1.8700000000000001 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 6.9800000000000004 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 8.1899999999999995 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.1499999999999999 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 45' ' ' VAL . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 1.8100000000000001 110.558 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 0.83999999999999997 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.0 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 3.1400000000000001 110.791 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.68000000000000005 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 0.46999999999999997 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 1.46 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 4.75 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 0.88 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.1200000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 0.51000000000000001 108.085 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 1.5600000000000001 109.179 -176.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.0300000000000002 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 1.9099999999999999 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 1.8999999999999999 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.84999999999999998 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.0 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 1.28 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 57' ' ' ILE . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 1.5 111.199 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 0.87 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 3.2799999999999998 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 52' ' ' ILE . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 2.2799999999999998 111.618 176.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 0.67000000000000004 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 2.7200000000000002 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 3.1699999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 1.04 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 2.8900000000000001 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.81000000000000005 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 0.83999999999999997 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 1.3899999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 0.66000000000000003 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 2.77 106.262 178.659 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.509 -0.182 . . . . 2.8300000000000001 110.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 2.3999999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.0800000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.6699999999999999 106.488 169.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 3.9100000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 0.72999999999999998 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 2.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.0499999999999998 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 2.8500000000000001 110.106 176.551 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.746 -0.835 . . . . 3.73 108.746 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 2.5800000000000001 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 1.8799999999999999 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 1.1399999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.3999999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 2.4900000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 3.9900000000000002 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 2.4500000000000002 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 1.78 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 7.25 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 5.6900000000000004 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.05 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 28' ' ' GLU . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 1.48 109.907 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 2.2999999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 0.81999999999999995 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.0699999999999998 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 1.99 113.07 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 0.67000000000000004 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 0.53000000000000003 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 1.3 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.0999999999999996 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 0.96999999999999997 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81000000000000005 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 5.7000000000000002 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 0.69999999999999996 109.44 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 1.5900000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 3.8999999999999999 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 2.0 110.135 -170.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 1.25 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 1.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.79000000000000004 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 4.4000000000000004 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 1.8899999999999999 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 0.70999999999999996 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 2.0 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 0.85999999999999999 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.1400000000000001 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 1.53 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.01 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 3.02 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.85999999999999999 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 1.4199999999999999 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 0.68999999999999995 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 1.48 109.644 -177.842 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 2.1800000000000002 116.588 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 1.8300000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 3.75 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 1.74 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 2.4199999999999999 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 0.90000000000000002 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 2.6699999999999999 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 2.4300000000000002 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.0099999999999998 109.903 -176.679 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 1.9099999999999999 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 2.6800000000000002 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 0.68000000000000005 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 1.96 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' CG2' HD21 ' A' ' 35' ' ' LEU . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 109.622 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.21 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 2.8999999999999999 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 2.4700000000000002 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 6.5099999999999998 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 6.5599999999999996 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.1799999999999997 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 0.92000000000000004 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 57' ' ' ILE . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 1.6699999999999999 109.791 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 2.2999999999999998 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 0.81000000000000005 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 3.1400000000000001 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 35' ' ' LEU . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 1.6599999999999999 111.767 -173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 0.94999999999999996 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 0.68000000000000005 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 1.8100000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 4.6900000000000004 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 0.88 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.69999999999999996 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.0600000000000001 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 0.44 107.157 -168.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.3599999999999999 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 2.3999999999999999 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.0599999999999996 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 2.2999999999999998 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.0899999999999999 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.5600000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 1.46 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 1.9399999999999999 112.689 -157.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 2.6400000000000001 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 1.77 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.48 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 3.9399999999999999 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 2.3300000000000001 111.023 176.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 0.71999999999999997 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 2.1800000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 0.89000000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 3.4300000000000002 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.88 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 2.3900000000000001 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.90000000000000002 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 0.73999999999999999 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 1.48 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 0.56999999999999995 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 2.7400000000000002 106.981 -170.41 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 2.5800000000000001 105.61 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 4.9900000000000002 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.425 ' SG ' HG13 ' A' ' 45' ' ' VAL . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.6099999999999999 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 4.7999999999999998 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 1.1200000000000001 105.961 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.0299999999999998 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 2.73 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 2.5800000000000001 109.652 -177.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.947 0.88 . . . . 2.5499999999999998 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.0699999999999998 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 2.5099999999999998 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 1.03 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.1399999999999999 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.413 ' CG1' HD11 ' A' ' 64' ' ' LEU . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 2.0299999999999998 109.387 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.1600000000000001 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.0 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 1.78 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 6.3200000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 9.3200000000000003 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.05 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 45' ' ' VAL . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 1.5600000000000001 109.899 173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 2.3100000000000001 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 0.77000000000000002 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.0 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 1.79 111.076 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 0.54000000000000004 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 0.40999999999999998 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 1.5900000000000001 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 4.7699999999999996 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 0.92000000000000004 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.0199999999999996 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 0.52000000000000002 108.614 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.5 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 1.6200000000000001 108.777 -177.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 5.1200000000000001 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 1.95 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 1.8500000000000001 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 0.96999999999999997 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 1.29 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 HG23 ' A' ' 57' ' ' ILE . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 1.4399999999999999 113.129 -169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.81999999999999995 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 4.3399999999999999 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 2.2000000000000002 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 0.64000000000000001 110.994 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 2.1099999999999999 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 0.68000000000000005 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 2.3999999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 1.4099999999999999 111.512 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 2.8799999999999999 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 0.66000000000000003 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 1.6100000000000001 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 0.59999999999999998 108.932 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt . . . . . 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 1.5 109.504 178.51 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 112.687 0.625 . . . . 2.9300000000000002 112.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 3.21 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 3.8300000000000001 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 1.74 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 3.1699999999999999 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 1.1499999999999999 105.631 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 3.6400000000000001 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 3.1299999999999999 108.028 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 2.1899999999999999 109.65 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.2599999999999998 114.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 2.8399999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 2.4399999999999999 110.124 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 0.92000000000000004 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.1200000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 64' ' ' LEU . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 1.9099999999999999 109.435 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 7.71 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.4199999999999999 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 1.9399999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 5.7800000000000002 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.1500000000000004 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.29 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 57' ' ' ILE . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 1.6299999999999999 110.243 174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 2.6800000000000002 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 2.4199999999999999 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 3.3300000000000001 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 1.8100000000000001 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 0.68000000000000005 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 0.56000000000000005 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 1.2 110.952 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 3.8500000000000001 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 0.94999999999999996 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.68999999999999995 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 3.6299999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 0.55000000000000004 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.2200000000000002 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 1.6100000000000001 108.286 -177.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 3.6499999999999999 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 2.0899999999999999 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.29 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.2 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 1.3500000000000001 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 57' ' ' ILE . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 1.53 112.173 -169.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 2.8900000000000001 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 0.93999999999999995 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.0699999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 2.3799999999999999 111.453 177.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 0.79000000000000004 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 2.4300000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 2.52 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 21' ' ' ILE . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 1.2 112.53 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.95999999999999996 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 2.73 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.75 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 0.60999999999999999 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 1.24 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 1.6100000000000001 107.964 174.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.664 -0.495 . . . . 2.1600000000000001 109.664 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 2.1099999999999999 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 3.52 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 1.74 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 3.2000000000000002 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 0.70999999999999996 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 2.5 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 1.99 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 1.99 111.522 -177.834 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.711 0.634 . . . . 1.8799999999999999 112.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 2.02 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 1.0 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.22 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 21' ' ' ILE . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 1.76 109.067 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 3.9199999999999999 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 3.5800000000000001 109.608 172.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 1.97 111.455 -165.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 6.5199999999999996 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.2400000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 0.93999999999999995 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 1.53 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 2.21 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 0.79000000000000004 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 4.2400000000000002 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 34' ' ' ILE . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 1.8999999999999999 111.745 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 0.56999999999999995 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 0.45000000000000001 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 1.3200000000000001 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 4.6100000000000003 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 0.98999999999999999 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 3.25 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 0.58999999999999997 109.683 -168.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.3799999999999999 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 1.75 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 4.6600000000000001 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 1.7 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.1499999999999999 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 1.48 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 1.22 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 0.85999999999999999 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.02 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 1.9299999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 0.76000000000000001 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 2.0899999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 0.77000000000000002 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 3.8100000000000001 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 1.27 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 2.4399999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.59999999999999998 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 0.53000000000000003 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 1.1799999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 0.59999999999999998 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 1.6699999999999999 108.221 175.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 2.8399999999999999 108.176 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 1.79 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 2.9900000000000002 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 1.3600000000000001 107.28 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 2.6400000000000001 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 0.97999999999999998 106.091 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 4.5499999999999998 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 2.52 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 2.4100000000000001 110.059 -177.34 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.311 0.485 . . . . 2.1499999999999999 112.311 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.2400000000000002 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 2.2400000000000002 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 0.87 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.1799999999999999 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 1.6899999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 5.5300000000000002 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 2.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 2.3799999999999999 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 5.9000000000000004 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 8.8399999999999999 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 0.85999999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 1.5900000000000001 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 2.9399999999999999 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 1.02 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.1200000000000001 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 112.929 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 0.58999999999999997 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 1.9199999999999999 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 4.5 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 1.3700000000000001 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.1200000000000001 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 2.8999999999999999 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 0.57999999999999996 108.158 -169.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 2.9100000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 1.6299999999999999 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 3.98 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 1.9199999999999999 110.793 -170.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.27 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 1.48 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 1.3799999999999999 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 57' ' ' ILE . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 1.3600000000000001 112.192 -169.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 0.89000000000000001 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 3.29 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 2.2599999999999998 111.538 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 0.81999999999999995 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 2.3599999999999999 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 2.2999999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 1.1799999999999999 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 2.7599999999999998 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.85999999999999999 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 0.68000000000000005 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 1.51 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 0.71999999999999997 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 1.6899999999999999 108.225 -173.318 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 3.3700000000000001 107.161 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 2.0299999999999998 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.1800000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 1.6499999999999999 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 3.2599999999999998 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 0.71999999999999997 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 1.9199999999999999 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 1.99 109.144 -178.855 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.447 0.906 . . . . 2.0299999999999998 113.447 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 2.46 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 2.7400000000000002 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 0.66000000000000003 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.0600000000000001 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 1.9199999999999999 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.0800000000000001 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 3.25 107.434 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 1.99 114.583 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 8.5399999999999991 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 6.7199999999999998 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 0.94999999999999996 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 HD23 ' A' ' 25' ' ' LEU . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 2.1499999999999999 108.057 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 2.4399999999999999 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 0.77000000000000002 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 3.2000000000000002 112.132 -174.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.0099999999999998 111.842 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 0.80000000000000004 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 1.28 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 4.4000000000000004 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 0.80000000000000004 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.68999999999999995 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 2.96 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 0.68000000000000005 109.72 -163.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 1.6499999999999999 109.435 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 3.9300000000000002 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 1.8200000000000001 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 2.8399999999999999 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.1399999999999999 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 1.3700000000000001 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 1.6399999999999999 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 1.8500000000000001 110.539 -166.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 0.92000000000000004 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 4.2300000000000004 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.625 HG23 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 1.8999999999999999 111.056 175.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 0.71999999999999997 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 2.1899999999999999 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 0.73999999999999999 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 3.3300000000000001 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 1.74 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.77000000000000002 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 2.8500000000000001 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.02 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 0.93000000000000005 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 2.7799999999999998 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 0.71999999999999997 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 1.5700000000000001 111.221 -178.283 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 2.2599999999999998 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.0099999999999998 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 3.9500000000000002 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 1.6100000000000001 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 2.6899999999999999 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 0.72999999999999998 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 2.25 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 2.3199999999999998 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 2.1299999999999999 109.274 178.523 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.159 0.8 . . . . 2.0499999999999998 113.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.1699999999999999 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 1.8700000000000001 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 1.28 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.1799999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 1.9099999999999999 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 34' ' ' ILE . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 6.3200000000000003 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.0499999999999998 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' A' ' 34' ' ' ILE . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 2.5499999999999998 113.408 -165.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 6.1699999999999999 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 5.5300000000000002 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 0.94999999999999996 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 1.6299999999999999 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 2.1099999999999999 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.29 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 5.6699999999999999 111.664 -170.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 1.95 112.027 -163.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 0.68999999999999995 110.841 -174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 0.46000000000000002 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 1.25 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 3.5800000000000001 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 1.1100000000000001 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 3.1600000000000001 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 0.72999999999999998 111.329 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 2.8999999999999999 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 2.4300000000000002 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 3.2200000000000002 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 1.9199999999999999 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 1.8799999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.0900000000000001 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 1.3100000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 57' ' ' ILE . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 1.25 112.238 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.03 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.2200000000000002 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 52' ' ' ILE . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 2.8999999999999999 111.666 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 0.65000000000000002 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 2.2400000000000002 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 0.79000000000000004 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 2.3500000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 1.1899999999999999 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 2.2999999999999998 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 0.84999999999999998 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 2.0299999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 0.83999999999999997 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 1.8200000000000001 108.312 176.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 119.208 -0.425 . . . . 1.97 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 1.8300000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 2.8900000000000001 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 1.6200000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 3.3599999999999999 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 0.87 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 2.54 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 2.7200000000000002 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 2.71 110.468 -177.745 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.745 0.783 . . . . 2.9100000000000001 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 2.5499999999999998 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 1.9299999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 0.93000000000000005 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 2.5099999999999998 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.601 HD11 HD21 ' A' ' 64' ' ' LEU . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 3.2200000000000002 110.363 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 6.7000000000000002 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 2.7000000000000002 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.77 HD23 HG11 ' A' ' 45' ' ' VAL . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 1.8300000000000001 111.244 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 7.7400000000000002 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.0899999999999999 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.0 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 0.88 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 1.6799999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 2.0699999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 0.75 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 3.3700000000000001 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 3.2599999999999998 110.72 170.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 0.67000000000000004 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 0.95999999999999996 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 2.3999999999999999 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 3.8900000000000001 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 1.21 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 0.77000000000000002 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 4.8099999999999996 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 0.58999999999999997 109.06 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.2799999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.77 HG11 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 2.23 108.856 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 3.6499999999999999 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 2.52 110.312 -171.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 1.98 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 1.46 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 1.5 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 57' ' ' ILE . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 1.3400000000000001 113.658 -166.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.7400000000000002 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.26 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.29 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 3.1899999999999999 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 2.3700000000000001 111.954 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 0.62 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 2.3399999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 0.92000000000000004 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 3.79 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.636 ' HG2' HD23 ' A' ' 64' ' ' LEU . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.636 HD23 ' HG2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 113.184 175.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.69999999999999996 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 2.8999999999999999 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.68000000000000005 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 0.68999999999999995 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 1.48 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 0.88 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 2.1000000000000001 108.623 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.1200000000000001 109.092 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 1.8500000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 5.9800000000000004 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 2.8300000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 2.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 0.88 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 2.8199999999999998 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 2.54 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 2.1600000000000001 109.588 178.286 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 113.894 1.072 . . . . 2.25 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 2.7200000000000002 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 2.27 111.164 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 1.1899999999999999 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6699999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 2.21 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 5.0599999999999996 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 2.6200000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 45' ' ' VAL . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 2.5600000000000001 113.433 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 8.3000000000000007 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 9.3599999999999994 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.72 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 1.72 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 2.48 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 0.84999999999999998 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 3.3199999999999998 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 1.6599999999999999 111.473 175.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 0.72999999999999998 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 1.8200000000000001 109.889 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 3.8300000000000001 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.05 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 2.7000000000000002 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 0.48999999999999999 109.13 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 2.79 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 2.5499999999999998 108.199 176.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.0 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 2.3999999999999999 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 2.6699999999999999 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 1.78 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 3.29 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.669 HD12 HG23 ' A' ' 57' ' ' ILE 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 3.1299999999999999 108.065 -172.17 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 52' ' ' ILE . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.1899999999999999 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 2.6200000000000001 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.669 HG23 HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 2.5499999999999998 111.015 176.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 1.3899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 2.1499999999999999 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 2.8599999999999999 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 1.3 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.76000000000000001 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 2.5600000000000001 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.75 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 1.3600000000000001 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 0.80000000000000004 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 1.6899999999999999 108.305 -173.46 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 113.085 0.772 . . . . 3.6499999999999999 113.085 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 1.8100000000000001 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 3.3700000000000001 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 1.6200000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 2.4199999999999999 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 70' ' ' VAL . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 0.73999999999999999 107.337 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 2.6400000000000001 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 1.8500000000000001 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 2.0899999999999999 110.322 -178.46 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.555 0.576 . . . . 2.4500000000000002 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 2.7400000000000002 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 2.0 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 0.68000000000000005 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.25 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 1.79 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 6.5300000000000002 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.3500000000000001 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 2.6899999999999999 111.882 -172.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 7.0800000000000001 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.0700000000000003 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 0.98999999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 1.8300000000000001 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 2.3999999999999999 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 0.96999999999999997 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 5.5199999999999996 110.142 -173.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.649 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 1.98 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.77000000000000002 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 0.5 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 2.5299999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 5.2699999999999996 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 1.28 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.80000000000000004 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 3.4700000000000002 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 0.47999999999999998 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 1.6399999999999999 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 4.1799999999999997 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 1.8100000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 1.76 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 1.02 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 1.3100000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 1.24 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.80000000000000004 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.0699999999999998 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 1.96 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 0.89000000000000001 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 1.97 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 2.3900000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 1.29 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 2.5600000000000001 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 0.90000000000000002 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 1.2 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 7' ' ' ILE . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 0.72999999999999998 108.283 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 2.3399999999999999 108.299 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 2.9300000000000002 108.738 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.0 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 3.29 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.3599999999999999 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 3.7000000000000002 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG12 HG23 ' A' ' 70' ' ' VAL . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 0.92000000000000004 106.519 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 3.73 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 2.5099999999999998 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 1.73 109.5 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.764 0.283 . . . . 2.1800000000000002 111.764 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 2.1400000000000001 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 2.1899999999999999 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 0.88 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.1100000000000001 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 1.74 109.073 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 5.4900000000000002 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 3.2799999999999998 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 45' ' ' VAL . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 2.77 110.457 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 5.5199999999999996 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 6.3499999999999996 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 0.83999999999999997 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 1.5600000000000001 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 2.5299999999999998 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 45' ' ' VAL . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 0.76000000000000001 109.833 -174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 3.5499999999999998 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.727 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 1.6799999999999999 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 0.85999999999999999 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 0.54000000000000004 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 1.52 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 5.71 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 0.95999999999999996 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.0299999999999998 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 0.53000000000000003 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 2.46 109.702 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 3.7200000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 1.98 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 1.8700000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 0.98999999999999999 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 1.28 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 1.28 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 2.1800000000000002 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.3200000000000001 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.3100000000000001 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 2.6899999999999999 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 2.1600000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 0.84999999999999998 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 2.4199999999999999 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 1.3999999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 2.7799999999999998 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 21' ' ' ILE . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 1.04 111.443 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 6.1600000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 1.3500000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG23 HG12 ' A' ' 7' ' ' ILE . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 0.75 106.446 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 1.8700000000000001 107.938 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 114.322 1.23 . . . . 3.0299999999999998 114.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 1.8 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 4.3700000000000001 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 45' ' ' VAL . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 1.9099999999999999 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 3.29 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 70' ' ' VAL . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 0.77000000000000002 105.882 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 2.9100000000000001 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 1.8500000000000001 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 2.4399999999999999 109.265 176.943 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 112.39 0.515 . . . . 1.8600000000000001 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.1899999999999999 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 1.7 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 0.73999999999999999 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.25 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 3.6499999999999999 111.458 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 5.1500000000000004 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.0299999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 2.8300000000000001 112.231 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 8.4700000000000006 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 9.1600000000000001 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.1499999999999999 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 1.3999999999999999 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 2.3199999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.0600000000000001 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 4.8300000000000001 111.717 -175.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 34' ' ' ILE . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 1.8999999999999999 112.901 -174.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 0.65000000000000002 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 0.70999999999999996 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 1.5600000000000001 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 4.6900000000000004 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 1.0700000000000001 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 3.3599999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 0.57999999999999996 108.896 -168.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 2.5 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 1.76 109.421 -173.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 3.8399999999999999 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 1.76 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 1.8 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 1.6100000000000001 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 1.3400000000000001 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 0.94999999999999996 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 0.97999999999999998 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 4.0899999999999999 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 1.98 112.203 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 0.92000000000000004 111.759 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 2.4900000000000002 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 0.92000000000000004 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 3.1299999999999999 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 21' ' ' ILE . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 1.1299999999999999 111.474 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.72999999999999998 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 2.2999999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.77000000000000002 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 0.63 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 1.22 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.567 HG23 HG12 ' A' ' 7' ' ' ILE . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 0.75 108.453 -172.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 1.6699999999999999 109.983 179.39 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 112.225 0.454 . . . . 2.2599999999999998 112.225 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 1.79 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 2.96 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 1.54 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 2.4300000000000002 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 0.73999999999999999 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 2.3199999999999998 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 2.1499999999999999 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 2.54 109.148 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 120.995 0.426 . . . . 3.2200000000000002 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.2200000000000002 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 1.8899999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 1.02 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.21 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 1.95 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' ILE . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 3.96 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 2.8300000000000001 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 34' ' ' ILE . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 2.2000000000000002 110.316 -173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 8.1500000000000004 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 6.4699999999999998 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.1599999999999999 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 1.5600000000000001 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 2.1000000000000001 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 0.81000000000000005 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 22' ' ' GLU . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 5.71 112.248 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.515 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 1.95 112.346 -169.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 0.69999999999999996 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 0.48999999999999999 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 1.3600000000000001 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 4.0800000000000001 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.1699999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.01 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 5.4400000000000004 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 0.93000000000000005 107.653 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.3500000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 2.3999999999999999 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.0800000000000001 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 2.0099999999999998 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 3.1299999999999999 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.1299999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 1.26 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.425 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 1.3799999999999999 112.779 -165.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.23 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 3.2999999999999998 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 3.1200000000000001 111.685 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 0.71999999999999997 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 2.0499999999999998 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 0.65000000000000002 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 2.52 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 1.0700000000000001 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.68000000000000005 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 2.73 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 0.53000000000000003 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 1.8500000000000001 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 0.80000000000000004 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 1.8 108.807 177.9 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.575 -0.898 . . . . 3.4300000000000002 108.575 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 1.8200000000000001 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 2.75 109.179 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 2.5800000000000001 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 1.53 105.754 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 2.8999999999999999 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.02 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 -176.464 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 110.309 -0.256 . . . . 2.0800000000000001 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 2.5 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 2.04 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 0.87 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 2.0800000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 4.9199999999999999 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.1400000000000001 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 35' ' ' LEU . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 1.9399999999999999 113.975 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 7.6399999999999997 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 6.4299999999999997 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 1.73 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 2.3300000000000001 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 0.78000000000000003 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 3.1000000000000001 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.849 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 2.6800000000000002 113.745 -168.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 0.95999999999999996 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' LYS . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 0.52000000000000002 108.697 162.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 1.79 110.594 174.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 3.9900000000000002 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 0.87 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.69999999999999996 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.0699999999999998 107.42 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.849 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 0.48999999999999999 109.149 -170.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.1899999999999999 109.117 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 1.6000000000000001 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 3.79 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 2.3999999999999999 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 2.3500000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 1.5700000000000001 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 3.5600000000000001 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 3.3100000000000001 109.879 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 1.8400000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.24 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 2.75 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 47' ' ' TYR . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 2.6800000000000002 111.567 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 1.0 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 2.2200000000000002 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 0.68999999999999995 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 2.7400000000000002 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.26 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.1000000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 2.6299999999999999 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.62 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 0.55000000000000004 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 1.3799999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 0.96999999999999997 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 2.23 109.21 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.0800000000000001 107.78 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 1.8799999999999999 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 3.8500000000000001 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 1.75 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 3.3500000000000001 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 1.23 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 2.4300000000000002 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 1.8899999999999999 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 2.5299999999999998 109.277 177.059 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 119.862 -0.113 . . . . 1.98 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 1.8400000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 0.70999999999999996 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.1799999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 2.04 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 5.9500000000000002 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.1299999999999999 107.685 172.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.916 ' HG ' HD13 ' A' ' 31' ' ' ILE . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 2.0600000000000001 113.635 -170.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 8.4100000000000001 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 7.0499999999999998 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 1.24 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 25' ' ' LEU . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 2.5299999999999998 109.638 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 2.3300000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 1.0700000000000001 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 2.9399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 2.29 111.453 172.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 1.1399999999999999 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 1.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 4.4000000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 1.05 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.70999999999999996 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.1000000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 0.5 109.493 -164.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 1.6499999999999999 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 3.8700000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 2.2400000000000002 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 1.74 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.21 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 1.3799999999999999 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 1.25 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.2999999999999998 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.1200000000000001 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.05 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 3.1099999999999999 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 0.93999999999999995 111.159 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 0.81999999999999995 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 2.4500000000000002 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 1.1899999999999999 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.77000000000000002 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 2.6099999999999999 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 0.51000000000000001 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 2.46 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 0.78000000000000003 109.563 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 1.6799999999999999 107.48 -176.898 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 118.046 -0.978 . . . . 5.0499999999999998 108.901 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 52.77 83.02 0.07 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.825 0.85 . . . . 2.3300000000000001 110.578 -166.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1099999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.1499999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 2.2000000000000002 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 3.04 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 0.95999999999999996 105.967 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 2.4399999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 2.5899999999999999 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p -74.46 73.1 1.9 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 3.3300000000000001 110.155 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.52 25.09 0.05 OUTLIER Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.73 1.634 . . . . 1.8700000000000001 112.293 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.67 -42.5 3.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 6.4400000000000004 112.603 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.08 -19.35 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.662 1.585 . . . . 5.4100000000000001 113.365 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.5 47.02 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.297 0.953 . . . . 2.7599999999999998 111.644 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 18.69 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.467 2.707 . . . . 4.0700000000000003 114.512 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -47.95 -29.43 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.588 1.955 . . . . 2.52 113.852 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 2.4399999999999999 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 35' ' ' LEU . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 2.0299999999999998 109.768 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 0.79000000000000004 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 1.9299999999999999 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 2.3100000000000001 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 3.9100000000000001 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 2.5800000000000001 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.1000000000000001 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 6.4000000000000004 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 6.96 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.05 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 1.4099999999999999 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 2.23 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 0.92000000000000004 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 3.2200000000000002 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 3.54 112.28 175.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 0.92000000000000004 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 0.59999999999999998 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 1.72 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 3.98 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 3.8599999999999999 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 0.47999999999999998 106.019 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 2.8500000000000001 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 2.3500000000000001 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 4.8600000000000003 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 2.8999999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 0.97999999999999998 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.0900000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 1.55 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 1.3999999999999999 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 3.48 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.28 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.21 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 3.29 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 0.66000000000000003 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 2.3399999999999999 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 1.22 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 4.54 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 2.1899999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.21 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 2.8999999999999999 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 0.93999999999999995 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 0.64000000000000001 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 1.3400000000000001 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 1.21 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.64 90.62 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 3.2999999999999998 106.669 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -67.86 130.7 43.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.554 -1.276 . . . . 6.5800000000000001 107.554 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -84.92 -62.88 1.44 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.802 -0.444 . . . . 5.6299999999999999 109.802 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 tt -176.14 165.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 126.41 1.884 . . . . 5.7999999999999998 106.143 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.62 -2.41 17.04 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.877 1.066 . . . . 6.29 113.877 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.31 115.6 0.33 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.824 -0.91 . . . . 5.46 110.824 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 104.841 -2.281 . . . . 11.720000000000001 104.841 164.037 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.158 -0.682 . . . . 3.3799999999999999 109.158 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -97.54 175.27 6.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.727 1.611 . . . . 2.3500000000000001 109.543 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.27 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 4.3600000000000003 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.55 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 2.75 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 1.4199999999999999 107.582 -177.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 2.21 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 3.0600000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -104.44 87.49 2.73 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 2.4199999999999999 108.784 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.47 80.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 106.319 -2.712 . . . . 2.5699999999999998 106.319 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.7 mtm -49.85 143.48 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.161 -0.681 . . . . 5.6900000000000004 109.161 166.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -19.14 -64.5 0.02 OUTLIER 'General case' 0 C--N 1.339 0.112 0 C-N-CA 127.366 2.266 . . . . 9.6199999999999992 114.471 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.24 -174.23 0.87 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.235 -1.765 . . . . 2.9399999999999999 106.235 165.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.75 -70.4 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.41 0.624 . . . . 3.3599999999999999 110.487 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -86.62 91.3 8.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 3.8900000000000001 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 2.5 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 1.28 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.3400000000000001 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 2.2400000000000002 109.762 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.0 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 2.8999999999999999 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 35' ' ' LEU . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 1.95 110.789 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 7.0899999999999999 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 6.6200000000000001 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.3700000000000001 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.0 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 1.8799999999999999 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 2.29 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 1.1699999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.1299999999999999 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 1.76 113.248 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 0.68000000000000005 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 0.5 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 1.53 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 5.1900000000000004 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.05 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 0.91000000000000003 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.0899999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 35' ' ' LEU . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 0.51000000000000001 109.924 -166.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 35' ' ' LEU . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 2.02 110.046 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 5.5099999999999998 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 2.3999999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 3.04 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.3999999999999999 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 1.22 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 1.3799999999999999 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.0 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 3.2799999999999998 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 2.46 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 0.85999999999999999 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 2.5800000000000001 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 0.71999999999999997 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 3.3300000000000001 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 1.5700000000000001 112.136 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.90000000000000002 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 3.1299999999999999 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1599999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 0.79000000000000004 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 2.1400000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 0.96999999999999997 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.26 115.59 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 3.1800000000000002 106.998 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -71.96 158.24 36.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.731 -1.122 . . . . 6.5899999999999999 108.651 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -132.18 159.39 39.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.521 -1.659 . . . . 5.0 106.521 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -51.5 146.11 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 123.588 0.555 . . . . 4.7300000000000004 110.385 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.0 144.69 44.39 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.843 -0.535 . . . . 4.2599999999999998 109.62 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.82 -59.93 0.35 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-O 119.159 -0.801 . . . . 5.8799999999999999 111.135 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.343 -1.313 . . . . 14.699999999999999 110.645 -170.531 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 107.674 -1.232 . . . . 3.8100000000000001 107.674 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -85.44 144.59 27.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.752 0.657 . . . . 2.7000000000000002 111.647 -171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 1.77 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 4.3200000000000003 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 1.3600000000000001 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 2.29 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 1.3 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 2.9199999999999999 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 2.2200000000000002 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p -86.8 56.79 4.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 1.6799999999999999 110.749 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.28 56.87 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.452 -1.059 . . . . 1.8500000000000001 110.452 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -54.12 15.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.107 0.563 . . . . 5.9900000000000002 109.634 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -70.7 56.91 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.846 2.058 . . . . 5.4900000000000002 111.413 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 m -113.97 66.47 0.67 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.535 -1.654 . . . . 2.6499999999999999 106.535 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 57.72 -73.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.012 2.125 . . . . 3.1699999999999999 112.76 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p -152.63 25.45 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.471 1.109 . . . . 2.29 111.497 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.2400000000000002 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 1.8 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 0.66000000000000003 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.1399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 1.73 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.2800000000000002 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 2.8999999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 2.5299999999999998 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 7.2199999999999998 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 5.7999999999999998 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.21 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' A' ' 45' ' ' VAL . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 1.6699999999999999 111.552 173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 2.2999999999999998 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 0.89000000000000001 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.0699999999999998 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 3.3300000000000001 112.105 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 0.65000000000000002 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 0.5 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 1.23 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 4.4100000000000001 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 0.85999999999999999 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 2.9100000000000001 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 0.44 109.944 -169.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.601 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 1.6000000000000001 108.538 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 3.4500000000000002 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 2.0 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 1.8200000000000001 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 1.1599999999999999 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 1.5900000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 1.3600000000000001 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 0.91000000000000003 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 0.93000000000000005 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 2.9300000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 1.95 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 0.71999999999999997 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 2.3199999999999998 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 0.62 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 3.5600000000000001 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 1.1699999999999999 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 2.8100000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.93000000000000005 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 0.77000000000000002 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.24 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 0.56000000000000005 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.74 -173.17 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 1.5800000000000001 109.279 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.51 176.64 11.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.436 1.494 . . . . 5.0899999999999999 107.305 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.42 -47.62 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.796 0.838 . . . . 5.79 109.815 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.35 174.63 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.632 1.173 . . . . 6.0 108.221 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 169.52 15.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.08 1.352 . . . . 4.7999999999999998 109.428 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.5 53.93 4.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.655 -0.978 . . . . 5.7400000000000002 110.655 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 . . . . . 0 C--O 1.254 1.307 0 N-CA-C 105.527 -2.027 . . . . 9.8499999999999996 105.527 179.445 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.874 -1.06 . . . . 4.1399999999999997 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p -166.09 127.49 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.418 1.463 . . . . 2.6299999999999999 109.74 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.1499999999999999 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 3.2599999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 1.6000000000000001 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 2.2400000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 0.77000000000000002 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 3.3700000000000001 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.0699999999999998 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -93.31 55.36 2.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.3100000000000001 111.663 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.29 40.53 0.1 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 122.129 -0.357 . . . . 1.75 112.212 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -27.58 63.84 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 122.399 -0.471 . . . . 7.1900000000000004 111.931 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.2 p -63.11 -10.99 16.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.066 0.546 . . . . 5.8200000000000003 111.454 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.2 t -62.15 126.79 28.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.983 0.81 . . . . 3.2599999999999998 111.693 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.61 -32.22 7.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.734 1.214 . . . . 2.77 112.547 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m -149.19 111.21 4.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.613 0.765 . . . . 3.1200000000000001 108.972 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 3.6000000000000001 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 1.96 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 0.88 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.27 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 1.99 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 4.4000000000000004 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 2.3199999999999998 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 1.8700000000000001 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 6.9800000000000004 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 8.1899999999999995 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.1499999999999999 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 45' ' ' VAL . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 1.8100000000000001 110.558 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 0.83999999999999997 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.0 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 3.1400000000000001 110.791 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.68000000000000005 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 0.46999999999999997 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 1.46 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 4.75 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 0.88 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.1200000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 0.51000000000000001 108.085 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 1.5600000000000001 109.179 -176.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.0300000000000002 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 1.9099999999999999 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 1.8999999999999999 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.84999999999999998 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.0 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 1.28 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 57' ' ' ILE . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 1.5 111.199 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 0.87 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 3.2799999999999998 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 52' ' ' ILE . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 2.2799999999999998 111.618 176.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 0.67000000000000004 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 2.7200000000000002 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 3.1699999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 1.04 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 2.8900000000000001 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.81000000000000005 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 0.83999999999999997 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 1.3899999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 0.66000000000000003 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.35 130.23 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 2.77 106.262 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -51.43 -66.18 0.43 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.93 1.292 . . . . 5.6600000000000001 111.106 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.477 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.6 t-20 57.56 85.41 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.218 1.407 . . . . 5.71 112.266 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 73' ' ' ASN . 4.9 tt 57.08 177.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.897 1.679 . . . . 4.5899999999999999 111.715 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.11 5.58 16.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.026 0.75 . . . . 4.7699999999999996 113.026 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.55 -47.64 0.84 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.391 -0.684 . . . . 5.8300000000000001 111.391 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 104.635 -2.357 . . . . 11.9 104.635 173.053 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.013 -0.518 . . . . 3.52 112.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t 77.74 147.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.607 1.563 . . . . 2.8300000000000001 110.509 -166.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 2.3999999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.0800000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.6699999999999999 106.488 169.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 3.9100000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 0.72999999999999998 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 2.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.0499999999999998 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -90.75 102.09 14.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 2.8500000000000001 110.106 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 37.91 1.69 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.672 -1.371 . . . . 1.7 109.672 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.0 ptp -75.69 -35.6 60.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 110.223 -0.288 . . . . 5.5 110.223 173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -74.63 60.39 0.9 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.366 1.066 . . . . 5.5800000000000001 110.087 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 m -137.57 67.34 1.43 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.681 0.792 . . . . 2.6800000000000002 109.254 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 71.26 -46.08 0.63 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.241 1.816 . . . . 2.8100000000000001 113.616 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 -89.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.843 0.857 . . . . 3.73 108.746 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 2.5800000000000001 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 1.8799999999999999 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 1.1399999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.3999999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 2.4900000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 3.9900000000000002 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 2.4500000000000002 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 1.78 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 7.25 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 5.6900000000000004 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.05 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 28' ' ' GLU . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 1.48 109.907 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 2.2999999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 0.81999999999999995 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.0699999999999998 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 1.99 113.07 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 0.67000000000000004 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 0.53000000000000003 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 1.3 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.0999999999999996 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 0.96999999999999997 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81000000000000005 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 5.7000000000000002 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 0.69999999999999996 109.44 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 1.5900000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 3.8999999999999999 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 2.0 110.135 -170.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 1.25 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 1.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.79000000000000004 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 4.4000000000000004 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 1.8899999999999999 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 0.70999999999999996 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 2.0 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 0.85999999999999999 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.1400000000000001 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 1.53 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.01 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 3.02 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.85999999999999999 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 1.4199999999999999 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 0.68999999999999995 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.51 140.18 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 1.48 109.644 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.43 156.83 30.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.894 -0.78 . . . . 5.6799999999999997 108.894 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -159.84 111.17 1.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.179 -1.786 . . . . 4.9199999999999999 106.179 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.264 2.4 tt 52.22 -167.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.943 1.297 . . . . 4.6600000000000001 110.953 -176.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -141.7 158.89 43.25 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.149 -1.426 . . . . 4.21 107.149 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.63 35.63 91.37 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 123.993 0.806 . . . . 6.0999999999999996 111.508 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? . . . . . 0 C--O 1.254 1.314 0 N-CA-C 103.427 -2.805 . . . . 11.16 103.427 167.336 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 106.867 -1.531 . . . . 5.2599999999999998 106.867 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 14.97 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 2.1800000000000002 116.588 136.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 1.8300000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 3.75 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 1.74 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 2.4199999999999999 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 0.90000000000000002 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 2.6699999999999999 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 2.4300000000000002 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -115.12 101.93 9.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.0099999999999998 109.903 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.2 17.13 2.5 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.136 1.35 . . . . 2.1499999999999999 112.191 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.5 ptp -64.32 -24.54 67.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.971 -0.723 . . . . 5.4900000000000002 112.087 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -61.81 -12.23 16.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.265 1.026 . . . . 5.4299999999999997 112.455 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -57.07 145.98 29.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.567 0.621 . . . . 2.2999999999999998 111.771 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -16.28 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 129.615 3.166 . . . . 3.3599999999999999 115.553 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -149.64 47.49 0.95 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 1.9099999999999999 109.219 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 2.6800000000000002 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 0.68000000000000005 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 1.96 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' CG2' HD21 ' A' ' 35' ' ' LEU . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 109.622 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.21 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 2.8999999999999999 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 2.4700000000000002 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 6.5099999999999998 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 6.5599999999999996 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.1799999999999997 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 0.92000000000000004 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 57' ' ' ILE . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 1.6699999999999999 109.791 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 2.2999999999999998 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 0.81000000000000005 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 3.1400000000000001 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 35' ' ' LEU . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 1.6599999999999999 111.767 -173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 0.94999999999999996 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 0.68000000000000005 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 1.8100000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 4.6900000000000004 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 0.88 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.69999999999999996 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.0600000000000001 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 0.44 107.157 -168.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.3599999999999999 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 2.3999999999999999 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.0599999999999996 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 2.2999999999999998 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.0899999999999999 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.5600000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 1.46 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 1.9399999999999999 112.689 -157.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 2.6400000000000001 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 1.77 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.48 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 3.9399999999999999 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 2.3300000000000001 111.023 176.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 0.71999999999999997 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 2.1800000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 0.89000000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 3.4300000000000002 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.88 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 2.3900000000000001 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.90000000000000002 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 0.73999999999999999 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 1.48 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 0.56999999999999995 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 131.32 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 2.7400000000000002 106.981 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -58.16 167.82 1.19 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.272 1.829 . . . . 6.0899999999999999 111.668 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.32 154.48 7.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.924 -0.769 . . . . 5.8499999999999996 108.924 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -74.73 178.94 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 124.121 0.888 . . . . 4.3700000000000001 110.902 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.73 150.73 21.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.337 1.455 . . . . 5.5800000000000001 110.606 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.81 64.45 3.03 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.829 -0.623 . . . . 7.0 111.56 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.861 2.064 . . . . 13.359999999999999 111.588 -170.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 106.839 -1.541 . . . . 4.0599999999999996 106.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p 176.35 133.91 0.05 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 2.5800000000000001 105.61 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 4.9900000000000002 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' SG ' HG13 ' A' ' 45' ' ' VAL . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.6099999999999999 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 4.7999999999999998 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 1.1200000000000001 105.961 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.0299999999999998 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 2.73 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p -138.64 96.58 3.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 2.5800000000000001 109.652 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.35 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.809 -2.516 . . . . 2.4700000000000002 106.809 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 mmt -44.36 -53.89 6.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.589 1.156 . . . . 6.1200000000000001 109.998 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.52 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.343 1.857 . . . . 8.7599999999999998 107.301 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -168.2 -158.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.16 -1.422 . . . . 4.4500000000000002 107.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.91 -78.88 0.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.755 1.161 . . . . 4.0099999999999998 110.368 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 78.09 4.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.895 -1.128 . . . . 2.5499999999999998 110.693 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.0699999999999998 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 2.5099999999999998 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 1.03 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.1399999999999999 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.413 ' CG1' HD11 ' A' ' 64' ' ' LEU . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 2.0299999999999998 109.387 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.1600000000000001 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.0 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 1.78 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 6.3200000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 9.3200000000000003 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.05 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 45' ' ' VAL . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 1.5600000000000001 109.899 173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 2.3100000000000001 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 0.77000000000000002 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.0 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 1.79 111.076 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 0.54000000000000004 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 0.40999999999999998 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 1.5900000000000001 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 4.7699999999999996 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 0.92000000000000004 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.0199999999999996 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 0.52000000000000002 108.614 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.5 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 1.6200000000000001 108.777 -177.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 5.1200000000000001 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 1.95 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 1.8500000000000001 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 0.96999999999999997 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 1.29 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 HG23 ' A' ' 57' ' ' ILE . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 1.4399999999999999 113.129 -169.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.81999999999999995 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 4.3399999999999999 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 2.2000000000000002 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 0.64000000000000001 110.994 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 2.1099999999999999 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 0.68000000000000005 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 2.3999999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 1.4099999999999999 111.512 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 2.8799999999999999 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 0.66000000000000003 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 1.6100000000000001 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 0.59999999999999998 108.932 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt -134.53 160.66 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 1.5 109.504 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.9 176.77 5.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.045 2.138 . . . . 5.4199999999999999 107.906 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -155.39 -50.99 0.09 Allowed 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 122.938 0.495 . . . . 4.8200000000000003 109.84 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.81 146.28 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.339 -0.986 . . . . 4.9500000000000002 108.339 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.14 3.29 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.54 1.536 . . . . 5.6699999999999999 111.737 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.94 134.84 7.22 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.141 -2.384 . . . . 7.2400000000000002 107.141 -160.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 105.29 -2.115 . . . . 12.51 105.29 168.862 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.843 -0.799 . . . . 6.04 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -42.75 129.64 4.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.537 1.535 . . . . 2.9300000000000002 112.687 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 3.21 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 3.8300000000000001 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 1.74 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 3.1699999999999999 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 1.1499999999999999 105.631 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 3.6400000000000001 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 12' ' ' MET . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 3.1299999999999999 108.028 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p -109.42 64.46 0.61 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 2.1899999999999999 109.65 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.34 43.69 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.701 0.667 . . . . 2.0 111.932 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.419 ' O ' HG11 ' A' ' 9' ' ' VAL . 30.3 mtm 44.99 -106.41 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.257 1.023 . . . . 6.96 110.447 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 18' ' ' VAL . 1.2 t -158.18 30.95 0.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.255 -1.387 . . . . 7.7999999999999998 107.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 68.81 -79.8 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.425 -0.797 . . . . 2.8300000000000001 111.704 -167.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.72 129.6 0.08 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.055 1.342 . . . . 2.75 108.876 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m 54.72 16.27 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.2599999999999998 114.114 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 2.8399999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.565 ' H ' HG21 ' A' ' 13' ' ' THR . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 2.4399999999999999 110.124 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 0.92000000000000004 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.1200000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 64' ' ' LEU . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 1.9099999999999999 109.435 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 7.71 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.4199999999999999 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 1.9399999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 5.7800000000000002 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.1500000000000004 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.29 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 57' ' ' ILE . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 1.6299999999999999 110.243 174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 2.6800000000000002 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 2.4199999999999999 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 3.3300000000000001 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 1.8100000000000001 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 0.68000000000000005 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 0.56000000000000005 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' A' ' 13' ' ' THR . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 1.2 110.952 171.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 3.8500000000000001 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 0.94999999999999996 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.68999999999999995 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 3.6299999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 0.55000000000000004 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.2200000000000002 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 1.6100000000000001 108.286 -177.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 3.6499999999999999 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 2.0899999999999999 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.29 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.2 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 1.3500000000000001 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 57' ' ' ILE . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 1.53 112.173 -169.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 2.8900000000000001 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 0.93999999999999995 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.0699999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 2.3799999999999999 111.453 177.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 0.79000000000000004 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 2.4300000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 2.52 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 21' ' ' ILE . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 1.2 112.53 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.95999999999999996 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 2.73 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.75 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 0.60999999999999999 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 1.24 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt -145.2 173.19 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 1.6100000000000001 107.964 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -159.09 176.68 11.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.666 -1.605 . . . . 5.5999999999999996 106.666 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.66 111.87 3.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.826 -1.546 . . . . 5.5899999999999999 106.826 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.3 pt 51.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.247 1.419 . . . . 4.6900000000000004 112.063 -172.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -141.84 158.56 43.64 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.967 1.707 . . . . 4.7599999999999998 106.604 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.24 -61.32 0.14 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.205 -0.758 . . . . 5.79 111.205 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 . . . . . 0 C--O 1.256 1.439 0 CA-C-O 115.951 -1.976 . . . . 15.51 106.356 -179.312 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 104.304 -2.48 . . . . 4.4000000000000004 104.304 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.51 148.05 10.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.939 -0.704 . . . . 2.1600000000000001 109.664 -144.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 2.1099999999999999 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 3.52 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 1.74 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 3.2000000000000002 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 0.70999999999999996 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 2.5 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 1.99 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -85.86 55.82 3.7 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 1.99 111.522 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.39 57.99 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 N-CA-C 109.908 -1.277 . . . . 1.71 109.908 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -41.37 73.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.267 0.227 . . . . 7.46 110.615 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.297 1.039 . . . . 6.2800000000000002 109.888 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.53 142.09 51.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.904 1.282 . . . . 2.52 109.328 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 90.63 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.351 0.66 . . . . 3.5699999999999998 110.601 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m 64.1 29.72 14.03 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.618 1.167 . . . . 1.8799999999999999 112.711 170.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 2.02 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 1.0 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.22 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 21' ' ' ILE . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 1.76 109.067 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 3.9199999999999999 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 3.5800000000000001 109.608 172.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 1.97 111.455 -165.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 6.5199999999999996 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.2400000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 0.93999999999999995 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 1.53 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 2.21 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 0.79000000000000004 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 4.2400000000000002 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 34' ' ' ILE . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 1.8999999999999999 111.745 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 0.56999999999999995 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 0.45000000000000001 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 1.3200000000000001 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 4.6100000000000003 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 0.98999999999999999 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 3.25 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 0.58999999999999997 109.683 -168.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.3799999999999999 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 1.75 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 4.6600000000000001 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 1.7 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.1499999999999999 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 1.48 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 1.22 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 0.85999999999999999 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.02 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 1.9299999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 0.76000000000000001 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 2.0899999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 0.77000000000000002 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 3.8100000000000001 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 1.27 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 2.4399999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.59999999999999998 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 0.53000000000000003 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 1.1799999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 0.59999999999999998 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt -135.94 -177.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 1.6699999999999999 108.221 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -169.11 -172.92 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.597 -2.001 . . . . 5.3700000000000001 105.597 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 -58.98 0.16 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.71 0.687 . . . . 6.2699999999999996 109.755 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.3 pt -145.39 146.59 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.05 -1.092 . . . . 4.5 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -75.74 147.18 39.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.742 1.217 . . . . 4.5599999999999996 109.37 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.37 55.35 4.38 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.398 -0.681 . . . . 6.0 111.398 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.978 -1.01 . . . . 9.9000000000000004 108.67 -158.769 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.473 -0.936 . . . . 4.5300000000000002 108.473 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t -77.47 151.02 34.86 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 2.8399999999999999 108.176 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 1.79 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 2.9900000000000002 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 1.3600000000000001 107.28 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 2.6400000000000001 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 0.97999999999999998 106.091 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 4.5499999999999998 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 2.52 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p -139.11 81.38 1.84 Allowed 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 2.4100000000000001 110.059 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.76 72.85 1.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.334 -2.307 . . . . 2.7000000000000002 107.334 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -48.86 16.01 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.298 1.039 . . . . 7.5199999999999996 110.675 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 177.69 -54.2 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.747 1.619 . . . . 8.9900000000000002 107.253 168.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -167.73 177.49 5.77 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.093 -1.447 . . . . 4.4800000000000004 107.093 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 32.17 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.198 1.799 . . . . 4.6200000000000001 115.002 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p -163.68 11.48 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.521 1.129 . . . . 2.1499999999999999 112.311 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.2400000000000002 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 2.2400000000000002 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 0.87 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.1799999999999999 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 1.6899999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 5.5300000000000002 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 2.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 2.3799999999999999 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 5.9000000000000004 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 8.8399999999999999 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 0.85999999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 1.5900000000000001 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 2.9399999999999999 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 1.02 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.1200000000000001 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 112.929 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 0.58999999999999997 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 1.9199999999999999 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 4.5 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 1.3700000000000001 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.1200000000000001 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 2.8999999999999999 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 0.57999999999999996 108.158 -169.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 2.9100000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 1.6299999999999999 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 3.98 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 1.9199999999999999 110.793 -170.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.27 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 1.48 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 1.3799999999999999 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 57' ' ' ILE . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 1.3600000000000001 112.192 -169.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 0.89000000000000001 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 3.29 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 2.2599999999999998 111.538 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 0.81999999999999995 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 2.3599999999999999 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 2.2999999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 1.1799999999999999 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 2.7599999999999998 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.85999999999999999 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 0.68000000000000005 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 1.51 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 0.71999999999999997 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp -144.79 164.28 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 1.6899999999999999 108.225 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.86 139.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.005 1.322 . . . . 8.5099999999999998 111.728 -176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.61 45.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.307 0.643 . . . . 7.7999999999999998 109.396 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.19 146.31 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.776 0.83 . . . . 4.2699999999999996 110.299 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -69.66 166.43 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 4.29 109.501 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -71.69 0.74 Allowed Glycine 0 CA--C 1.531 1.038 0 N-CA-C 112.073 -0.411 . . . . 6.7999999999999998 112.073 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.743 1.617 . . . . 10.43 112.625 -171.649 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 107.119 -1.437 . . . . 3.9500000000000002 107.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -143.03 148.83 37.39 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 3.3700000000000001 107.161 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 2.0299999999999998 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.1800000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 1.6499999999999999 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 3.2599999999999998 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 0.71999999999999997 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 1.9199999999999999 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p -115.49 78.39 1.17 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 1.99 109.144 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.48 28.09 0.85 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.511 1.053 . . . . 1.55 111.567 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -32.03 73.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.248 0.619 . . . . 5.1600000000000001 111.897 172.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -76.33 60.07 1.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.28 1.032 . . . . 5.3899999999999997 110.257 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -105.36 -85.92 0.48 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.366 0.666 . . . . 3.1000000000000001 109.858 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.47 92.24 0.88 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.811 -1.181 . . . . 3.3799999999999999 107.811 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p 43.18 35.75 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.769 1.628 . . . . 2.0299999999999998 113.447 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 2.46 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 2.7400000000000002 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 0.66000000000000003 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.0600000000000001 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 1.9199999999999999 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.0800000000000001 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 3.25 107.434 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 1.99 114.583 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 8.5399999999999991 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 6.7199999999999998 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 0.94999999999999996 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 HD23 ' A' ' 25' ' ' LEU . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 2.1499999999999999 108.057 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 2.4399999999999999 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 0.77000000000000002 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 3.2000000000000002 112.132 -174.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.0099999999999998 111.842 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 0.80000000000000004 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 1.28 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 4.4000000000000004 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 0.80000000000000004 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.68999999999999995 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 2.96 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 0.68000000000000005 109.72 -163.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 1.6499999999999999 109.435 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 3.9300000000000002 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 1.8200000000000001 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 2.8399999999999999 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.1399999999999999 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 1.3700000000000001 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 1.6399999999999999 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 1.8500000000000001 110.539 -166.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 0.92000000000000004 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 4.2300000000000004 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.625 HG23 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 1.8999999999999999 111.056 175.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 0.71999999999999997 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 2.1899999999999999 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 0.73999999999999999 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 3.3300000000000001 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 1.74 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.77000000000000002 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 2.8500000000000001 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.02 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 0.93000000000000005 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 2.7799999999999998 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 0.71999999999999997 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt -136.97 172.39 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 1.5700000000000001 111.221 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 67.48 -67.17 0.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.209 2.203 . . . . 8.5299999999999994 112.011 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 58.02 23.71 10.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 8.5500000000000007 112.731 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 pt -64.88 133.32 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.783 -0.573 . . . . 5.4500000000000002 112.405 -166.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -90.05 4.24 50.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.922 1.289 . . . . 5.2199999999999998 113.484 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.14 129.59 2.34 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.982 -2.047 . . . . 5.9800000000000004 107.982 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.377 0 N-CA-C 104.888 -2.264 . . . . 12.16 104.888 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.028 -1.101 . . . . 3.71 108.028 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -170.04 151.14 3.93 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 2.2599999999999998 107.552 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.0099999999999998 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 3.9500000000000002 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 1.6100000000000001 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 2.6899999999999999 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 0.72999999999999998 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 2.25 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 2.3199999999999998 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -130.98 123.52 28.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 2.1299999999999999 109.274 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.89 33.7 3.99 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.929 1.252 . . . . 1.5900000000000001 110.017 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -44.66 93.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 117.009 0.405 . . . . 5.71 110.517 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m -70.14 59.56 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.347 1.859 . . . . 5.8499999999999996 110.494 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.38 170.4 8.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.333 1.453 . . . . 2.21 109.366 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.75 77.22 0.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.743 0.817 . . . . 4.0999999999999996 110.742 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m 70.1 46.71 0.61 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.568 1.547 . . . . 2.0499999999999998 113.159 169.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.1699999999999999 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 1.8700000000000001 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 1.28 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.1799999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 1.9099999999999999 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 34' ' ' ILE . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 6.3200000000000003 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.0499999999999998 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' A' ' 34' ' ' ILE . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 2.5499999999999998 113.408 -165.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 6.1699999999999999 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 5.5300000000000002 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 0.94999999999999996 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 1.6299999999999999 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 2.1099999999999999 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.29 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 5.6699999999999999 111.664 -170.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 1.95 112.027 -163.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 0.68999999999999995 110.841 -174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 0.46000000000000002 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 1.25 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 3.5800000000000001 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 1.1100000000000001 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 3.1600000000000001 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 0.72999999999999998 111.329 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 2.8999999999999999 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 2.4300000000000002 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 3.2200000000000002 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 1.9199999999999999 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 1.8799999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.0900000000000001 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 1.3100000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 57' ' ' ILE . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 1.25 112.238 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.03 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.2200000000000002 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 52' ' ' ILE . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 2.8999999999999999 111.666 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 0.65000000000000002 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 2.2400000000000002 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 0.79000000000000004 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 2.3500000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 1.1899999999999999 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 2.2999999999999998 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 0.84999999999999998 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 2.0299999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 0.83999999999999997 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt -141.6 171.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 1.8200000000000001 108.312 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -142.75 106.43 4.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.014 -1.846 . . . . 6.3399999999999999 106.014 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -74.73 -54.25 7.72 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 109.732 -0.47 . . . . 5.54 109.732 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 pt -149.27 159.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.274 1.83 . . . . 4.7999999999999998 106.237 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.85 167.21 9.92 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.539 1.136 . . . . 4.3200000000000003 109.815 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.44 -67.34 2.54 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.642 0.639 . . . . 6.6399999999999997 111.75 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.361 -1.304 . . . . 11.18 108.912 175.701 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 104.521 -2.4 . . . . 4.5 104.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -48.14 154.41 0.58 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 1.97 111.124 142.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 1.8300000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 2.8900000000000001 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 1.6200000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 3.3599999999999999 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 0.87 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 2.54 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 2.7200000000000002 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -139.78 55.01 1.66 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 2.71 110.468 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.8 36.09 0.07 OUTLIER Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.261 -0.881 . . . . 1.5600000000000001 111.389 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -29.13 70.17 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.56 -0.965 . . . . 6.9199999999999999 111.594 -173.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -51.34 -15.22 0.36 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.037 1.335 . . . . 6.6200000000000001 112.287 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -40.69 -36.67 0.63 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.174 0.99 . . . . 2.8500000000000001 113.272 165.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 66.08 87.16 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.44 0.696 . . . . 3.3700000000000001 112.101 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p 79.83 115.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.953 2.101 . . . . 2.9100000000000001 109.333 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 2.5499999999999998 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 1.9299999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 0.93000000000000005 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 2.5099999999999998 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.601 HD11 HD21 ' A' ' 64' ' ' LEU . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 3.2200000000000002 110.363 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 6.7000000000000002 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 2.7000000000000002 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.77 HD23 HG11 ' A' ' 45' ' ' VAL . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 1.8300000000000001 111.244 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 7.7400000000000002 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.0899999999999999 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.0 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 0.88 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 1.6799999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 2.0699999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 0.75 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 3.3700000000000001 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 3.2599999999999998 110.72 170.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 0.67000000000000004 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 0.95999999999999996 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 2.3999999999999999 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 3.8900000000000001 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 1.21 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 0.77000000000000002 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 4.8099999999999996 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 0.58999999999999997 109.06 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.2799999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.77 HG11 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 2.23 108.856 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 3.6499999999999999 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 2.52 110.312 -171.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 1.98 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 1.46 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 1.5 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 57' ' ' ILE . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 1.3400000000000001 113.658 -166.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.7400000000000002 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.26 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.29 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 3.1899999999999999 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 2.3700000000000001 111.954 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 0.62 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 2.3399999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 0.92000000000000004 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 3.79 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.636 ' HG2' HD23 ' A' ' 64' ' ' LEU . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.636 HD23 ' HG2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 113.184 175.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.69999999999999996 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 2.8999999999999999 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.68000000000000005 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 0.68999999999999995 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 1.48 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 0.88 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.81 147.92 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 2.1000000000000001 108.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -165.25 -168.73 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.086 1.354 . . . . 6.5599999999999996 107.459 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.51 164.42 24.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.945 -1.502 . . . . 5.4199999999999999 106.945 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 pt -61.36 143.9 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.621 -0.511 . . . . 10.5 109.621 173.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.57 176.32 12.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.364 1.466 . . . . 7.1699999999999999 107.231 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.73 46.9 6.14 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.616 -0.547 . . . . 10.369999999999999 111.877 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.603 1.961 . . . . 17.699999999999999 108.844 -173.3 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.161 -0.447 . . . . 4.3099999999999996 110.097 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -72.77 110.85 7.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.1200000000000001 109.092 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 1.8500000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 5.9800000000000004 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 2.8300000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 2.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 0.88 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 2.8199999999999998 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 2.54 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m -74.3 114.76 13.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 2.1600000000000001 109.588 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.71 41.09 6.93 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.245 -1.142 . . . . 2.4300000000000002 110.245 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.1 mtt 58.86 -158.45 0.3 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 7.6900000000000004 110.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.775 HG21 ' HB ' ' A' ' 18' ' ' VAL . 11.4 t -103.65 35.45 2.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.966 1.707 . . . . 7.7300000000000004 107.953 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t 64.19 -68.82 0.09 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.602 1.561 . . . . 3.0099999999999998 113.535 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.48 -124.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.324 1.45 . . . . 3.4900000000000002 107.603 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -71.2 30.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.945 -1.097 . . . . 2.25 113.894 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 2.7200000000000002 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.775 ' HB ' HG21 ' A' ' 13' ' ' THR . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 2.27 111.164 -178.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 1.1899999999999999 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6699999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 2.21 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 5.0599999999999996 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 2.6200000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 45' ' ' VAL . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 2.5600000000000001 113.433 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 8.3000000000000007 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 9.3599999999999994 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.72 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 1.72 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 2.48 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 0.84999999999999998 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 3.3199999999999998 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 1.6599999999999999 111.473 175.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 0.72999999999999998 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.482 ' HG ' HG22 ' A' ' 13' ' ' THR . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 1.8200000000000001 109.889 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 3.8300000000000001 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.05 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 2.7000000000000002 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 0.48999999999999999 109.13 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 2.79 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 2.5499999999999998 108.199 176.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.0 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 2.3999999999999999 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 2.6699999999999999 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 1.78 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 3.29 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.669 HD12 HG23 ' A' ' 57' ' ' ILE 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 3.1299999999999999 108.065 -172.17 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 52' ' ' ILE . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.1899999999999999 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 2.6200000000000001 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.669 HG23 HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 2.5499999999999998 111.015 176.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 1.3899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 2.1499999999999999 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 2.8599999999999999 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 1.3 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.76000000000000001 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 2.5600000000000001 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.75 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 1.3600000000000001 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 0.80000000000000004 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.86 -165.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 1.6899999999999999 108.305 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 41.4 73.11 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.175 1.39 . . . . 8.7799999999999994 112.972 171.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.0 72.14 1.0 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.958 1.303 . . . . 8.0 107.96 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.8 mt -106.94 4.53 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 122.54 1.162 . . . . 7.4900000000000002 112.144 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -98.41 121.95 40.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.203 2.201 . . . . 7.7400000000000002 110.325 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.15 73.43 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.446 -1.862 . . . . 9.6799999999999997 108.446 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 . . . . . 0 C--O 1.253 1.266 0 CA-C-O 116.667 -1.635 . . . . 16.539999999999999 110.299 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 107.587 -1.264 . . . . 5.1399999999999997 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m 65.86 56.51 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.197 0.999 . . . . 3.6499999999999999 113.085 171.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 1.8100000000000001 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 3.3700000000000001 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 1.6200000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 2.4199999999999999 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 70' ' ' VAL . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 0.73999999999999999 107.337 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 2.6400000000000001 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 1.8500000000000001 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -73.54 110.11 7.58 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 2.0899999999999999 110.322 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.45 35.08 12.42 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.863 -0.895 . . . . 2.6099999999999999 110.863 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 52.93 -150.53 0.35 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.223 1.009 . . . . 7.0800000000000001 110.197 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -105.32 30.82 5.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.655 0.782 . . . . 7.5700000000000003 109.095 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 56.5 -162.22 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.794 -0.566 . . . . 2.2400000000000002 111.884 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.7 89.85 6.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.088 -1.079 . . . . 3.6699999999999999 108.088 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m 75.95 74.77 0.09 Allowed 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 125.498 1.519 . . . . 2.4500000000000002 112.555 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 2.7400000000000002 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 2.0 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 0.68000000000000005 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.25 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 1.79 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 6.5300000000000002 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.3500000000000001 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 2.6899999999999999 111.882 -172.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 7.0800000000000001 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.0700000000000003 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 0.98999999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 1.8300000000000001 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 2.3999999999999999 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 0.96999999999999997 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 5.5199999999999996 110.142 -173.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.649 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 1.98 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.77000000000000002 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 0.5 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 2.5299999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 5.2699999999999996 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 1.28 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.80000000000000004 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 3.4700000000000002 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 0.47999999999999998 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 1.6399999999999999 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 4.1799999999999997 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 1.8100000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 1.76 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 1.02 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 1.3100000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 1.24 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.80000000000000004 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.0699999999999998 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 1.96 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 0.89000000000000001 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 1.97 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 2.3900000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 1.29 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 2.5600000000000001 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 0.90000000000000002 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 1.2 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 7' ' ' ILE . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 0.72999999999999998 108.283 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.66 161.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 2.3399999999999999 108.299 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.34 -162.37 0.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.008 1.323 . . . . 6.3399999999999999 109.499 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.37 -85.73 0.05 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.369 -0.832 . . . . 5.7699999999999996 109.284 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.03 10.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 122.499 1.142 . . . . 4.7800000000000002 112.239 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -162.6 176.25 10.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.097 2.159 . . . . 6.5499999999999998 107.595 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.92 91.99 1.41 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.835 -1.706 . . . . 11.65 108.835 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.187 -1.387 . . . . 20.280000000000001 109.109 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 108.082 -1.081 . . . . 4.1600000000000001 108.082 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -147.17 133.84 19.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 2.9300000000000002 108.738 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.0 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 3.29 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.3599999999999999 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 3.7000000000000002 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG12 HG23 ' A' ' 70' ' ' VAL . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 0.92000000000000004 106.519 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 3.73 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 2.5099999999999998 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p -104.33 72.55 1.07 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 1.73 109.5 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.09 49.05 0.05 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.455 1.026 . . . . 1.5700000000000001 111.884 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -31.76 62.3 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.921 -0.752 . . . . 6.5300000000000002 110.561 176.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 t -73.21 59.11 0.54 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.471 1.108 . . . . 5.5999999999999996 109.803 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.87 171.42 7.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.091 1.356 . . . . 2.1099999999999999 108.325 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 83.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.252 1.021 . . . . 3.5899999999999999 112.409 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m 63.18 29.56 16.04 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.459 1.503 . . . . 2.1800000000000002 111.764 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 2.1400000000000001 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 2.1899999999999999 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 0.88 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.1100000000000001 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 1.74 109.073 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 5.4900000000000002 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 3.2799999999999998 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 45' ' ' VAL . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 2.77 110.457 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 5.5199999999999996 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 6.3499999999999996 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 0.83999999999999997 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 1.5600000000000001 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 2.5299999999999998 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 45' ' ' VAL . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 0.76000000000000001 109.833 -174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 3.5499999999999998 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.727 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 1.6799999999999999 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 0.85999999999999999 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 0.54000000000000004 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 1.52 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 5.71 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 0.95999999999999996 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.0299999999999998 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 0.53000000000000003 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 2.46 109.702 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 3.7200000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 1.98 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 1.8700000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 0.98999999999999999 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 1.28 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 1.28 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 2.1800000000000002 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.3200000000000001 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.3100000000000001 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 2.6899999999999999 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 2.1600000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 0.84999999999999998 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 2.4199999999999999 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 1.3999999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 2.7799999999999998 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 21' ' ' ILE . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 1.04 111.443 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 6.1600000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 1.3500000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG23 HG12 ' A' ' 7' ' ' ILE . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 0.75 106.446 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.12 154.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 1.8700000000000001 107.938 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -103.27 169.64 8.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.404 -0.962 . . . . 5.5 108.404 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.98 -64.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.447 -1.686 . . . . 6.0300000000000002 106.447 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -165.23 178.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.004 -1.48 . . . . 4.71 107.004 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -68.16 169.94 9.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.371 1.068 . . . . 5.4800000000000004 111.319 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.5 -66.45 2.58 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.829 -0.544 . . . . 6.5099999999999998 111.771 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 N-CA-C 103.019 -2.956 . . . . 13.869999999999999 103.019 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 115.721 -2.085 . . . . 4.3399999999999999 105.822 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m 80.93 82.55 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 121.234 1.834 . . . . 3.0299999999999998 114.322 167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 1.8 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 4.3700000000000001 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 45' ' ' VAL . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 1.9099999999999999 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 3.29 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 70' ' ' VAL . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 0.77000000000000002 105.882 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 2.9100000000000001 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 1.8500000000000001 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -94.85 67.16 3.16 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 2.4399999999999999 109.265 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.13 36.32 0.12 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.44 0.543 . . . . 1.6399999999999999 112.832 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.14 93.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.535 0.668 . . . . 4.96 111.054 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -70.63 61.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.747 2.019 . . . . 5.5300000000000002 111.008 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -113.26 -167.99 1.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.963 1.305 . . . . 2.1899999999999999 108.066 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.2 76.97 0.36 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.983 -1.073 . . . . 3.4300000000000002 110.801 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m 61.67 39.2 14.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.27 1.428 . . . . 1.8600000000000001 112.39 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.1899999999999999 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 1.7 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 0.73999999999999999 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.25 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 3.6499999999999999 111.458 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 5.1500000000000004 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.0299999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 2.8300000000000001 112.231 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 8.4700000000000006 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 9.1600000000000001 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.1499999999999999 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 1.3999999999999999 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 2.3199999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.0600000000000001 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 4.8300000000000001 111.717 -175.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 34' ' ' ILE . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 1.8999999999999999 112.901 -174.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 0.65000000000000002 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 0.70999999999999996 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 1.5600000000000001 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 4.6900000000000004 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 1.0700000000000001 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 3.3599999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 0.57999999999999996 108.896 -168.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 2.5 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 1.76 109.421 -173.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 3.8399999999999999 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 1.76 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 1.8 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 1.6100000000000001 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 1.3400000000000001 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 0.94999999999999996 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 0.97999999999999998 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 4.0899999999999999 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 1.98 112.203 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 0.92000000000000004 111.759 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 2.4900000000000002 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 0.92000000000000004 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 3.1299999999999999 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 21' ' ' ILE . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 1.1299999999999999 111.474 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.72999999999999998 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 2.2999999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.77000000000000002 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 0.63 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 1.22 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.567 HG23 HG12 ' A' ' 7' ' ' ILE . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 0.75 108.453 -172.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.93 159.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 1.6699999999999999 109.983 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.74 168.91 8.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.595 -0.729 . . . . 6.5700000000000003 109.314 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -169.91 -176.68 2.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.634 -1.247 . . . . 6.0099999999999998 107.634 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 pt -52.18 109.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.855 0.36 . . . . 7.29 111.525 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -71.28 172.43 9.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.093 0.557 . . . . 5.0499999999999998 110.563 172.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -51.87 -52.19 35.93 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.873 0.749 . . . . 6.4199999999999999 111.377 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.441 -1.742 . . . . 10.449999999999999 109.992 -176.138 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.8 p30 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 117.484 -1.246 . . . . 4.1500000000000004 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -59.28 143.27 49.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.609 1.095 . . . . 2.2599999999999998 112.225 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 1.79 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 2.96 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 1.54 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 2.4300000000000002 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 0.73999999999999999 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 2.3199999999999998 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 2.1499999999999999 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -89.23 80.5 6.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 2.54 109.148 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.44 56.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.112 -0.795 . . . . 1.74 111.112 172.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.11 -44.09 22.75 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.939 0.496 . . . . 6.1799999999999997 110.323 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -74.83 61.64 1.03 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 5.9100000000000001 110.334 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 m -117.4 151.92 36.03 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.678 1.591 . . . . 2.71 108.17 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 77.23 0.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.642 0.777 . . . . 3.9399999999999999 110.926 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 79.6 123.61 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 127.31 2.244 . . . . 3.2200000000000002 110.248 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.2200000000000002 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 1.8899999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 1.02 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.21 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 1.95 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' ILE . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 3.96 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 2.8300000000000001 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 34' ' ' ILE . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 2.2000000000000002 110.316 -173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 8.1500000000000004 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 6.4699999999999998 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.1599999999999999 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 1.5600000000000001 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 2.1000000000000001 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 0.81000000000000005 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 22' ' ' GLU . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 5.71 112.248 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.515 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 1.95 112.346 -169.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 0.69999999999999996 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 0.48999999999999999 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 1.3600000000000001 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 4.0800000000000001 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.1699999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.01 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 5.4400000000000004 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 0.93000000000000005 107.653 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.3500000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 2.3999999999999999 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.0800000000000001 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 2.0099999999999998 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 3.1299999999999999 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.1299999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 1.26 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.425 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 1.3799999999999999 112.779 -165.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.23 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 3.2999999999999998 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 3.1200000000000001 111.685 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 0.71999999999999997 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 2.0499999999999998 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 0.65000000000000002 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 2.52 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 1.0700000000000001 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.68000000000000005 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 2.73 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 0.53000000000000003 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 1.8500000000000001 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 0.80000000000000004 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt -143.28 159.11 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 1.8 108.807 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.14 -68.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.828 -1.545 . . . . 6.1500000000000004 106.828 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.13 31.48 8.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.218 0.533 . . . . 6.5 110.899 172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.8 pt -149.66 167.7 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 126.85 2.06 . . . . 6.2699999999999996 106.473 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.86 166.84 21.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.156 -0.683 . . . . 7.0700000000000003 109.156 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.93 51.84 0.18 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.562 -1.415 . . . . 9.4100000000000001 109.562 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.428 1.491 . . . . 15.529999999999999 107.385 -179.033 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 117.961 -1.018 . . . . 4.1100000000000003 108.7 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -144.11 149.45 36.57 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.55 1.14 . . . . 3.4300000000000002 108.575 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 1.8200000000000001 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 2.75 109.179 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 2.5800000000000001 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 1.53 105.754 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 2.8999999999999999 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.02 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p -81.56 69.9 8.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.07 48.74 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.679 1.133 . . . . 1.4099999999999999 111.075 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.476 ' CE ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -60.95 -36.79 80.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.173 -0.604 . . . . 6.5 112.192 177.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 38' ' ' LEU . 2.7 p -67.0 25.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.327 1.851 . . . . 5.4199999999999999 113.256 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 m -80.75 70.53 7.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.099 -1.001 . . . . 2.4900000000000002 109.563 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.89 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.266 1.827 . . . . 3.3300000000000001 112.579 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -155.01 35.21 0.39 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.847 1.259 . . . . 2.0800000000000001 110.309 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 2.5 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 2.04 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 0.87 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 2.0800000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 4.9199999999999999 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.1400000000000001 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 35' ' ' LEU . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 1.9399999999999999 113.975 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 7.6399999999999997 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 6.4299999999999997 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 1.73 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 2.3300000000000001 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 0.78000000000000003 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 3.1000000000000001 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.849 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 2.6800000000000002 113.745 -168.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 0.95999999999999996 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' LYS . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 0.52000000000000002 108.697 162.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 13' ' ' THR . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 1.79 110.594 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 3.9900000000000002 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 0.87 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.69999999999999996 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.0699999999999998 107.42 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.849 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 0.48999999999999999 109.149 -170.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.1899999999999999 109.117 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 1.6000000000000001 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 3.79 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 2.3999999999999999 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 2.3500000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 1.5700000000000001 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 3.5600000000000001 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 3.3100000000000001 109.879 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 1.8400000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.24 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 2.75 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 47' ' ' TYR . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 2.6800000000000002 111.567 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 1.0 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 2.2200000000000002 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 0.68999999999999995 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 2.7400000000000002 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.26 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.1000000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 2.6299999999999999 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.62 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 0.55000000000000004 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 1.3799999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 0.96999999999999997 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.39 168.08 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 2.23 109.21 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 54.89 -179.82 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.355 0.597 . . . . 9.6999999999999993 111.056 -167.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 169.56 91.17 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 126.805 2.042 . . . . 7.0599999999999996 107.606 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.36 157.61 34.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.526 0.679 . . . . 5.1900000000000004 109.68 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -73.92 165.81 24.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.566 -0.743 . . . . 6.1799999999999997 109.589 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.62 95.22 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.609 -0.996 . . . . 7.7000000000000002 110.609 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.834 1.254 . . . . 11.77 109.407 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 106.726 -1.583 . . . . 3.9300000000000002 106.726 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -165.28 158.13 16.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.0800000000000001 107.78 -168.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 1.8799999999999999 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 3.8500000000000001 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 1.75 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 3.3500000000000001 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 1.23 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 2.4300000000000002 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 1.8899999999999999 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -103.4 88.93 3.23 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 2.5299999999999998 109.277 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.63 36.85 0.34 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.104 0.859 . . . . 1.46 112.006 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 tpp -75.03 -37.95 61.59 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.976 -0.72 . . . . 6.29 111.004 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -72.4 61.67 0.49 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.709 1.204 . . . . 5.9800000000000004 110.476 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.18 -58.73 1.85 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.151 0.981 . . . . 3.3900000000000001 110.182 -169.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.13 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.637 1.575 . . . . 3.2200000000000002 107.324 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -131.78 25.28 4.69 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.099 0.96 . . . . 1.98 110.865 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 1.8400000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 0.70999999999999996 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.1799999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 2.04 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 5.9500000000000002 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.1299999999999999 107.685 172.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.916 ' HG ' HD13 ' A' ' 31' ' ' ILE . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 2.0600000000000001 113.635 -170.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 8.4100000000000001 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 7.0499999999999998 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 1.24 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 25' ' ' LEU . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 2.5299999999999998 109.638 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 2.3300000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 1.0700000000000001 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 2.9399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 2.29 111.453 172.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 1.1399999999999999 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 1.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 4.4000000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 1.05 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.70999999999999996 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.1000000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 0.5 109.493 -164.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 1.6499999999999999 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 3.8700000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 2.2400000000000002 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 1.74 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.21 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 1.3799999999999999 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 1.25 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.2999999999999998 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.1200000000000001 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.05 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 3.1099999999999999 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 0.93999999999999995 111.159 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 0.81999999999999995 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 2.4500000000000002 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 1.1899999999999999 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.77000000000000002 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 2.6099999999999999 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 0.51000000000000001 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 2.46 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 0.78000000000000003 109.563 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.96 169.0 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 1.6799999999999999 107.48 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -172.21 -168.54 0.56 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.71 -1.589 . . . . 5.6200000000000001 106.71 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -131.04 -58.87 1.0 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.526 0.73 . . . . 5.0800000000000001 110.062 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -146.31 156.22 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.781 0.832 . . . . 4.8200000000000003 109.259 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.72 166.98 14.87 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 6.2300000000000004 110.477 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.23 55.29 4.81 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.404 -1.22 . . . . 6.8200000000000003 113.837 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 128.35 2.66 . . . . 13.140000000000001 115.395 174.245 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 121.265 0.555 . . . . 2.3300000000000001 110.578 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1099999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.1499999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 2.2000000000000002 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 3.04 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 0.95999999999999996 105.967 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 2.4399999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 2.5899999999999999 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p . . . . . 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 3.3300000000000001 110.155 179.645 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 113.852 1.056 . . . . 2.52 113.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 2.4399999999999999 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 35' ' ' LEU . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 2.0299999999999998 109.768 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 0.79000000000000004 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 1.9299999999999999 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 2.3100000000000001 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 3.9100000000000001 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 2.5800000000000001 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.1000000000000001 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 6.4000000000000004 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 6.96 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.05 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 1.4099999999999999 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 2.23 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 0.92000000000000004 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 3.2200000000000002 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 3.54 112.28 175.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 0.92000000000000004 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 0.59999999999999998 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 1.72 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 3.98 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 3.8599999999999999 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 0.47999999999999998 106.019 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 2.8500000000000001 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 2.3500000000000001 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 4.8600000000000003 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 2.8999999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 0.97999999999999998 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.0900000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 1.55 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 1.3999999999999999 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 3.48 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.28 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.21 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 3.29 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 0.66000000000000003 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 2.3399999999999999 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 1.22 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 4.54 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 2.1899999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.21 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 2.8999999999999999 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 0.93999999999999995 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 0.64000000000000001 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 1.3400000000000001 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 1.21 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 3.2999999999999998 106.669 -179.694 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.543 -0.54 . . . . 2.3500000000000001 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.27 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 4.3600000000000003 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.55 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 2.75 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 1.4199999999999999 107.582 -177.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 2.21 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 3.0600000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 2.4199999999999999 108.784 -177.452 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 3.8900000000000001 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 2.5 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 1.28 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.3400000000000001 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 2.2400000000000002 109.762 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.0 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 2.8999999999999999 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 35' ' ' LEU . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 1.95 110.789 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 7.0899999999999999 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 6.6200000000000001 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.3700000000000001 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.0 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 1.8799999999999999 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 2.29 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 1.1699999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.1299999999999999 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 1.76 113.248 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 0.68000000000000005 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 0.5 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 1.53 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 5.1900000000000004 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.05 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 0.91000000000000003 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.0899999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 35' ' ' LEU . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 0.51000000000000001 109.924 -166.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 35' ' ' LEU . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 2.02 110.046 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 5.5099999999999998 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 2.3999999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 3.04 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.3999999999999999 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 1.22 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 1.3799999999999999 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.0 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 3.2799999999999998 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 2.46 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 0.85999999999999999 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 2.5800000000000001 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 0.71999999999999997 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 3.3300000000000001 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 1.5700000000000001 112.136 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.90000000000000002 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 3.1299999999999999 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1599999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 0.79000000000000004 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 2.1400000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 0.96999999999999997 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 3.1800000000000002 106.998 179.051 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 111.647 0.24 . . . . 2.7000000000000002 111.647 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 1.77 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 4.3200000000000003 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 1.3600000000000001 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 2.29 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 1.3 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 2.9199999999999999 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 2.2200000000000002 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 1.6799999999999999 110.749 -177.167 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 111.497 0.184 . . . . 2.29 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.2400000000000002 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 1.8 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 0.66000000000000003 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.1399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 1.73 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.2800000000000002 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 2.8999999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 2.5299999999999998 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 7.2199999999999998 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 5.7999999999999998 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.21 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' A' ' 45' ' ' VAL . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 1.6699999999999999 111.552 173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 2.2999999999999998 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 0.89000000000000001 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.0699999999999998 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 3.3300000000000001 112.105 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 0.65000000000000002 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 0.5 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 1.23 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 4.4100000000000001 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 0.85999999999999999 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 2.9100000000000001 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 0.44 109.944 -169.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.601 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 1.6000000000000001 108.538 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 3.4500000000000002 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 2.0 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 1.8200000000000001 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 1.1599999999999999 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 1.5900000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 1.3600000000000001 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 0.91000000000000003 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 0.93000000000000005 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 2.9300000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 1.95 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 0.71999999999999997 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 2.3199999999999998 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 0.62 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 3.5600000000000001 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 1.1699999999999999 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 2.8100000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.93000000000000005 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 0.77000000000000002 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.24 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 0.56000000000000005 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 1.5800000000000001 109.279 177.752 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 118.141 -0.933 . . . . 2.6299999999999999 109.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.1499999999999999 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 3.2599999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 1.6000000000000001 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 2.2400000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 0.77000000000000002 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 3.3700000000000001 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.0699999999999998 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.3100000000000001 111.663 -171.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.972 -0.751 . . . . 3.1200000000000001 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 3.6000000000000001 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 1.96 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 0.88 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.27 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 1.99 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 4.4000000000000004 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 2.3199999999999998 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 1.8700000000000001 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 6.9800000000000004 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 8.1899999999999995 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.1499999999999999 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 45' ' ' VAL . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 1.8100000000000001 110.558 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 0.83999999999999997 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.0 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 3.1400000000000001 110.791 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.68000000000000005 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 0.46999999999999997 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 1.46 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 4.75 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 0.88 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.1200000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 0.51000000000000001 108.085 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 1.5600000000000001 109.179 -176.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.0300000000000002 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 1.9099999999999999 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 1.8999999999999999 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.84999999999999998 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.0 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 1.28 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 57' ' ' ILE . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 1.5 111.199 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 0.87 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 3.2799999999999998 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 52' ' ' ILE . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 2.2799999999999998 111.618 176.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 0.67000000000000004 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 2.7200000000000002 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 3.1699999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 1.04 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 2.8900000000000001 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.81000000000000005 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 0.83999999999999997 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 1.3899999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 0.66000000000000003 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 2.77 106.262 178.659 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 110.509 -0.182 . . . . 2.8300000000000001 110.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 2.3999999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.0800000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.6699999999999999 106.488 169.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 3.9100000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 0.72999999999999998 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 2.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.0499999999999998 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 2.8500000000000001 110.106 176.551 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.746 -0.835 . . . . 3.73 108.746 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 2.5800000000000001 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 1.8799999999999999 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 1.1399999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.3999999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 2.4900000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 3.9900000000000002 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 2.4500000000000002 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 1.78 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 7.25 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 5.6900000000000004 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.05 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 28' ' ' GLU . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 1.48 109.907 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 2.2999999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 0.81999999999999995 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.0699999999999998 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 1.99 113.07 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 0.67000000000000004 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 0.53000000000000003 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 1.3 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.0999999999999996 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 0.96999999999999997 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81000000000000005 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 5.7000000000000002 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 0.69999999999999996 109.44 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 1.5900000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 3.8999999999999999 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 2.0 110.135 -170.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 1.25 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 1.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.79000000000000004 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 4.4000000000000004 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 1.8899999999999999 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 0.70999999999999996 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 2.0 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 0.85999999999999999 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.1400000000000001 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 1.53 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.01 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 3.02 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.85999999999999999 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 1.4199999999999999 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 0.68999999999999995 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt . . . . . 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 1.48 109.644 -177.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 2.1800000000000002 116.588 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 1.8300000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 3.75 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 1.74 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 2.4199999999999999 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 0.90000000000000002 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 2.6699999999999999 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 2.4300000000000002 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.0099999999999998 109.903 -176.679 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 1.9099999999999999 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 2.6800000000000002 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 0.68000000000000005 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 1.96 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' CG2' HD21 ' A' ' 35' ' ' LEU . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 109.622 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.21 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 2.8999999999999999 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 2.4700000000000002 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 6.5099999999999998 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 6.5599999999999996 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.1799999999999997 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 0.92000000000000004 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 57' ' ' ILE . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 1.6699999999999999 109.791 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 2.2999999999999998 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 0.81000000000000005 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 3.1400000000000001 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 35' ' ' LEU . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 1.6599999999999999 111.767 -173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 0.94999999999999996 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 0.68000000000000005 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 1.8100000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 4.6900000000000004 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 0.88 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.69999999999999996 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.0600000000000001 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 0.44 107.157 -168.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.3599999999999999 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 2.3999999999999999 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.0599999999999996 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 2.2999999999999998 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.0899999999999999 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.5600000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 1.46 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 1.9399999999999999 112.689 -157.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 2.6400000000000001 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 1.77 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.48 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 3.9399999999999999 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 2.3300000000000001 111.023 176.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 0.71999999999999997 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 2.1800000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 0.89000000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 3.4300000000000002 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.88 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 2.3900000000000001 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.90000000000000002 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 0.73999999999999999 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 1.48 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 0.56999999999999995 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 2.7400000000000002 106.981 -170.41 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 2.5800000000000001 105.61 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 4.9900000000000002 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.425 ' SG ' HG13 ' A' ' 45' ' ' VAL . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.6099999999999999 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 4.7999999999999998 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 1.1200000000000001 105.961 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.0299999999999998 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 2.73 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 2.5800000000000001 109.652 -177.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.947 0.88 . . . . 2.5499999999999998 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.0699999999999998 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 2.5099999999999998 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 1.03 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.1399999999999999 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.413 ' CG1' HD11 ' A' ' 64' ' ' LEU . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 2.0299999999999998 109.387 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.1600000000000001 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.0 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 1.78 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 6.3200000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 9.3200000000000003 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.05 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 45' ' ' VAL . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 1.5600000000000001 109.899 173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 2.3100000000000001 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 0.77000000000000002 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.0 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 1.79 111.076 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 0.54000000000000004 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 0.40999999999999998 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 1.5900000000000001 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 4.7699999999999996 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 0.92000000000000004 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.0199999999999996 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 0.52000000000000002 108.614 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.5 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 1.6200000000000001 108.777 -177.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 5.1200000000000001 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 1.95 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 1.8500000000000001 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 0.96999999999999997 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 1.29 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 HG23 ' A' ' 57' ' ' ILE . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 1.4399999999999999 113.129 -169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.81999999999999995 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 4.3399999999999999 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 2.2000000000000002 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 0.64000000000000001 110.994 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 2.1099999999999999 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 0.68000000000000005 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 2.3999999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 1.4099999999999999 111.512 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 2.8799999999999999 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 0.66000000000000003 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 1.6100000000000001 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 0.59999999999999998 108.932 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt . . . . . 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 1.5 109.504 178.51 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 112.687 0.625 . . . . 2.9300000000000002 112.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 3.21 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 3.8300000000000001 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 1.74 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 3.1699999999999999 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 1.1499999999999999 105.631 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 3.6400000000000001 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 3.1299999999999999 108.028 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 2.1899999999999999 109.65 -179.141 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.2599999999999998 114.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 2.8399999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 2.4399999999999999 110.124 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 0.92000000000000004 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.1200000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 64' ' ' LEU . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 1.9099999999999999 109.435 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 7.71 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.4199999999999999 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 1.9399999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 5.7800000000000002 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.1500000000000004 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.29 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 57' ' ' ILE . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 1.6299999999999999 110.243 174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 2.6800000000000002 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 2.4199999999999999 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 3.3300000000000001 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 1.8100000000000001 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 0.68000000000000005 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 0.56000000000000005 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 1.2 110.952 171.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 3.8500000000000001 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 0.94999999999999996 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.68999999999999995 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 3.6299999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 0.55000000000000004 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.2200000000000002 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 1.6100000000000001 108.286 -177.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 3.6499999999999999 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 2.0899999999999999 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.29 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.2 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 1.3500000000000001 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 57' ' ' ILE . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 1.53 112.173 -169.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 2.8900000000000001 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 0.93999999999999995 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.0699999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 2.3799999999999999 111.453 177.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 0.79000000000000004 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 2.4300000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 2.52 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 21' ' ' ILE . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 1.2 112.53 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.95999999999999996 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 2.73 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.75 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 0.60999999999999999 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 1.24 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt . . . . . 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 1.6100000000000001 107.964 174.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.664 -0.495 . . . . 2.1600000000000001 109.664 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 2.1099999999999999 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 3.52 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 1.74 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 3.2000000000000002 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 0.70999999999999996 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 2.5 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 1.99 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 1.99 111.522 -177.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 CA--C 1.529 0.152 0 N-CA-C 112.711 0.634 . . . . 1.8799999999999999 112.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 2.02 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 1.0 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.22 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 21' ' ' ILE . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 1.76 109.067 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 3.9199999999999999 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.589 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 3.5800000000000001 109.608 172.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.589 HD13 HD21 ' A' ' 24' ' ' ASN . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 1.97 111.455 -165.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 6.5199999999999996 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.2400000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 0.93999999999999995 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 1.53 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 2.21 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 0.79000000000000004 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 4.2400000000000002 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 34' ' ' ILE . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 1.8999999999999999 111.745 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 0.56999999999999995 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 0.45000000000000001 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 1.3200000000000001 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 4.6100000000000003 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 0.98999999999999999 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 3.25 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 0.58999999999999997 109.683 -168.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.3799999999999999 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 1.75 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 4.6600000000000001 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 1.7 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.1499999999999999 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 1.48 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 1.22 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 0.85999999999999999 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.02 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 1.9299999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 0.76000000000000001 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 2.0899999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 0.77000000000000002 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 3.8100000000000001 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 1.27 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 2.4399999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.59999999999999998 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 0.53000000000000003 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 1.1799999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 0.59999999999999998 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 1.6699999999999999 108.221 175.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 2.8399999999999999 108.176 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 1.79 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 2.9900000000000002 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 1.3600000000000001 107.28 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 2.6400000000000001 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 0.97999999999999998 106.091 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 4.5499999999999998 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 2.52 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 2.4100000000000001 110.059 -177.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 112.311 0.485 . . . . 2.1499999999999999 112.311 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.2400000000000002 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 2.2400000000000002 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 0.87 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.1799999999999999 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 1.6899999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 5.5300000000000002 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 2.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 2.3799999999999999 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 5.9000000000000004 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 8.8399999999999999 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 0.85999999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 1.5900000000000001 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 2.9399999999999999 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 1.02 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.1200000000000001 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 112.929 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 0.58999999999999997 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 1.9199999999999999 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 4.5 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 1.3700000000000001 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.1200000000000001 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 2.8999999999999999 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 0.57999999999999996 108.158 -169.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 2.9100000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 1.6299999999999999 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 3.98 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 1.9199999999999999 110.793 -170.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.27 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 1.48 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 1.3799999999999999 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 57' ' ' ILE . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 1.3600000000000001 112.192 -169.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 0.89000000000000001 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 3.29 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 2.2599999999999998 111.538 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 0.81999999999999995 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 2.3599999999999999 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 2.2999999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 1.1799999999999999 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 2.7599999999999998 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.85999999999999999 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 0.68000000000000005 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 1.51 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 0.71999999999999997 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 1.6899999999999999 108.225 -173.318 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 3.3700000000000001 107.161 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 2.0299999999999998 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.1800000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 1.6499999999999999 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 3.2599999999999998 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 0.71999999999999997 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 1.9199999999999999 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 1.99 109.144 -178.855 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.447 0.906 . . . . 2.0299999999999998 113.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 2.46 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 2.7400000000000002 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 0.66000000000000003 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.0600000000000001 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 1.9199999999999999 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.0800000000000001 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.404 HD22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 3.25 107.434 172.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 1.99 114.583 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 8.5399999999999991 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 6.7199999999999998 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 0.94999999999999996 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 HD23 ' A' ' 25' ' ' LEU . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 2.1499999999999999 108.057 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 2.4399999999999999 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 0.77000000000000002 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 3.2000000000000002 112.132 -174.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.0099999999999998 111.842 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 0.80000000000000004 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 1.28 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 4.4000000000000004 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 0.80000000000000004 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.68999999999999995 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 2.96 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 0.68000000000000005 109.72 -163.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 1.6499999999999999 109.435 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 3.9300000000000002 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 1.8200000000000001 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 2.8399999999999999 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.1399999999999999 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 1.3700000000000001 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 1.6399999999999999 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 1.8500000000000001 110.539 -166.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 0.92000000000000004 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 4.2300000000000004 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.625 HG23 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 1.8999999999999999 111.056 175.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 0.71999999999999997 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 2.1899999999999999 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 0.73999999999999999 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 3.3300000000000001 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 1.74 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.77000000000000002 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 2.8500000000000001 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.02 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 0.93000000000000005 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 2.7799999999999998 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 0.71999999999999997 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 1.5700000000000001 111.221 -178.283 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 2.2599999999999998 107.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.0099999999999998 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 3.9500000000000002 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 1.6100000000000001 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 2.6899999999999999 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 0.72999999999999998 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 2.25 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 2.3199999999999998 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 2.1299999999999999 109.274 178.523 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.159 0.8 . . . . 2.0499999999999998 113.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.1699999999999999 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 1.8700000000000001 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 1.28 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.1799999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 1.9099999999999999 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 34' ' ' ILE . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 6.3200000000000003 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.0499999999999998 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' A' ' 34' ' ' ILE . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 2.5499999999999998 113.408 -165.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 6.1699999999999999 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 5.5300000000000002 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 0.94999999999999996 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 1.6299999999999999 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 2.1099999999999999 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.29 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 5.6699999999999999 111.664 -170.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 1.95 112.027 -163.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 0.68999999999999995 110.841 -174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 0.46000000000000002 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 1.25 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 3.5800000000000001 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 1.1100000000000001 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 3.1600000000000001 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 0.72999999999999998 111.329 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 2.8999999999999999 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 2.4300000000000002 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 3.2200000000000002 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 1.9199999999999999 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 1.8799999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.0900000000000001 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 1.3100000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 57' ' ' ILE . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 1.25 112.238 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.03 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.2200000000000002 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 52' ' ' ILE . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 2.8999999999999999 111.666 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 0.65000000000000002 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 2.2400000000000002 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 0.79000000000000004 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 2.3500000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 1.1899999999999999 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 2.2999999999999998 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 0.84999999999999998 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 2.0299999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 0.83999999999999997 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 1.8200000000000001 108.312 176.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 119.208 -0.425 . . . . 1.97 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 1.8300000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 2.8900000000000001 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 1.6200000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 3.3599999999999999 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 0.87 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 2.54 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 2.7200000000000002 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 2.71 110.468 -177.745 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 121.745 0.783 . . . . 2.9100000000000001 109.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 2.5499999999999998 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 1.9299999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 0.93000000000000005 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 2.5099999999999998 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.601 HD11 HD21 ' A' ' 64' ' ' LEU . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 3.2200000000000002 110.363 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 6.7000000000000002 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 2.7000000000000002 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.77 HD23 HG11 ' A' ' 45' ' ' VAL . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 1.8300000000000001 111.244 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 7.7400000000000002 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.0899999999999999 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.0 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 0.88 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 1.6799999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 2.0699999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 0.75 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 3.3700000000000001 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 3.2599999999999998 110.72 170.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 0.67000000000000004 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 0.95999999999999996 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 2.3999999999999999 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 3.8900000000000001 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 1.21 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 0.77000000000000002 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 4.8099999999999996 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 0.58999999999999997 109.06 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.2799999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.77 HG11 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 2.23 108.856 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 3.6499999999999999 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 2.52 110.312 -171.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 1.98 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 1.46 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 1.5 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 57' ' ' ILE . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 1.3400000000000001 113.658 -166.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.7400000000000002 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.26 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.29 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 3.1899999999999999 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 2.3700000000000001 111.954 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 0.62 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 2.3399999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 0.92000000000000004 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 3.79 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.636 ' HG2' HD23 ' A' ' 64' ' ' LEU . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.636 HD23 ' HG2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 113.184 175.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.69999999999999996 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 2.8999999999999999 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.68000000000000005 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 0.68999999999999995 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 1.48 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 0.88 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 2.1000000000000001 108.623 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.1200000000000001 109.092 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 1.8500000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 5.9800000000000004 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 2.8300000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 2.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 0.88 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 2.8199999999999998 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 2.54 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 2.1600000000000001 109.588 178.286 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 113.894 1.072 . . . . 2.25 113.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 2.7200000000000002 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 2.27 111.164 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 1.1899999999999999 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6699999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 2.21 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 5.0599999999999996 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 2.6200000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 45' ' ' VAL . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 2.5600000000000001 113.433 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 8.3000000000000007 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 9.3599999999999994 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.72 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 1.72 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 2.48 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 0.84999999999999998 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 3.3199999999999998 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.44 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 1.6599999999999999 111.473 175.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 0.72999999999999998 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 1.8200000000000001 109.889 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 3.8300000000000001 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.05 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 2.7000000000000002 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 0.48999999999999999 109.13 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 2.79 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 2.5499999999999998 108.199 176.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.0 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 2.3999999999999999 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 2.6699999999999999 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 1.78 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 3.29 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.669 HD12 HG23 ' A' ' 57' ' ' ILE 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 3.1299999999999999 108.065 -172.17 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 52' ' ' ILE . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.1899999999999999 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 2.6200000000000001 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.669 HG23 HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 2.5499999999999998 111.015 176.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 1.3899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 2.1499999999999999 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 2.8599999999999999 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 1.3 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.76000000000000001 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 2.5600000000000001 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.75 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 1.3600000000000001 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 0.80000000000000004 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 1.6899999999999999 108.305 -173.46 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 113.085 0.772 . . . . 3.6499999999999999 113.085 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 1.8100000000000001 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 3.3700000000000001 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 1.6200000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 2.4199999999999999 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 70' ' ' VAL . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 0.73999999999999999 107.337 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 2.6400000000000001 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 1.8500000000000001 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 2.0899999999999999 110.322 -178.46 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.457 -0.079 0 N-CA-C 112.555 0.576 . . . . 2.4500000000000002 112.555 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 2.7400000000000002 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 2.0 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 0.68000000000000005 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.25 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 1.79 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 6.5300000000000002 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.3500000000000001 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 2.6899999999999999 111.882 -172.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 7.0800000000000001 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.0700000000000003 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 0.98999999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 1.8300000000000001 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 2.3999999999999999 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 0.96999999999999997 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 5.5199999999999996 110.142 -173.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.649 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 1.98 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.77000000000000002 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 0.5 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 2.5299999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 5.2699999999999996 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 1.28 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.80000000000000004 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 3.4700000000000002 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 0.47999999999999998 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 1.6399999999999999 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 4.1799999999999997 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 1.8100000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 1.76 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 1.02 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 1.3100000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 1.24 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.80000000000000004 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.0699999999999998 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 1.96 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 0.89000000000000001 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 1.97 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 2.3900000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 1.29 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 2.5600000000000001 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 0.90000000000000002 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 1.2 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 7' ' ' ILE . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 0.72999999999999998 108.283 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 2.3399999999999999 108.299 -177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 2.9300000000000002 108.738 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.0 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 3.29 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.3599999999999999 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 3.7000000000000002 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG12 HG23 ' A' ' 70' ' ' VAL . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 0.92000000000000004 106.519 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 3.73 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 2.5099999999999998 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 1.73 109.5 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.764 0.283 . . . . 2.1800000000000002 111.764 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 2.1400000000000001 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 2.1899999999999999 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 0.88 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.1100000000000001 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 1.74 109.073 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 5.4900000000000002 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 3.2799999999999998 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 45' ' ' VAL . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 2.77 110.457 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 5.5199999999999996 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 6.3499999999999996 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 0.83999999999999997 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 1.5600000000000001 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 2.5299999999999998 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 45' ' ' VAL . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 0.76000000000000001 109.833 -174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 3.5499999999999998 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.727 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 1.6799999999999999 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 0.85999999999999999 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 0.54000000000000004 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 1.52 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 5.71 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 0.95999999999999996 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.0299999999999998 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 0.53000000000000003 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 2.46 109.702 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 3.7200000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 1.98 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 1.8700000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 0.98999999999999999 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 1.28 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 1.28 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 2.1800000000000002 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.3200000000000001 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.3100000000000001 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 2.6899999999999999 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 2.1600000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 0.84999999999999998 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 2.4199999999999999 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 1.3999999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 2.7799999999999998 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 21' ' ' ILE . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 1.04 111.443 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 6.1600000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 1.3500000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG23 HG12 ' A' ' 7' ' ' ILE . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 0.75 106.446 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 1.8700000000000001 107.938 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 114.322 1.23 . . . . 3.0299999999999998 114.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 1.8 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 4.3700000000000001 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 45' ' ' VAL . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 1.9099999999999999 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 3.29 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 70' ' ' VAL . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 0.77000000000000002 105.882 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 2.9100000000000001 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 1.8500000000000001 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 2.4399999999999999 109.265 176.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 112.39 0.515 . . . . 1.8600000000000001 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.1899999999999999 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 1.7 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 0.73999999999999999 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.25 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 3.6499999999999999 111.458 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 5.1500000000000004 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.0299999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 2.8300000000000001 112.231 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 8.4700000000000006 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 9.1600000000000001 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.1499999999999999 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 1.3999999999999999 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 2.3199999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.0600000000000001 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 4.8300000000000001 111.717 -175.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 34' ' ' ILE . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 1.8999999999999999 112.901 -174.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 0.65000000000000002 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 0.70999999999999996 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 1.5600000000000001 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 4.6900000000000004 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 1.0700000000000001 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 3.3599999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 0.57999999999999996 108.896 -168.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 2.5 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 1.76 109.421 -173.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 3.8399999999999999 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 1.76 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 1.8 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 1.6100000000000001 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 1.3400000000000001 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 0.94999999999999996 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 0.97999999999999998 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 4.0899999999999999 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 1.98 112.203 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 0.92000000000000004 111.759 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 2.4900000000000002 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 0.92000000000000004 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 3.1299999999999999 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 21' ' ' ILE . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 1.1299999999999999 111.474 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.72999999999999998 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 2.2999999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.77000000000000002 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 0.63 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 1.22 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.567 HG23 HG12 ' A' ' 7' ' ' ILE . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 0.75 108.453 -172.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 1.6699999999999999 109.983 179.39 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 112.225 0.454 . . . . 2.2599999999999998 112.225 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 1.79 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 2.96 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 1.54 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 2.4300000000000002 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 0.73999999999999999 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 2.3199999999999998 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 2.1499999999999999 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 2.54 109.148 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.225 -0.203 0 CA-C-O 120.995 0.426 . . . . 3.2200000000000002 110.248 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.2200000000000002 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 1.8899999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 1.02 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.21 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 1.95 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' ILE . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 3.96 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 2.8300000000000001 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 34' ' ' ILE . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 2.2000000000000002 110.316 -173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 8.1500000000000004 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 6.4699999999999998 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.1599999999999999 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 1.5600000000000001 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 2.1000000000000001 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 0.81000000000000005 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 22' ' ' GLU . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 5.71 112.248 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.515 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 1.95 112.346 -169.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 0.69999999999999996 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 0.48999999999999999 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 1.3600000000000001 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 4.0800000000000001 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.1699999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.01 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 5.4400000000000004 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 0.93000000000000005 107.653 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.3500000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 2.3999999999999999 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.0800000000000001 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 2.0099999999999998 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 3.1299999999999999 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.1299999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 1.26 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.425 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 1.3799999999999999 112.779 -165.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.23 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 3.2999999999999998 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 3.1200000000000001 111.685 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 0.71999999999999997 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 2.0499999999999998 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 0.65000000000000002 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 2.52 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 1.0700000000000001 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.68000000000000005 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 2.73 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 0.53000000000000003 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 1.8500000000000001 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 0.80000000000000004 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 1.8 108.807 177.9 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.575 -0.898 . . . . 3.4300000000000002 108.575 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 1.8200000000000001 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 2.75 109.179 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 2.5800000000000001 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 1.53 105.754 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 2.8999999999999999 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.02 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 -176.464 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 110.309 -0.256 . . . . 2.0800000000000001 110.309 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 2.5 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 2.04 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 0.87 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 2.0800000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 4.9199999999999999 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.1400000000000001 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 35' ' ' LEU . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 1.9399999999999999 113.975 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 7.6399999999999997 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 6.4299999999999997 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 1.73 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 2.3300000000000001 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 0.78000000000000003 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 3.1000000000000001 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.849 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 2.6800000000000002 113.745 -168.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 0.95999999999999996 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' LYS . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 0.52000000000000002 108.697 162.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 1.79 110.594 174.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 3.9900000000000002 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 0.87 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.69999999999999996 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.0699999999999998 107.42 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.849 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 0.48999999999999999 109.149 -170.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.1899999999999999 109.117 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 1.6000000000000001 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 3.79 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 2.3999999999999999 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 2.3500000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 1.5700000000000001 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 3.5600000000000001 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 3.3100000000000001 109.879 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 1.8400000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.24 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 2.75 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 47' ' ' TYR . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 2.6800000000000002 111.567 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 1.0 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 2.2200000000000002 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 0.68999999999999995 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 2.7400000000000002 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.26 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.1000000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 2.6299999999999999 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.62 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 0.55000000000000004 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 1.3799999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 0.96999999999999997 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 2.23 109.21 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.0800000000000001 107.78 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 1.8799999999999999 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 3.8500000000000001 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 1.75 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 3.3500000000000001 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 1.23 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 2.4300000000000002 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 1.8899999999999999 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 2.5299999999999998 109.277 177.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 119.862 -0.113 . . . . 1.98 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 1.8400000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 0.70999999999999996 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.1799999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 2.04 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 5.9500000000000002 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.467 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.1299999999999999 107.685 172.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.916 ' HG ' HD13 ' A' ' 31' ' ' ILE . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 2.0600000000000001 113.635 -170.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 8.4100000000000001 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 7.0499999999999998 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 1.24 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 25' ' ' LEU . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 2.5299999999999998 109.638 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 2.3300000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 1.0700000000000001 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 2.9399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 2.29 111.453 172.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 1.1399999999999999 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 1.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 4.4000000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 1.05 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.70999999999999996 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.1000000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 0.5 109.493 -164.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 1.6499999999999999 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 3.8700000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 2.2400000000000002 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 1.74 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.21 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 1.3799999999999999 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 1.25 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.2999999999999998 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.1200000000000001 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.05 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 3.1099999999999999 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 0.93999999999999995 111.159 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 0.81999999999999995 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 2.4500000000000002 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 1.1899999999999999 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.77000000000000002 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 2.6099999999999999 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 0.51000000000000001 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 2.46 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 0.78000000000000003 109.563 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 1.6799999999999999 107.48 -176.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 118.046 -0.978 . . . . 5.0499999999999998 108.901 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m 52.77 83.02 0.07 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.825 0.85 . . . . 2.3300000000000001 110.578 -166.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -138.05 178.55 7.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.51 1.124 . . . . 3.1099999999999999 110.377 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -93.64 127.22 39.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.062 1.345 . . . . 3.1499999999999999 109.854 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.2 t -110.12 132.91 53.75 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.917 -1.512 . . . . 2.2000000000000002 106.917 164.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -92.97 149.96 20.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.348 -1.723 . . . . 3.04 106.348 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 2.6 mt -142.02 154.49 19.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 105.967 -1.864 . . . . 0.95999999999999996 105.967 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -127.95 149.13 50.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.056 -1.461 . . . . 2.4399999999999999 107.056 164.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 125.88 61.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.965 0.791 . . . . 2.5899999999999999 110.8 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 p -74.46 73.1 1.9 Allowed 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.35 0.66 . . . . 3.3300000000000001 110.155 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.52 25.09 0.05 OUTLIER Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.73 1.634 . . . . 1.8700000000000001 112.293 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.67 -42.5 3.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 6.4400000000000004 112.603 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.08 -19.35 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.662 1.585 . . . . 5.4100000000000001 113.365 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -79.5 47.02 0.79 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.297 0.953 . . . . 2.7599999999999998 111.644 -172.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 18.69 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.467 2.707 . . . . 4.0700000000000003 114.512 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -47.95 -29.43 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.588 1.955 . . . . 2.52 113.852 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.1 m -52.19 -47.64 65.44 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.166 0.586 . . . . 2.4399999999999999 110.506 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.592 HG13 HD21 ' A' ' 35' ' ' LEU . 3.1 t -63.03 -46.83 95.23 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-O 118.651 -0.69 . . . . 2.0299999999999998 109.768 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.52 -38.56 71.98 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.284 0.947 . . . . 0.79000000000000004 111.924 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -62.23 -55.56 27.3 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.891 -0.781 . . . . 1.9299999999999999 108.891 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 78.3 mt -51.81 -47.94 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 118.445 -0.788 . . . . 2.3100000000000001 110.713 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -46.16 -67.11 0.31 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.641 1.11 . . . . 1.99 110.296 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -46.38 -53.02 11.75 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 126.574 1.949 . . . . 3.9100000000000001 111.213 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -53.38 -54.93 29.51 Favored 'General case' 0 C--N 1.337 0.022 0 C-N-CA 123.273 0.629 . . . . 2.5800000000000001 109.624 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.69 -44.33 93.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.434 0.694 . . . . 2.1000000000000001 110.592 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.25 -42.56 52.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.474 1.11 . . . . 6.4000000000000004 112.108 -172.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -68.05 -24.31 65.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.184 0.809 . . . . 6.96 113.184 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 141.91 48.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.182 0.515 . . . . 3.46 112.21 -159.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -74.75 79.56 2.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.567 1.147 . . . . 4.7699999999999996 109.922 -167.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.43 -20.4 1.52 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.243 -0.89 . . . . 1.05 111.816 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.58 120.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 118.576 1.188 . . . . 1.4099999999999999 109.11 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -93.37 -28.44 16.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.686 -0.688 . . . . 2.23 110.267 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -152.84 147.21 25.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.252 0.478 . . . . 0.92000000000000004 110.244 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.99 176.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.726 2.01 . . . . 3.2200000000000002 111.689 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -79.77 145.81 32.66 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.981 1.312 . . . . 3.54 112.28 175.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 p -160.73 103.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 122.956 0.502 . . . . 0.92000000000000004 110.101 159.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 41.44 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.6 0.714 . . . . 0.59999999999999998 109.225 156.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tt -48.13 -48.08 34.29 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.515 1.526 . . . . 1.72 108.477 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -24.29 -54.38 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.845 2.458 . . . . 3.98 113.309 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.31 1.31 11.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.077 0.951 . . . . 2.2200000000000002 111.704 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.83 59.89 3.32 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.192 0.901 . . . . 1.1899999999999999 112.14 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -138.59 176.58 8.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.156 1.782 . . . . 3.8599999999999999 108.753 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.15 141.64 30.09 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 127.857 2.463 . . . . 0.47999999999999998 106.019 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.19 100.35 4.24 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.722 0.809 . . . . 2.8500000000000001 109.012 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.63 135.04 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.532 -0.914 . . . . 2.3500000000000001 108.532 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -84.5 113.93 21.58 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 106.138 -1.801 . . . . 4.8600000000000003 106.138 162.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.3 163.18 23.11 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.513 1.525 . . . . 2.8999999999999999 109.563 -173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -132.69 84.13 51.26 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.501 0.72 . . . . 2.9199999999999999 109.603 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.2 74.62 2.47 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.91 3.073 . . . . 0.97999999999999998 111.601 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.95 -62.23 0.64 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.598 -1.63 . . . . 1.0900000000000001 106.598 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.2 t -76.06 -64.23 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.295 -0.631 . . . . 1.55 109.295 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 tt -67.38 -54.81 20.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 N-CA-C 113.465 0.913 . . . . 1.3999999999999999 113.465 -162.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 77.1 127.86 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 128.076 2.55 . . . . 3.48 112.24 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.21 -45.2 38.35 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.121 3.214 . . . . 1.28 115.314 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -56.37 -37.6 96.72 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 CA-C-N 121.531 1.582 . . . . 1.21 111.761 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.0 mtt -66.38 -36.94 84.13 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.441 1.019 . . . . 3.29 110.267 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 mt -54.38 -54.21 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.51 -50.6 69.53 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 122.166 -0.334 . . . . 0.66000000000000003 111.873 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -48.04 -54.78 11.92 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.846 0.859 . . . . 2.27 109.97 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -40.01 7.84 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.48 1.112 . . . . 2.3399999999999999 112.488 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -73.07 -48.63 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.223 -0.658 . . . . 1.22 109.223 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -57.52 -27.37 62.51 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.409 -0.805 . . . . 4.54 112.861 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -45.69 -43.85 12.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.15 0.887 . . . . 5.4000000000000004 112.918 175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.01 24.23 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.21 -0.931 . . . . 2.1899999999999999 111.839 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.17 9.74 86.63 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.516 1.055 . . . . 1.21 113.385 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -84.25 133.41 34.57 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.28 1.04 . . . . 2.8999999999999999 110.825 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.05 84.64 1.33 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.612 -2.195 . . . . 0.93999999999999995 107.612 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.47 143.41 31.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.496 0.718 . . . . 0.64000000000000001 109.33 175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -135.44 138.62 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.391 -1.707 . . . . 1.3400000000000001 106.391 169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.83 139.98 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.882 0.873 . . . . 1.21 110.122 -158.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.6 mt -133.64 90.62 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.669 -1.604 . . . . 3.2999999999999998 106.669 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -67.86 130.7 43.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.554 -1.276 . . . . 6.5800000000000001 107.554 168.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -84.92 -62.88 1.44 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.802 -0.444 . . . . 5.6299999999999999 109.802 -175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 tt -176.14 165.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 126.41 1.884 . . . . 5.7999999999999998 106.143 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.62 -2.41 17.04 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.877 1.066 . . . . 6.29 113.877 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.31 115.6 0.33 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.824 -0.91 . . . . 5.46 110.824 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 104.841 -2.281 . . . . 11.720000000000001 104.841 164.037 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.158 -0.682 . . . . 3.3799999999999999 109.158 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -97.54 175.27 6.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.727 1.611 . . . . 2.3500000000000001 109.543 169.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 t -141.83 175.19 9.91 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.748 -0.834 . . . . 2.27 108.748 162.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -88.62 134.72 33.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.821 1.249 . . . . 4.3600000000000003 108.197 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 3.0 t -121.64 120.9 36.11 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.842 -1.17 . . . . 1.55 107.842 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -102.17 110.61 22.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.848 -1.538 . . . . 2.75 106.848 -168.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -108.01 136.68 42.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.582 -1.266 . . . . 1.4199999999999999 107.582 -177.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -128.51 152.08 48.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.568 -0.901 . . . . 2.21 108.568 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.26 153.68 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.023 -1.843 . . . . 3.0600000000000001 106.023 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.5 p -104.44 87.49 2.73 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.784 -0.821 . . . . 2.4199999999999999 108.784 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.47 80.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 106.319 -2.712 . . . . 2.5699999999999998 106.319 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.7 mtm -49.85 143.48 7.55 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.161 -0.681 . . . . 5.6900000000000004 109.161 166.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.1 p -19.14 -64.5 0.02 OUTLIER 'General case' 0 C--N 1.339 0.112 0 C-N-CA 127.366 2.266 . . . . 9.6199999999999992 114.471 -171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.24 -174.23 0.87 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.235 -1.765 . . . . 2.9399999999999999 106.235 165.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.75 -70.4 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.41 0.624 . . . . 3.3599999999999999 110.487 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 m -86.62 91.3 8.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.263 -0.643 . . . . 2.8500000000000001 109.263 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.288 1.435 . . . . 3.8900000000000001 109.026 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -49.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 118.216 0.462 . . . . 2.5 109.817 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.74 -41.8 1.15 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.103 1.761 . . . . 1.28 114.39 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.74 -58.03 7.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.584 0.707 . . . . 1.3400000000000001 109.138 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' CG2' HD21 ' A' ' 35' ' ' LEU . 2.0 mp -55.4 -42.07 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.999 0.919 . . . . 2.2400000000000002 109.762 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -49.93 -69.87 0.1 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.24 1.016 . . . . 1.8500000000000001 108.653 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -48.89 -47.03 43.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.383 1.073 . . . . 4.0 112.173 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -51.97 -53.72 38.18 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.697 -0.482 . . . . 2.8999999999999999 109.697 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 35' ' ' LEU . 9.0 mp -64.4 -45.16 88.85 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 119.369 -0.348 . . . . 1.95 110.789 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -34.6 10.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.733 1.213 . . . . 7.0899999999999999 110.196 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -93.36 -12.54 29.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.406 1.882 . . . . 6.6200000000000001 114.326 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -59.11 126.23 26.84 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 120.809 1.641 . . . . 3.54 109.463 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.63 78.46 0.28 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.435 1.094 . . . . 4.3700000000000001 109.785 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.15 0.93 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.705 -1.053 . . . . 1.0 113.451 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.2 mm -72.97 145.35 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.412 1.106 . . . . 1.8799999999999999 109.479 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -109.55 -39.8 5.05 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.21 1.804 . . . . 2.29 110.378 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.0 t -139.66 144.37 37.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.08 0.552 . . . . 1.1699999999999999 109.843 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.0 168.08 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 127.96 2.504 . . . . 3.1299999999999999 113.547 -178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.605 HD23 HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -79.8 127.01 31.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.094 1.357 . . . . 1.76 113.248 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.03 81.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-N 114.517 -1.219 . . . . 0.68000000000000005 110.791 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.18 47.22 1.61 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.086 -1.009 . . . . 0.5 109.05 165.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.87 -35.5 66.56 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.941 1.696 . . . . 1.53 110.143 172.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -28.35 -46.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.046 2.139 . . . . 5.1900000000000004 113.066 169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -119.6 -38.43 2.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.666 0.786 . . . . 1.05 112.501 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.31 53.66 0.23 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.404 1.478 . . . . 0.91000000000000003 110.036 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.92 178.17 7.23 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.423 1.089 . . . . 3.0899999999999999 108.979 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 35' ' ' LEU . . . -144.87 114.29 7.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.529 1.132 . . . . 0.51000000000000001 109.924 -166.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -113.15 99.5 7.88 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.226 -1.398 . . . . 3.4199999999999999 107.226 -170.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 35' ' ' LEU . 3.0 m -114.6 167.05 7.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 CA-C-N 119.648 1.113 . . . . 2.02 110.046 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -130.92 124.59 31.44 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.656 -1.609 . . . . 5.5099999999999998 106.656 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -134.37 -161.27 1.13 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 125.121 1.368 . . . . 2.3999999999999999 110.956 -167.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -147.58 117.91 4.41 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 109.533 -0.543 . . . . 3.04 109.533 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.11 66.32 8.82 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 CA-C-N 120.694 1.284 . . . . 1.1499999999999999 109.919 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.52 -70.28 0.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.314 1.046 . . . . 1.3999999999999999 108.266 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -89.75 -49.13 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.804 0.335 . . . . 1.22 110.647 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 tt -71.52 -45.56 67.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 C-N-CA 123.166 0.586 . . . . 1.3799999999999999 110.311 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 84.68 126.85 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.218 2.207 . . . . 3.3700000000000001 113.096 170.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -52.23 -50.47 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.019 2.479 . . . . 1.0 114.107 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.85 -3.28 11.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.228 1.285 . . . . 1.5600000000000001 113.042 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.3 mtt -95.05 -46.67 6.71 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.004 1.275 . . . . 3.2799999999999998 109.732 171.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -41.13 -54.38 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 118.702 0.683 . . . . 2.46 112.047 171.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.91 -69.44 0.11 Allowed 'General case' 0 C--N 1.342 0.24 0 CA-C-N 118.022 0.374 . . . . 0.85999999999999999 110.298 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -39.41 -57.74 1.36 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.66 1.584 . . . . 3.1800000000000002 112.433 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -43.0 -42.56 3.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.659 1.184 . . . . 2.5800000000000001 113.722 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.3 -47.93 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 121.501 0.667 . . . . 0.71999999999999997 109.225 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.45 -9.57 26.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.858 -1.068 . . . . 3.3300000000000001 113.338 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.65 -31.98 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.996 1.318 . . . . 3.8100000000000001 111.909 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.3 mt -81.89 -26.21 34.35 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.034 0.934 . . . . 1.5700000000000001 112.136 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.76 46.78 5.31 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.528 1.061 . . . . 0.90000000000000002 111.81 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -115.34 160.03 20.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.656 1.182 . . . . 3.1299999999999999 110.293 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.64 68.03 3.61 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.961 -1.255 . . . . 1.1599999999999999 109.961 -173.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.67 150.33 29.44 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.561 -0.533 . . . . 0.79000000000000004 109.561 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.0 p -142.18 107.67 5.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.166 -2.161 . . . . 2.1400000000000001 105.166 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.52 115.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 124.731 1.213 . . . . 0.96999999999999997 108.115 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 82.8 mt -108.26 115.59 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.998 -1.482 . . . . 3.1800000000000002 106.998 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -71.96 158.24 36.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.731 -1.122 . . . . 6.5899999999999999 108.651 171.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -132.18 159.39 39.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.521 -1.659 . . . . 5.0 106.521 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -51.5 146.11 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 123.588 0.555 . . . . 4.7300000000000004 110.385 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -59.0 144.69 44.39 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.843 -0.535 . . . . 4.2599999999999998 109.62 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.82 -59.93 0.35 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-O 119.159 -0.801 . . . . 5.8799999999999999 111.135 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 117.343 -1.313 . . . . 14.699999999999999 110.645 -170.531 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 107.674 -1.232 . . . . 3.8100000000000001 107.674 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -85.44 144.59 27.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.752 0.657 . . . . 2.7000000000000002 111.647 -171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 m -129.18 164.11 24.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.19 1.796 . . . . 1.77 108.366 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.94 140.53 31.02 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.013 -0.736 . . . . 4.3200000000000003 109.013 174.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 t -112.57 121.04 43.64 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 125.035 1.334 . . . . 1.3600000000000001 107.794 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -111.39 97.78 7.01 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.728 -1.212 . . . . 2.29 107.728 -167.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.28 155.45 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.586 -0.894 . . . . 1.3 108.586 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -132.55 154.31 50.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.745 -0.835 . . . . 2.9199999999999999 108.745 171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.26 139.58 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.393 -0.965 . . . . 2.2200000000000002 108.393 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 p -86.8 56.79 4.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.628 0.771 . . . . 1.6799999999999999 110.749 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 167.28 56.87 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.452 -1.059 . . . . 1.8500000000000001 110.452 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -54.12 15.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.107 0.563 . . . . 5.9900000000000002 109.634 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -70.7 56.91 0.18 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.846 2.058 . . . . 5.4900000000000002 111.413 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 m -113.97 66.47 0.67 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 106.535 -1.654 . . . . 2.6499999999999999 106.535 -176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 57.72 -73.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.012 2.125 . . . . 3.1699999999999999 112.76 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 p -152.63 25.45 0.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.471 1.109 . . . . 2.29 111.497 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.76 -51.96 26.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.45 1.119 . . . . 2.2400000000000002 110.54 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -50.09 -38.71 15.13 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 114.224 -1.353 . . . . 1.8 112.084 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.05 77.9 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.123 0.874 . . . . 0.66000000000000003 110.972 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -66.18 -56.83 9.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.036 -0.727 . . . . 1.1399999999999999 109.036 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -51.0 -41.98 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.54 0.736 . . . . 1.73 110.666 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -53.04 -68.12 0.2 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 119.508 1.049 . . . . 2.54 109.28 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -45.35 -47.42 13.34 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.012 1.325 . . . . 5.2800000000000002 110.653 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -57.06 -63.41 1.22 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.86 0.864 . . . . 2.8999999999999999 110.271 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.7 mt -57.42 -34.9 69.4 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 124.386 1.074 . . . . 2.5299999999999998 110.738 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -36.92 7.27 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.3 1.44 . . . . 7.2199999999999998 110.872 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -90.92 -71.29 0.64 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.877 1.271 . . . . 5.7999999999999998 109.234 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.66 -153.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.064 0.945 . . . . 3.2400000000000002 110.051 -163.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -111.36 32.44 5.35 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.251 1.021 . . . . 5.2199999999999998 111.681 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.85 36.81 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 CA-C-O 119.16 -0.8 . . . . 1.21 113.75 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.601 HD12 ' CG2' ' A' ' 45' ' ' VAL . 15.7 mm -87.71 156.11 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 118.484 1.142 . . . . 1.6699999999999999 111.552 173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -116.36 -34.95 4.45 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.408 1.883 . . . . 2.2999999999999998 112.51 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -155.49 151.84 28.19 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 108.397 -0.964 . . . . 0.89000000000000001 108.397 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.44 172.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.924 1.083 . . . . 3.0699999999999998 113.924 -173.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.52 138.7 33.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 125.412 1.485 . . . . 3.3300000000000001 112.105 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -162.32 82.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 112.46 0.541 . . . . 0.65000000000000002 112.46 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.7 48.55 1.82 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 120.197 -1.564 . . . . 0.5 109.818 166.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -28.98 68.54 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.422 1.489 . . . . 1.23 110.877 173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.2 ttm -46.42 -34.02 4.37 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.521 1.528 . . . . 4.4100000000000001 112.92 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.5 -47.42 1.98 Allowed 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.201 0.601 . . . . 0.85999999999999999 110.77 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 134.86 51.29 0.07 OUTLIER Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.613 1.102 . . . . 0.73999999999999999 111.04 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.52 179.3 6.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.418 1.087 . . . . 2.9100000000000001 110.355 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -142.92 124.32 14.72 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.031 1.732 . . . . 0.44 109.944 -169.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -124.62 59.95 1.18 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.008 1.323 . . . . 3.8700000000000001 111.375 -169.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.601 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -83.36 150.42 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.538 -0.912 . . . . 1.6000000000000001 108.538 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 52.7 ttp85 -117.36 134.99 54.18 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.695 1.198 . . . . 3.4500000000000002 108.619 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -142.1 178.1 7.77 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 123.598 0.759 . . . . 2.0 111.987 -162.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -132.67 94.38 22.06 Favored Pre-proline 0 N--CA 1.464 0.25 0 C-N-CA 123.722 0.809 . . . . 1.8200000000000001 111.202 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.72 78.64 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 111.34 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.25 -61.85 0.35 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.161 1.385 . . . . 1.1599999999999999 108.339 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.2 -57.28 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.036 0.934 . . . . 1.5900000000000001 109.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.25 -34.25 63.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 C-N-CA 123.802 0.841 . . . . 1.3600000000000001 112.41 -168.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 69.86 118.48 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.27 1.828 . . . . 2.6000000000000001 112.626 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.66 -46.95 22.35 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.808 2.339 . . . . 0.91000000000000003 114.895 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 -30.27 70.17 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 120.971 1.382 . . . . 0.93000000000000005 112.136 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.2 mmt -72.18 -39.78 68.4 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.47 -0.768 . . . . 2.9300000000000002 111.002 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -43.28 -58.08 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.681 0.792 . . . . 1.95 111.406 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.24 -62.62 1.0 Allowed 'General case' 0 C--N 1.342 0.262 0 CA-C-O 119.143 -0.456 . . . . 0.71999999999999997 111.278 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.62 -51.12 39.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.649 0.659 . . . . 2.6899999999999999 112.581 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.96 -43.16 8.83 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.801 0.84 . . . . 2.3199999999999998 112.645 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.36 -40.38 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 O-C-N 121.691 -0.63 . . . . 0.62 110.062 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -65.9 -7.36 16.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 117.743 -1.122 . . . . 3.5600000000000001 113.158 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -34.93 1.13 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.81 1.187 . . . . 5.1600000000000001 111.423 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.5 mt -81.05 -25.32 37.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.932 1.293 . . . . 1.1699999999999999 112.362 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.2 24.96 27.76 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.689 1.138 . . . . 0.88 113.262 -175.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -91.36 157.58 17.02 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.599 1.2 . . . . 2.8100000000000001 111.804 176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.0 73.83 2.62 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 109.877 -1.289 . . . . 0.93000000000000005 109.877 -175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.35 149.54 30.21 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.786 -0.449 . . . . 0.77000000000000002 109.786 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.04 98.5 3.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.652 -1.61 . . . . 1.24 106.652 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 p -85.22 125.59 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.415 1.486 . . . . 0.56000000000000005 108.931 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.74 -173.17 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 124.529 1.132 . . . . 1.5800000000000001 109.279 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.51 176.64 11.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.436 1.494 . . . . 5.0899999999999999 107.305 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.42 -47.62 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.796 0.838 . . . . 5.79 109.815 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.9 tt -126.35 174.63 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.632 1.173 . . . . 6.0 108.221 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 169.52 15.69 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.08 1.352 . . . . 4.7999999999999998 109.428 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.5 53.93 4.9 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.655 -0.978 . . . . 5.7400000000000002 110.655 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 . . . . . 0 C--O 1.254 1.307 0 N-CA-C 105.527 -2.027 . . . . 9.8499999999999996 105.527 179.445 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 117.874 -1.06 . . . . 4.1399999999999997 110.315 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.0 p -166.09 127.49 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.418 1.463 . . . . 2.6299999999999999 109.74 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 p -132.54 160.26 37.05 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.636 1.175 . . . . 2.1499999999999999 109.882 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.62 113.81 25.93 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.415 -0.957 . . . . 3.2599999999999998 108.415 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 6.4 t -83.7 122.56 28.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.886 -1.153 . . . . 1.6000000000000001 107.886 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.62 118.79 30.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.237 -1.764 . . . . 2.2400000000000002 106.237 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.18 156.71 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.126 -1.805 . . . . 0.77000000000000002 106.126 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -137.48 155.39 49.34 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.343 -1.354 . . . . 3.3700000000000001 107.343 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 71.4 t -141.22 135.04 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.228 1.011 . . . . 2.0699999999999998 109.109 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -93.31 55.36 2.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.073 1.349 . . . . 2.3100000000000001 111.663 -171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.29 40.53 0.1 OUTLIER Glycine 0 C--N 1.336 0.555 0 O-C-N 122.129 -0.357 . . . . 1.75 112.212 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -27.58 63.84 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 122.399 -0.471 . . . . 7.1900000000000004 111.931 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.2 p -63.11 -10.99 16.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.066 0.546 . . . . 5.8200000000000003 111.454 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.2 t -62.15 126.79 28.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 118.983 0.81 . . . . 3.2599999999999998 111.693 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -48.61 -32.22 7.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.734 1.214 . . . . 2.77 112.547 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.6 m -149.19 111.21 4.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.613 0.765 . . . . 3.1200000000000001 108.972 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.9 p -136.61 -54.09 0.72 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.856 0.862 . . . . 3.6000000000000001 108.83 166.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -59.08 -48.87 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 124.314 1.046 . . . . 1.96 110.666 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.87 -38.45 7.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.627 1.171 . . . . 0.88 113.923 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.29 -53.46 16.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.469 0.652 . . . . 1.27 109.789 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mt -51.93 -41.13 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.39 1.076 . . . . 1.99 110.182 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -49.67 -79.81 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 119.319 0.963 . . . . 2.2200000000000002 109.497 173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -40.69 -45.86 2.48 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.714 1.143 . . . . 4.4000000000000004 113.166 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -50.31 -60.8 2.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.335 0.588 . . . . 2.3199999999999998 109.995 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mp -61.59 -44.53 96.84 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 122.964 0.506 . . . . 1.8700000000000001 110.978 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.44 -37.68 26.7 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.739 -1.226 . . . . 6.9800000000000004 110.001 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -83.05 -33.48 26.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.61 1.164 . . . . 8.1899999999999995 113.957 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.68 121.38 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.364 0.984 . . . . 2.4900000000000002 112.169 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.74 84.05 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.892 1.277 . . . . 3.8199999999999998 110.724 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.32 -16.49 1.88 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.641 1.115 . . . . 1.1499999999999999 112.063 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.49 HD12 ' CG2' ' A' ' 45' ' ' VAL . 24.7 mm -70.17 145.35 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.718 1.259 . . . . 1.8100000000000001 110.558 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.95 -32.46 6.81 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.17 1.788 . . . . 2.6000000000000001 110.185 173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 t -154.91 149.01 25.88 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.235 -0.654 . . . . 0.83999999999999997 109.235 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.2 170.89 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.691 0.797 . . . . 3.0 112.334 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.504 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -82.51 142.24 32.01 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.5 1.12 . . . . 3.1400000000000001 110.791 177.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.83 91.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 120.877 0.37 . . . . 0.68000000000000005 111.298 174.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.09 48.71 1.06 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 120.729 -1.232 . . . . 0.46999999999999997 109.405 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -24.14 63.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 1.46 109.955 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.23 -38.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.174 0.989 . . . . 4.75 112.299 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.98 -43.92 1.32 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.391 0.676 . . . . 0.88 111.661 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.09 48.43 0.12 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.87 1.224 . . . . 0.78000000000000003 110.808 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -130.32 175.62 8.79 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.838 -1.171 . . . . 3.1200000000000001 107.838 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.52 125.6 10.66 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.667 1.187 . . . . 0.51000000000000001 108.085 -172.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.41 59.93 1.02 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.356 1.062 . . . . 3.7999999999999998 111.216 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -83.22 129.01 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.179 -0.675 . . . . 1.5600000000000001 109.179 -176.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -97.12 128.42 44.02 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.538 0.735 . . . . 4.0300000000000002 109.506 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -137.26 -166.73 1.98 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.709 1.604 . . . . 1.9099999999999999 110.622 -169.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -152.98 99.36 2.74 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.52 1.128 . . . . 1.8999999999999999 109.908 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.97 78.0 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.49 2.127 . . . . 0.84999999999999998 111.263 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -47.05 0.19 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.818 1.247 . . . . 1.0 110.208 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.03 -54.83 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.392 1.077 . . . . 1.28 109.913 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 57' ' ' ILE . 8.5 tt -63.6 -45.95 96.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 123.343 0.657 . . . . 1.5 111.199 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.31 128.21 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.857 2.063 . . . . 3.6699999999999999 112.741 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.94 -44.26 49.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.295 2.663 . . . . 0.87 115.114 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.84 -30.96 78.07 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 121.517 1.578 . . . . 1.1499999999999999 110.388 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -51.12 60.5 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.817 0.735 . . . . 3.2799999999999998 110.595 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 52' ' ' ILE . 1.2 pt -56.25 -46.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 119.708 -0.797 . . . . 2.2799999999999998 111.618 176.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.8 -55.36 23.49 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 120.723 -0.391 . . . . 0.67000000000000004 110.841 175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -53.94 -47.72 70.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.824 -0.548 . . . . 2.8799999999999999 111.817 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.11 -42.8 3.06 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.226 1.01 . . . . 2.7200000000000002 112.08 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -72.6 -48.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.2 mtp-105 -61.12 -18.46 58.14 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.937 -1.03 . . . . 3.1699999999999999 113.607 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -44.24 -32.34 1.25 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.716 1.144 . . . . 5.0099999999999998 111.603 167.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.7 mt -81.78 -15.31 54.65 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.326 0.65 . . . . 1.04 112.189 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.19 27.32 49.57 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.189 0.9 . . . . 0.84999999999999998 112.831 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -96.37 158.18 15.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.143 0.972 . . . . 2.8900000000000001 111.578 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.79 79.95 1.73 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 108.481 -1.848 . . . . 0.81000000000000005 108.481 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.43 164.93 20.66 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.067 0.947 . . . . 0.83999999999999997 109.376 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 91.66 1.28 Allowed 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.175 -1.046 . . . . 1.3899999999999999 108.175 -176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.92 136.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 123.843 0.857 . . . . 0.66000000000000003 109.839 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.35 130.23 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 126.372 1.869 . . . . 2.77 106.262 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -51.43 -66.18 0.43 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.93 1.292 . . . . 5.6600000000000001 111.106 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.477 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.6 t-20 57.56 85.41 0.09 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.218 1.407 . . . . 5.71 112.266 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 73' ' ' ASN . 4.9 tt 57.08 177.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.897 1.679 . . . . 4.5899999999999999 111.715 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.11 5.58 16.04 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.026 0.75 . . . . 4.7699999999999996 113.026 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.55 -47.64 0.84 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.391 -0.684 . . . . 5.8300000000000001 111.391 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 104.635 -2.357 . . . . 11.9 104.635 173.053 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.013 -0.518 . . . . 3.52 112.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 t 77.74 147.04 0.09 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.607 1.563 . . . . 2.8300000000000001 110.509 -166.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -156.65 170.36 22.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.975 1.31 . . . . 2.3999999999999999 108.445 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -80.52 140.04 36.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.838 0.855 . . . . 3.0800000000000001 109.586 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -109.51 120.12 41.53 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.488 -1.671 . . . . 1.6699999999999999 106.488 169.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.82 125.85 37.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.068 -1.456 . . . . 3.9100000000000001 107.068 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt -124.69 162.51 26.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.204 -1.406 . . . . 0.72999999999999998 107.204 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -140.16 151.72 45.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.277 -1.379 . . . . 2.7599999999999998 107.277 167.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.71 134.83 29.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 108.036 -1.098 . . . . 2.0499999999999998 108.036 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -90.75 102.09 14.84 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.479 0.657 . . . . 2.8500000000000001 110.106 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.52 37.91 1.69 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.672 -1.371 . . . . 1.7 109.672 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.0 ptp -75.69 -35.6 60.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 110.223 -0.288 . . . . 5.5 110.223 173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -74.63 60.39 0.9 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.366 1.066 . . . . 5.5800000000000001 110.087 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.9 m -137.57 67.34 1.43 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.681 0.792 . . . . 2.6800000000000002 109.254 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 71.26 -46.08 0.63 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.241 1.816 . . . . 2.8100000000000001 113.616 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.9 m -147.67 -89.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.843 0.857 . . . . 3.73 108.746 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m 57.84 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.578 1.951 . . . . 2.5800000000000001 110.725 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 p -48.19 -49.26 12.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 C-N-CA 125.178 1.391 . . . . 1.8799999999999999 110.046 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.48 49.39 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.145 0.578 . . . . 1.1399999999999999 111.833 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -46.51 76.94 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 109.276 -0.639 . . . . 2.3999999999999999 109.276 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.06 -42.03 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 118.964 -0.541 . . . . 2.4900000000000002 109.735 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.4 -55.58 33.16 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 119.964 1.256 . . . . 1.9299999999999999 109.992 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -44.6 -42.11 7.12 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 128.577 2.751 . . . . 3.9900000000000002 112.635 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.07 -62.11 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.838 0.827 . . . . 2.4500000000000002 109.406 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.74 -31.88 71.18 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.942 1.297 . . . . 1.78 111.694 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -56.05 -33.49 65.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.533 -0.729 . . . . 7.25 111.641 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.26 -27.95 13.91 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.278 1.431 . . . . 5.6900000000000004 113.544 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -33.89 123.74 0.46 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.285 1.434 . . . . 2.46 112.006 177.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.59 76.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.256 1.422 . . . . 4.6200000000000001 111.182 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.49 -27.5 0.96 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.079 0.847 . . . . 1.05 112.471 -174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 28' ' ' GLU . 2.3 mm -63.94 137.91 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.545 -0.974 . . . . 1.48 109.907 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -105.15 -30.44 9.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.181 1.392 . . . . 2.2999999999999998 110.771 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -155.2 153.0 30.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.949 0.795 . . . . 0.81999999999999995 110.566 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -82.88 157.66 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.874 1.669 . . . . 3.0699999999999998 111.102 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.5 pp -83.39 136.39 34.35 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.624 2.37 . . . . 1.99 113.07 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -157.52 103.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.531 1.133 . . . . 0.67000000000000004 109.757 174.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.69 49.67 1.14 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 122.25 1.024 . . . . 0.53000000000000003 109.598 158.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.29 -29.01 63.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 1.3 110.483 173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.5 ptm -39.39 -40.72 0.85 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.428 1.491 . . . . 4.0999999999999996 113.301 169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.89 -41.16 2.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.788 0.835 . . . . 0.96999999999999997 111.038 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.9 50.6 0.24 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.869 -1.692 . . . . 0.81000000000000005 108.869 -174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.95 175.12 10.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.335 1.054 . . . . 5.7000000000000002 111.872 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.3 130.79 12.97 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.664 1.185 . . . . 0.69999999999999996 109.44 -168.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -131.88 79.42 1.87 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.538 1.535 . . . . 3.4700000000000002 110.797 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.49 159.92 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.693 -1.225 . . . . 1.5900000000000001 107.693 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -119.93 133.28 55.61 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.574 -0.899 . . . . 3.8999999999999999 108.574 170.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 2.3 p90 -141.59 -166.78 2.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.164 1.385 . . . . 2.0 110.135 -170.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -146.97 99.41 4.0 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.825 1.25 . . . . 4.0599999999999996 110.895 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.31 79.64 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 120.813 1.326 . . . . 0.79000000000000004 111.65 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.44 -69.09 0.24 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.609 1.564 . . . . 1.25 108.06 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -89.02 -56.12 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.537 0.735 . . . . 1.3100000000000001 109.91 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.9 tt -63.62 -33.32 60.94 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 124.188 0.995 . . . . 1.3700000000000001 112.451 -167.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 71.67 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.04 2.136 . . . . 2.6600000000000001 112.516 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -48.4 -46.92 21.69 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.612 2.208 . . . . 0.79000000000000004 114.867 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.49 -34.0 86.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.17 1.454 . . . . 0.89000000000000001 112.032 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 30.4 mmt -71.41 -39.96 70.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.601 -0.714 . . . . 4.4000000000000004 110.913 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.0 mt -42.68 -58.72 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.706 1.139 . . . . 1.8899999999999999 111.564 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.05 -55.9 9.05 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.019 -0.425 . . . . 0.70999999999999996 111.383 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -52.77 -47.91 67.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 118.27 0.486 . . . . 2.21 111.886 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.96 -37.07 8.46 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.861 1.264 . . . . 2.0 112.652 171.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.67 -46.54 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.728 -0.608 . . . . 0.85999999999999999 109.678 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -56.98 -23.49 46.33 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.225 -0.893 . . . . 3.1400000000000001 112.464 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -42.1 -38.99 1.84 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.179 0.9 . . . . 4.9400000000000004 111.865 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.9 mt -83.82 -11.91 56.37 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.716 0.806 . . . . 1.53 112.451 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.02 27.29 60.52 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.359 0.98 . . . . 1.01 112.89 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -92.22 149.46 21.45 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.158 0.979 . . . . 3.02 111.381 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.49 72.59 2.74 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.81 -1.716 . . . . 0.85999999999999999 108.81 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.12 163.44 18.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.316 1.046 . . . . 0.71999999999999997 110.494 174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -154.95 131.43 10.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.648 -1.612 . . . . 1.4199999999999999 106.648 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.24 138.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.894 1.278 . . . . 0.68999999999999995 108.759 -171.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.0 pt -137.51 140.18 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.274 1.03 . . . . 1.48 109.644 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -77.43 156.83 30.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.894 -0.78 . . . . 5.6799999999999997 108.894 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -159.84 111.17 1.98 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.179 -1.786 . . . . 4.9199999999999999 106.179 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.264 2.4 tt 52.22 -167.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.943 1.297 . . . . 4.6600000000000001 110.953 -176.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -141.7 158.89 43.25 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.149 -1.426 . . . . 4.21 107.149 169.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.63 35.63 91.37 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 123.993 0.806 . . . . 6.0999999999999996 111.508 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? . . . . . 0 C--O 1.254 1.314 0 N-CA-C 103.427 -2.805 . . . . 11.16 103.427 167.336 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 106.867 -1.531 . . . . 5.2599999999999998 106.867 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 14.97 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.588 2.07 . . . . 2.1800000000000002 116.588 136.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 p -83.09 170.44 14.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.611 2.365 . . . . 1.8300000000000001 110.682 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -111.99 112.96 24.98 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.124 0.97 . . . . 3.75 111.184 178.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.6 p -84.53 143.73 29.14 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.731 -1.211 . . . . 1.74 107.731 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.4 122.13 36.65 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.776 -1.935 . . . . 2.4199999999999999 105.776 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -119.11 150.48 21.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.921 -1.511 . . . . 0.90000000000000002 106.921 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -135.68 149.74 49.37 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.313 -1.365 . . . . 2.6699999999999999 107.313 172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.17 165.35 9.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 105.607 -1.997 . . . . 2.4300000000000002 105.607 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -115.12 101.93 9.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.734 0.814 . . . . 2.0099999999999998 109.903 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.2 17.13 2.5 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.136 1.35 . . . . 2.1499999999999999 112.191 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.5 ptp -64.32 -24.54 67.69 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.971 -0.723 . . . . 5.4900000000000002 112.087 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.0 p -61.81 -12.23 16.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.265 1.026 . . . . 5.4299999999999997 112.455 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -57.07 145.98 29.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.567 0.621 . . . . 2.2999999999999998 111.771 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -16.28 -57.36 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 129.615 3.166 . . . . 3.3599999999999999 115.553 -173.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -149.64 47.49 0.95 Allowed 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.219 -0.66 . . . . 1.9099999999999999 109.219 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 t -71.26 -52.5 18.62 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.664 -0.865 . . . . 2.6400000000000001 108.664 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.42 -57.43 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-O 118.526 -0.749 . . . . 2.6800000000000002 110.313 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.01 -46.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.104 1.762 . . . . 0.68000000000000005 114.078 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.73 -65.28 0.7 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.689 0.757 . . . . 1.96 109.473 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' CG2' HD21 ' A' ' 35' ' ' LEU . 9.4 mt -52.97 -52.48 28.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.014 -0.994 . . . . 1.9099999999999999 109.622 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -39.56 -64.03 0.51 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 120.51 1.505 . . . . 2.1299999999999999 111.857 172.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -58.24 -45.36 87.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.256 1.022 . . . . 4.21 111.073 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -55.96 -56.38 21.39 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.103 0.954 . . . . 2.8999999999999999 108.564 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -56.11 -38.21 70.44 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.743 1.217 . . . . 2.4700000000000002 110.238 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -34.95 62.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 119.661 1.119 . . . . 6.5099999999999998 110.74 177.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -87.42 -31.46 20.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.246 1.418 . . . . 6.5599999999999996 112.4 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.33 132.43 2.64 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.871 0.868 . . . . 2.9300000000000002 112.676 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -73.0 69.77 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.832 1.253 . . . . 4.1799999999999997 111.948 -164.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.62 -26.57 0.85 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.573 -0.571 . . . . 0.92000000000000004 113.156 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 57' ' ' ILE . 11.7 mm -68.44 134.67 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 118.161 0.981 . . . . 1.6699999999999999 109.791 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -102.67 -24.58 13.75 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.007 1.323 . . . . 2.2999999999999998 110.754 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -156.41 145.36 20.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.0 0.818 . . . . 0.81000000000000005 110.842 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.8 164.72 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 126.401 1.88 . . . . 3.1400000000000001 112.749 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.57 ' O ' HD12 ' A' ' 35' ' ' LEU . 4.5 pp -89.8 134.82 33.98 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.657 1.583 . . . . 1.6599999999999999 111.767 -173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -160.57 87.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 112.219 0.452 . . . . 0.94999999999999996 112.219 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.54 46.1 1.81 Allowed 'General case' 0 CA--C 1.53 0.186 0 O-C-N 120.69 -1.256 . . . . 0.68000000000000005 109.336 161.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.74 -37.64 52.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.561 1.544 . . . . 1.8100000000000001 109.662 169.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -27.44 -45.15 0.03 OUTLIER 'General case' 0 C--N 1.342 0.273 0 C-N-CA 127.266 2.226 . . . . 4.6900000000000004 113.379 168.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.68 -47.5 2.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.444 0.698 . . . . 0.88 110.928 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 140.45 43.37 0.07 OUTLIER Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.427 1.013 . . . . 0.69999999999999996 111.694 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -129.59 175.3 8.91 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.309 1.055 . . . . 3.0600000000000001 110.126 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -141.8 133.2 26.62 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.51 1.524 . . . . 0.44 107.157 -168.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 10.4 pt-20 -133.35 82.61 2.0 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.363 0.602 . . . . 2.3599999999999999 112.129 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.64 128.36 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.399 0.68 . . . . 2.3999999999999999 109.853 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -83.92 126.02 32.58 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.51 -0.552 . . . . 4.0599999999999996 109.51 172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -126.28 -167.71 1.75 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.664 1.586 . . . . 2.2999999999999998 109.504 -170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -151.41 96.77 3.18 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.158 -0.449 . . . . 2.0899999999999999 110.732 -174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.7 68.94 6.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.757 2.971 . . . . 1.7 107.3 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.54 -47.94 0.12 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.716 2.007 . . . . 2.5600000000000001 106.704 -167.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -123.33 -60.5 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.256 1.022 . . . . 1.46 109.899 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -73.44 -48.52 41.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 N-CA-C 112.689 0.625 . . . . 1.9399999999999999 112.689 -157.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 81.83 129.12 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 127.733 2.413 . . . . 2.6400000000000001 112.485 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.53 -29.4 88.7 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.441 2.76 . . . . 1.77 115.854 -174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 -31.76 68.31 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 CA-C-N 122.826 2.045 . . . . 1.48 112.381 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.0 mtt -72.45 -45.69 58.37 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.399 0.999 . . . . 3.9399999999999999 111.417 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.577 HG21 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -52.89 -48.75 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 119.854 -0.738 . . . . 2.3300000000000001 111.023 176.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.09 -51.56 61.45 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.769 -0.582 . . . . 0.71999999999999997 111.936 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.95 -53.0 56.09 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.414 0.552 . . . . 2.1600000000000001 111.566 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -44.14 -50.22 8.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.16 0.584 . . . . 2.1800000000000002 111.01 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.63 -40.93 86.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 121.676 -0.64 . . . . 0.89000000000000001 109.468 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.86 -9.45 20.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 117.51 -1.233 . . . . 3.4300000000000002 113.339 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.62 -28.66 33.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.74 1.609 . . . . 3.9100000000000001 110.326 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.8 mt -82.41 -11.25 58.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 112.002 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.27 21.41 78.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.65 0.643 . . . . 0.88 113.216 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -85.75 150.88 24.27 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.409 1.105 . . . . 2.3900000000000001 110.627 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.29 71.26 2.94 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.264 -1.534 . . . . 0.90000000000000002 109.264 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.07 148.9 29.45 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.582 -0.525 . . . . 0.73999999999999999 109.582 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 t -139.82 129.62 24.64 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.012 -2.218 . . . . 1.48 105.012 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.39 139.7 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.116 1.366 . . . . 0.56999999999999995 107.994 -171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 58.9 mt -130.74 131.32 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.627 1.571 . . . . 2.7400000000000002 106.981 -170.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -58.16 167.82 1.19 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.272 1.829 . . . . 6.0899999999999999 111.668 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.32 154.48 7.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.924 -0.769 . . . . 5.8499999999999996 108.924 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -74.73 178.94 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 124.121 0.888 . . . . 4.3700000000000001 110.902 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -98.73 150.73 21.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.337 1.455 . . . . 5.5800000000000001 110.606 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.81 64.45 3.03 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.829 -0.623 . . . . 7.0 111.56 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 C-N-CA 126.861 2.064 . . . . 13.359999999999999 111.588 -170.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 106.839 -1.541 . . . . 4.0599999999999996 106.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p 176.35 133.91 0.05 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.61 -1.996 . . . . 2.5800000000000001 105.61 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.4 m -136.03 174.75 10.27 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.711 -0.848 . . . . 1.77 108.711 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.19 148.3 31.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 110.029 -0.359 . . . . 4.9900000000000002 110.029 168.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' SG ' HG13 ' A' ' 45' ' ' VAL . 1.6 p -120.84 110.16 16.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.984 2.113 . . . . 2.6099999999999999 105.782 -172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.13 117.52 30.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.329 -1.36 . . . . 4.7999999999999998 107.329 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -101.88 122.54 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.961 -1.866 . . . . 1.1200000000000001 105.961 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -96.76 149.03 22.29 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.063 -1.088 . . . . 3.0299999999999998 108.063 165.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -159.32 169.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 104.991 -2.225 . . . . 2.73 104.991 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 p -138.64 96.58 3.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 118.775 0.716 . . . . 2.5800000000000001 109.652 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.35 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.809 -2.516 . . . . 2.4700000000000002 106.809 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.5 mmt -44.36 -53.89 6.36 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.589 1.156 . . . . 6.1200000000000001 109.998 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -179.52 -55.02 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.343 1.857 . . . . 8.7599999999999998 107.301 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -168.2 -158.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.16 -1.422 . . . . 4.4500000000000002 107.16 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.91 -78.88 0.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.755 1.161 . . . . 4.0099999999999998 110.368 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 78.09 4.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.895 -1.128 . . . . 2.5499999999999998 110.693 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -131.13 -44.88 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.675 -1.148 . . . . 3.0699999999999998 110.241 168.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.92 -46.78 87.52 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-O 119.105 -0.474 . . . . 2.5099999999999998 109.746 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -35.57 -42.3 0.23 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.176 1.39 . . . . 1.03 114.111 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.56 -57.19 13.09 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.059 -0.401 . . . . 1.1399999999999999 110.716 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.413 ' CG1' HD11 ' A' ' 64' ' ' LEU . 3.4 mp -52.24 -53.98 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.738 -1.601 . . . . 2.0299999999999998 109.387 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -40.64 -68.45 0.18 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 120.668 1.576 . . . . 3.7000000000000002 109.891 172.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -52.02 -34.19 41.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.1600000000000001 112.442 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -36.88 72.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.18 0.9 . . . . 3.0 109.906 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -39.87 51.22 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.903 1.281 . . . . 1.78 110.937 174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -26.03 13.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.907 1.683 . . . . 6.3200000000000003 112.239 -173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -103.28 -11.23 18.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.506 2.323 . . . . 9.3200000000000003 112.934 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.9 127.95 33.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 2.54 109.729 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -66.04 83.57 0.08 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.126 1.37 . . . . 3.8399999999999999 110.62 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.82 -20.66 1.81 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.602 1.096 . . . . 1.05 111.949 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 45' ' ' VAL . 26.8 mm -71.36 138.85 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 118.316 1.058 . . . . 1.5600000000000001 109.899 173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -106.65 -33.64 7.57 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.701 1.201 . . . . 2.3100000000000001 111.025 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 t -154.8 149.54 26.56 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.765 -0.828 . . . . 0.77000000000000002 108.765 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pp -82.65 169.79 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 124.28 1.032 . . . . 3.0 112.646 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.518 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.6 pp -87.32 133.95 33.63 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.408 2.283 . . . . 1.79 111.076 176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -160.4 96.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.19 0.596 . . . . 0.54000000000000004 109.572 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.17 46.45 1.24 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.197 -0.939 . . . . 0.40999999999999998 109.68 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.44 -29.81 59.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.982 1.313 . . . . 1.5900000000000001 110.23 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -37.79 -38.61 0.3 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.312 1.445 . . . . 4.7699999999999996 113.053 172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -42.79 2.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.288 1.035 . . . . 0.92000000000000004 111.14 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.81 44.18 0.23 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.477 1.513 . . . . 1.2 110.355 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -126.47 177.8 6.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.416 1.487 . . . . 5.0199999999999996 110.011 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -148.49 128.86 13.87 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.81 1.644 . . . . 0.52000000000000002 108.614 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -133.18 71.65 1.47 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.181 0.992 . . . . 4.3600000000000003 110.388 -172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.5 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -84.38 155.21 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.777 -0.823 . . . . 1.6200000000000001 108.777 -177.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -120.55 135.36 55.11 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.793 1.237 . . . . 5.1200000000000001 110.021 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.29 -169.82 3.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.826 0.851 . . . . 1.95 111.298 -165.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -142.63 103.63 5.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.898 0.879 . . . . 1.8500000000000001 110.14 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.67 69.31 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.673 2.249 . . . . 0.81999999999999995 111.132 -175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.33 -58.49 0.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.817 1.647 . . . . 0.96999999999999997 108.078 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.0 t -101.53 -57.67 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.247 1.019 . . . . 1.29 109.864 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.536 HD11 HG23 ' A' ' 57' ' ' ILE . 6.9 tt -63.78 -34.7 69.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 N-CA-C 113.129 0.788 . . . . 1.4399999999999999 113.129 -169.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 73.7 119.17 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.608 1.963 . . . . 2.7200000000000002 112.664 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.12 -41.6 74.24 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.004 2.469 . . . . 0.81999999999999995 115.396 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.79 -31.81 57.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 121.655 1.627 . . . . 0.91000000000000003 111.35 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -72.54 -47.06 51.38 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 118.485 -0.769 . . . . 4.3399999999999999 109.553 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -52.2 -49.05 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 119.508 1.049 . . . . 2.2000000000000002 111.883 174.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -46.6 -59.92 2.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.01 0.368 . . . . 0.64000000000000001 110.994 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -56.7 -45.69 81.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 112.789 0.662 . . . . 2.3500000000000001 112.789 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.07 -40.03 6.38 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.528 0.731 . . . . 2.1099999999999999 112.194 170.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.5 mt -73.27 -49.23 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.471 -0.937 . . . . 0.68000000000000005 108.471 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.48 -14.0 46.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.029 -0.986 . . . . 2.3999999999999999 113.199 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.31 -30.77 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.528 1.058 . . . . 5.0800000000000001 112.103 164.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 21' ' ' ILE . 6.9 mt -80.68 -14.99 57.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.379 0.672 . . . . 1.4099999999999999 111.512 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.55 60.98 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.558 1.075 . . . . 0.92000000000000004 111.88 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -91.65 155.71 18.12 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.696 0.748 . . . . 2.8799999999999999 109.546 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.1 61.66 4.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.045 -1.222 . . . . 0.93999999999999995 110.045 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.71 153.68 25.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.324 0.649 . . . . 0.66000000000000003 109.706 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -155.26 117.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.63 -1.989 . . . . 1.6100000000000001 105.63 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.8 p -95.58 133.62 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.751 0.82 . . . . 0.59999999999999998 108.932 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.3 pt -134.53 160.66 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 123.535 0.734 . . . . 1.5 109.504 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.9 176.77 5.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.045 2.138 . . . . 5.4199999999999999 107.906 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -155.39 -50.99 0.09 Allowed 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 122.938 0.495 . . . . 4.8200000000000003 109.84 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.81 146.28 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.339 -0.986 . . . . 4.9500000000000002 108.339 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.14 3.29 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.54 1.536 . . . . 5.6699999999999999 111.737 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.94 134.84 7.22 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 107.141 -2.384 . . . . 7.2400000000000002 107.141 -160.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--O 1.255 1.365 0 N-CA-C 105.29 -2.115 . . . . 12.51 105.29 168.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.843 -0.799 . . . . 6.04 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 p -42.75 129.64 4.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.537 1.535 . . . . 2.9300000000000002 112.687 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -144.59 178.61 7.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.5 1.52 . . . . 3.21 109.236 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -78.94 145.76 33.85 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 110.021 -0.363 . . . . 3.8300000000000001 110.021 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.2 t -100.36 118.99 37.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.883 -1.155 . . . . 1.74 107.883 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.23 131.72 38.07 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.889 -1.523 . . . . 3.1699999999999999 106.889 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.5 mt -129.22 136.73 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 105.631 -1.988 . . . . 1.1499999999999999 105.631 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -113.14 170.7 8.03 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.5 -0.556 . . . . 3.6400000000000001 109.5 170.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 12' ' ' MET . 6.4 p -152.78 152.9 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -1.101 . . . . 3.1299999999999999 108.028 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.2 p -109.42 64.46 0.61 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.23 0.612 . . . . 2.1899999999999999 109.65 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.34 43.69 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.701 0.667 . . . . 2.0 111.932 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.419 ' O ' HG11 ' A' ' 9' ' ' VAL . 30.3 mtm 44.99 -106.41 0.11 Allowed 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.257 1.023 . . . . 6.96 110.447 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 18' ' ' VAL . 1.2 t -158.18 30.95 0.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.255 -1.387 . . . . 7.7999999999999998 107.255 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 68.81 -79.8 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.425 -0.797 . . . . 2.8300000000000001 111.704 -167.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.72 129.6 0.08 Allowed 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.055 1.342 . . . . 2.75 108.876 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m 54.72 16.27 1.34 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.114 1.153 . . . . 2.2599999999999998 114.114 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.4 t -84.33 -38.32 20.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.864 -0.791 . . . . 2.8399999999999999 108.864 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.565 ' H ' HG21 ' A' ' 13' ' ' THR . 0.6 OUTLIER -49.76 -48.66 21.25 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-O 117.995 -1.003 . . . . 2.4399999999999999 110.124 179.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.14 -46.47 1.04 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.606 1.162 . . . . 0.92000000000000004 112.37 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.93 -56.7 16.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.874 0.47 . . . . 1.1200000000000001 111.021 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 64' ' ' LEU . 3.1 mp -53.65 -55.12 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.435 -0.58 . . . . 1.9099999999999999 109.435 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -40.18 -63.49 0.61 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.662 1.585 . . . . 1.9199999999999999 110.092 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.98 -37.09 42.69 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.131 1.772 . . . . 7.71 112.804 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -44.86 64.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.328 1.051 . . . . 3.4199999999999999 108.538 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -42.93 91.19 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 109.873 -0.417 . . . . 1.9399999999999999 109.873 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -30.57 29.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.967 1.307 . . . . 5.7800000000000002 111.537 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptt85 -100.25 -9.55 22.29 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.141 1.377 . . . . 9.1500000000000004 114.015 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.72 120.92 13.85 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.591 1.087 . . . . 2.5299999999999998 109.714 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -55.18 107.63 0.33 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.753 0.821 . . . . 4.3899999999999997 110.197 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.48 -26.56 5.71 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.371 0.986 . . . . 1.29 110.912 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 57' ' ' ILE . 29.1 mm -68.83 140.6 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 118.211 1.005 . . . . 1.6299999999999999 110.243 174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -110.29 -28.64 8.51 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.976 1.31 . . . . 2.6800000000000002 111.401 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -155.92 148.04 23.41 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 121.394 -0.817 . . . . 2.4199999999999999 109.891 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.55 171.17 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.191 0.996 . . . . 3.3300000000000001 112.413 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.634 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.0 130.62 38.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.919 2.088 . . . . 1.8100000000000001 112.487 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.45 81.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 121.739 -0.601 . . . . 0.68000000000000005 110.827 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.78 47.99 2.13 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.907 -1.121 . . . . 0.56000000000000005 110.303 167.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' A' ' 13' ' ' THR . 1.2 tt -59.62 -28.03 66.85 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 114.802 -1.09 . . . . 1.2 110.952 171.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.9 ptp -44.18 -31.8 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.948 1.299 . . . . 3.8500000000000001 112.912 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.31 -47.3 1.75 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.554 0.741 . . . . 0.94999999999999996 111.221 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.24 56.17 0.09 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.869 -1.292 . . . . 0.68999999999999995 109.869 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -143.26 177.01 8.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.98 0.912 . . . . 3.6299999999999999 109.569 174.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -145.76 127.2 14.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.4 1.88 . . . . 0.55000000000000004 107.733 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -125.09 64.89 1.13 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.349 1.06 . . . . 3.2200000000000002 111.904 -171.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -81.28 158.61 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.286 -1.005 . . . . 1.6100000000000001 108.286 -177.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.4 ttp85 -128.44 135.66 49.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 O-C-N 120.741 -1.224 . . . . 3.6499999999999999 109.608 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -162.15 1.49 Allowed 'General case' 0 CA--C 1.533 0.326 0 O-C-N 124.026 0.829 . . . . 2.0899999999999999 111.419 -164.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.38 103.17 2.93 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.06 0.944 . . . . 2.29 109.834 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.16 76.51 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.34 2.027 . . . . 1.0900000000000001 110.752 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.46 -50.73 0.22 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.526 1.13 . . . . 1.2 109.156 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.44 -61.21 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.165 0.986 . . . . 1.3500000000000001 109.186 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HG23 ' A' ' 57' ' ' ILE . 9.1 tt -61.06 -38.85 80.49 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 123.857 0.863 . . . . 1.53 112.173 -169.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 75.34 124.69 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 127.331 2.252 . . . . 2.8900000000000001 113.826 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -55.19 -45.87 37.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.468 2.778 . . . . 0.93999999999999995 115.048 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.59 -35.33 90.37 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 CA-C-N 121.094 1.427 . . . . 1.22 110.323 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -53.26 52.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.711 0.687 . . . . 3.0699999999999998 110.541 -174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -54.58 -49.09 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.993 -0.683 . . . . 2.3799999999999999 111.453 177.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.38 -58.72 5.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 111.503 0.186 . . . . 0.79000000000000004 111.503 175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -50.28 -50.41 50.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.449 0.7 . . . . 2.29 111.243 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -43.06 3.97 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.71 0.633 . . . . 2.4300000000000002 112.71 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -72.17 -44.34 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 O-C-N 121.468 -0.77 . . . . 0.81999999999999995 108.957 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -61.57 -18.07 57.7 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.131 -0.938 . . . . 2.52 112.891 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -45.29 -28.82 0.88 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.378 0.99 . . . . 5.1500000000000004 112.097 168.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 21' ' ' ILE . 34.7 mt -81.63 -19.09 42.52 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.591 -0.693 . . . . 1.2 112.53 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.71 15.39 61.63 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.312 0.958 . . . . 0.95999999999999996 113.031 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -82.08 153.06 26.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.564 1.182 . . . . 2.73 110.828 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.78 70.76 2.98 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.869 -1.692 . . . . 0.75 108.869 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.51 159.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.183 -0.673 . . . . 0.60999999999999999 109.183 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.99 92.44 1.54 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.554 -1.647 . . . . 1.24 106.554 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -71.2 135.91 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 124.6 1.16 . . . . 0.73999999999999999 108.491 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.4 pt -145.2 173.19 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.517 1.127 . . . . 1.6100000000000001 107.964 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -159.09 176.68 11.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.666 -1.605 . . . . 5.5999999999999996 106.666 173.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.66 111.87 3.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.826 -1.546 . . . . 5.5899999999999999 106.826 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.3 pt 51.92 -168.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.247 1.419 . . . . 4.6900000000000004 112.063 -172.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -141.84 158.56 43.64 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.967 1.707 . . . . 4.7599999999999998 106.604 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.24 -61.32 0.14 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.205 -0.758 . . . . 5.79 111.205 170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 . . . . . 0 C--O 1.256 1.439 0 CA-C-O 115.951 -1.976 . . . . 15.51 106.356 -179.312 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 104.304 -2.48 . . . . 4.4000000000000004 104.304 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.51 148.05 10.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.939 -0.704 . . . . 2.1600000000000001 109.664 -144.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -133.32 161.68 33.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.012 1.725 . . . . 2.1099999999999999 109.166 -166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -89.3 120.13 30.38 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.136 0.574 . . . . 3.52 109.889 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 119.28 24.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.893 -1.891 . . . . 1.74 105.893 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -98.46 96.03 7.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.605 -1.628 . . . . 3.2000000000000002 106.605 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.82 154.94 6.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.834 -1.173 . . . . 0.70999999999999996 107.834 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -134.4 154.11 51.55 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.224 -0.658 . . . . 2.5 109.224 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.3 t -139.74 124.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.991 1.316 . . . . 1.99 109.091 -170.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -85.86 55.82 3.7 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.937 0.895 . . . . 1.99 111.522 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.39 57.99 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 N-CA-C 109.908 -1.277 . . . . 1.71 109.908 172.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -41.37 73.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.267 0.227 . . . . 7.46 110.615 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -75.87 61.48 1.46 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.297 1.039 . . . . 6.2800000000000002 109.888 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.53 142.09 51.69 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.904 1.282 . . . . 2.52 109.328 -174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 90.63 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.351 0.66 . . . . 3.5699999999999998 110.601 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m 64.1 29.72 14.03 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 124.618 1.167 . . . . 1.8799999999999999 112.711 170.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -61.89 2.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.851 -0.796 . . . . 2.25 108.851 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.0 t -59.86 -23.94 28.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 118.236 -0.888 . . . . 2.02 111.091 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.05 84.24 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.013 1.279 . . . . 1.0 111.891 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.13 -51.48 61.02 Favored 'General case' 0 C--N 1.339 0.133 0 O-C-N 121.589 -0.694 . . . . 1.22 109.328 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 21' ' ' ILE . 3.8 mp -55.98 -38.75 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 109.067 -0.716 . . . . 1.76 109.067 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 27.2 mt-10 -51.25 -59.96 3.64 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.303 0.956 . . . . 2.1299999999999999 110.964 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.1 mmm-85 -65.11 -9.64 24.26 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.733 -1.121 . . . . 3.9199999999999999 113.442 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.589 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.1 -45.77 9.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.67 1.123 . . . . 3.5800000000000001 109.608 172.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.589 HD13 HD21 ' A' ' 24' ' ' ASN . 1.1 tp -99.35 -8.28 25.07 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.949 0.795 . . . . 1.97 111.455 -165.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -32.67 -49.75 0.23 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.894 2.078 . . . . 6.5199999999999996 114.668 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -142.45 -43.57 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.176 2.19 . . . . 7.2400000000000002 110.507 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.53 -141.7 0.82 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.351 1.06 . . . . 2.5299999999999998 110.081 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -113.78 62.29 0.65 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.597 1.159 . . . . 3.5699999999999998 109.082 170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.39 31.82 0.55 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-O 119.378 -0.679 . . . . 0.93999999999999995 113.364 169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.9 mt -119.44 147.27 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 117.98 0.89 . . . . 1.53 108.785 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.06 -8.95 5.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.85 1.66 . . . . 2.21 112.214 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -157.16 162.55 39.35 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.85 -1.537 . . . . 0.79000000000000004 106.85 162.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -117.06 157.3 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.833 1.253 . . . . 4.2400000000000002 110.114 -172.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 34' ' ' ILE . 2.2 pp -76.77 130.98 38.44 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.688 1.195 . . . . 1.8999999999999999 111.745 -176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -157.04 93.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.459 -1.246 . . . . 0.56999999999999995 109.726 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.43 43.59 1.2 Allowed 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.471 -0.768 . . . . 0.45000000000000001 108.982 158.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -51.26 -40.75 59.57 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.766 1.226 . . . . 1.3200000000000001 108.722 169.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.65 -32.61 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.014 2.526 . . . . 4.6100000000000003 114.154 172.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.94 -50.08 1.71 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.248 0.619 . . . . 0.98999999999999999 110.845 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.96 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.55 0 C-N-CA 125.004 1.287 . . . . 0.87 111.136 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -137.46 177.29 7.98 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.334 1.454 . . . . 3.25 108.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.43 114.4 3.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.079 0.952 . . . . 0.58999999999999997 109.683 -168.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -118.93 84.42 2.19 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.179 0.992 . . . . 3.3799999999999999 109.947 -173.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.11 142.74 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.817 -1.179 . . . . 1.75 107.817 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -108.34 113.39 26.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.522 0.729 . . . . 4.6600000000000001 109.16 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -118.13 -178.42 3.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 111.645 -170.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -133.85 102.13 12.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.899 0.88 . . . . 1.7 110.383 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.05 72.42 4.01 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.377 2.051 . . . . 0.93000000000000005 110.587 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.41 -53.13 0.72 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.079 1.752 . . . . 1.1499999999999999 108.627 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.71 -57.68 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 124.545 1.138 . . . . 1.48 109.603 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 tt -58.04 -44.63 87.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 C-N-CA 123.179 0.591 . . . . 1.22 112.353 -169.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 79.39 123.65 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 128.406 2.682 . . . . 3.1499999999999999 113.637 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -49.36 -50.2 13.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.269 2.646 . . . . 0.85999999999999999 114.624 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.12 -31.4 93.22 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.861 1.343 . . . . 0.91000000000000003 112.392 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.2 mmt -70.51 -41.91 72.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 118.703 -0.665 . . . . 3.02 110.88 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.7 mt -43.42 -60.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.042 0.837 . . . . 1.9299999999999999 111.041 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.2 -61.04 1.81 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 119.101 -0.476 . . . . 0.76000000000000001 112.04 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -50.91 -51.24 53.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.531 0.605 . . . . 2.3999999999999999 112.536 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -43.13 -50.39 6.22 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.809 0.843 . . . . 2.0899999999999999 110.837 171.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.7 -36.59 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.593 -0.692 . . . . 0.77000000000000002 109.301 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -68.03 -5.59 18.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 117.492 -1.242 . . . . 3.8100000000000001 113.2 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -47.72 -29.51 3.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.705 1.593 . . . . 4.6799999999999997 111.537 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.19 -22.54 38.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.431 1.492 . . . . 1.27 111.47 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.85 22.11 64.56 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.055 0.836 . . . . 0.83999999999999997 112.073 -172.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -83.6 156.63 22.63 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 117.857 0.828 . . . . 2.4399999999999999 111.147 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.16 68.57 3.42 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.062 -1.615 . . . . 0.59999999999999998 109.062 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.45 152.48 27.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.593 -0.891 . . . . 0.53000000000000003 108.593 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 t -146.28 117.87 8.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.765 -1.939 . . . . 1.1799999999999999 105.765 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.37 123.56 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.37 -1.344 . . . . 0.59999999999999998 107.37 -172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 pt -135.94 -177.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.221 -1.029 . . . . 1.6699999999999999 108.221 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -169.11 -172.92 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.597 -2.001 . . . . 5.3700000000000001 105.597 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 -58.98 0.16 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 118.71 0.687 . . . . 6.2699999999999996 109.755 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.3 pt -145.39 146.59 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.05 -1.092 . . . . 4.5 108.05 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -75.74 147.18 39.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.742 1.217 . . . . 4.5599999999999996 109.37 175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.37 55.35 4.38 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.398 -0.681 . . . . 6.0 111.398 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--O 1.25 1.089 0 CA-C-O 117.978 -1.01 . . . . 9.9000000000000004 108.67 -158.769 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 108.473 -0.936 . . . . 4.5300000000000002 108.473 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t -77.47 151.02 34.86 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.176 -1.046 . . . . 2.8399999999999999 108.176 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -130.58 157.4 42.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.5 -1.296 . . . . 1.79 107.5 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -84.15 150.52 25.46 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.69 -0.856 . . . . 2.9900000000000002 108.69 167.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 48.9 t -125.94 118.38 25.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.208 1.403 . . . . 1.3600000000000001 107.28 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.46 120.97 41.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.047 -1.835 . . . . 2.6400000000000001 106.047 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 4.1 mt -117.66 140.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.091 -1.818 . . . . 0.97999999999999998 106.091 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -117.46 149.71 40.12 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.144 -1.058 . . . . 4.5499999999999998 108.144 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.47 164.52 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.895 -1.52 . . . . 2.52 106.895 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 p -139.11 81.38 1.84 Allowed 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 121.515 0.674 . . . . 2.4100000000000001 110.059 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.76 72.85 1.29 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 107.334 -2.307 . . . . 2.7000000000000002 107.334 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -48.86 16.01 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.298 1.039 . . . . 7.5199999999999996 110.675 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 177.69 -54.2 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.747 1.619 . . . . 8.9900000000000002 107.253 168.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 t -167.73 177.49 5.77 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.093 -1.447 . . . . 4.4800000000000004 107.093 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 32.17 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.198 1.799 . . . . 4.6200000000000001 115.002 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.2 p -163.68 11.48 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.521 1.129 . . . . 2.1499999999999999 112.311 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.3 t -70.06 -47.01 63.73 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 121.694 -0.629 . . . . 2.2400000000000002 110.204 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -53.82 -45.03 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.82 0.848 . . . . 2.2400000000000002 109.917 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.4 -44.88 2.07 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.313 1.445 . . . . 0.87 113.138 173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.25 -56.43 20.65 Favored 'General case' 0 C--N 1.338 0.097 0 O-C-N 121.937 -0.477 . . . . 1.1799999999999999 109.794 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.35 -52.29 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.975 -0.75 . . . . 1.6899999999999999 108.975 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -46.07 -58.31 3.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.322 1.049 . . . . 2.1400000000000001 110.961 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -58.89 -22.82 60.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.738 1.615 . . . . 5.5300000000000002 112.674 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -29.55 18.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.234 1.013 . . . . 2.5299999999999998 109.958 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -80.54 -79.93 0.15 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.783 -1.191 . . . . 2.3799999999999999 107.783 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER 53.04 -77.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.491 2.317 . . . . 5.9000000000000004 112.932 -177.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -128.06 -9.11 5.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.7 1.37 . . . . 8.8399999999999999 114.7 170.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 43.97 -134.53 0.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.806 1.642 . . . . 2.6000000000000001 110.964 172.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.39 48.95 0.85 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.078 0.951 . . . . 5.2199999999999998 109.455 165.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.97 16.58 1.4 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.217 -0.768 . . . . 0.85999999999999999 114.306 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.6 mt -74.61 151.11 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 118.705 1.252 . . . . 1.5900000000000001 108.908 165.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -35.79 6.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.056 1.742 . . . . 2.9399999999999999 110.601 175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -156.2 155.34 32.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.291 0.496 . . . . 1.02 110.339 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 26' ' ' ARG . 2.4 pp -88.63 150.74 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.318 1.847 . . . . 3.1200000000000001 112.339 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.1 pp -83.13 133.14 35.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.587 1.555 . . . . 2.0499999999999998 112.929 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -155.69 98.8 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.623 0.769 . . . . 0.58999999999999997 109.985 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.18 48.92 0.77 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.192 -0.943 . . . . 0.76000000000000001 109.972 162.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -52.57 -35.92 54.92 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.202 1.401 . . . . 1.9199999999999999 109.719 170.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.43 -28.39 0.35 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.493 1.517 . . . . 4.5 113.984 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.44 -36.86 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.97 0.73 . . . . 1.3700000000000001 112.97 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.13 46.99 0.25 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.046 -1.222 . . . . 1.1200000000000001 110.046 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -135.06 176.57 8.55 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.994 0.917 . . . . 2.8999999999999999 108.626 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -151.74 129.11 11.3 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.697 1.199 . . . . 0.57999999999999996 108.158 -169.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.81 68.74 0.92 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.129 1.772 . . . . 2.9100000000000001 108.494 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.21 158.76 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 107.886 -1.153 . . . . 1.6299999999999999 107.886 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -124.35 145.16 49.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 O-C-N 121.259 -0.9 . . . . 3.98 108.585 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -156.05 -168.3 2.72 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.49 0.716 . . . . 1.9199999999999999 110.793 -170.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -140.5 107.93 6.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 124.34 1.056 . . . . 2.27 108.727 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -73.36 72.66 3.49 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.458 2.106 . . . . 1.0800000000000001 111.3 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.0 -64.35 0.54 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.157 1.383 . . . . 1.48 108.172 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.32 -56.89 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.553 0.741 . . . . 1.3799999999999999 109.53 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 57' ' ' ILE . 10.0 tt -61.34 -42.65 94.47 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 C-N-CA 123.724 0.809 . . . . 1.3600000000000001 112.192 -169.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 77.54 120.19 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 127.887 2.475 . . . . 3.0 111.743 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.15 -42.4 59.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.01 2.473 . . . . 0.89000000000000001 115.603 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.48 -36.93 84.34 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 CA-C-N 121.624 1.616 . . . . 1.1399999999999999 111.289 175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.1 mmt -64.92 -49.29 71.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.755 -0.641 . . . . 3.29 110.294 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -55.61 -48.2 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 119.315 -0.954 . . . . 2.2599999999999998 111.538 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.67 -55.55 21.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.794 -0.362 . . . . 0.81999999999999995 110.623 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -56.11 -45.87 79.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.297 0.851 . . . . 2.4199999999999999 113.297 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.11 -48.53 4.76 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.86 0.864 . . . . 2.3599999999999999 110.602 168.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.06 -40.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 -177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.49 -7.95 16.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.397 -1.287 . . . . 2.2999999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -50.77 -30.49 14.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.767 1.621 . . . . 4.4500000000000002 110.756 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.3 mt -81.37 -13.33 58.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.746 1.219 . . . . 1.1799999999999999 111.155 -176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.31 49.54 7.33 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.059 0.837 . . . . 0.88 111.451 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -118.51 157.8 26.58 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.872 0.869 . . . . 2.7599999999999998 110.895 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.05 68.48 3.49 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.735 -1.346 . . . . 0.85999999999999999 109.735 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 153.37 25.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.319 0.648 . . . . 0.68000000000000005 109.825 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 t -150.25 120.15 7.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.713 -1.958 . . . . 1.51 105.713 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.98 128.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 124.443 1.097 . . . . 0.71999999999999997 108.572 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp -144.79 164.28 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.847 1.259 . . . . 1.6899999999999999 108.225 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 68.86 139.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.005 1.322 . . . . 8.5099999999999998 111.728 -176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.61 45.8 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.307 0.643 . . . . 7.7999999999999998 109.396 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.19 146.31 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 123.776 0.83 . . . . 4.2699999999999996 110.299 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -69.66 166.43 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.858 1.263 . . . . 4.29 109.501 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -71.69 0.74 Allowed Glycine 0 CA--C 1.531 1.038 0 N-CA-C 112.073 -0.411 . . . . 6.7999999999999998 112.073 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.743 1.617 . . . . 10.43 112.625 -171.649 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 107.119 -1.437 . . . . 3.9500000000000002 107.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -143.03 148.83 37.39 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.161 -1.422 . . . . 3.3700000000000001 107.161 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 t -153.2 128.75 10.0 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.562 -0.903 . . . . 2.0299999999999998 108.562 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -85.74 121.35 28.28 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.263 -1.014 . . . . 3.1800000000000002 108.263 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.06 130.96 37.68 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.948 -1.13 . . . . 1.6499999999999999 107.948 169.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -106.72 98.77 8.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 105.838 -1.912 . . . . 3.2599999999999998 105.838 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.44 149.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 107.205 -1.406 . . . . 0.71999999999999997 107.205 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -122.63 157.4 32.27 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.089 -0.708 . . . . 3.2999999999999998 109.089 165.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.9 t -136.91 150.08 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.824 -1.547 . . . . 1.9199999999999999 106.824 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 70.6 p -115.49 78.39 1.17 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.557 0.743 . . . . 1.99 109.144 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.48 28.09 0.85 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.511 1.053 . . . . 1.55 111.567 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.8 -32.03 73.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.248 0.619 . . . . 5.1600000000000001 111.897 172.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -76.33 60.07 1.49 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.28 1.032 . . . . 5.3899999999999997 110.257 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -105.36 -85.92 0.48 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.366 0.666 . . . . 3.1000000000000001 109.858 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.47 92.24 0.88 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.811 -1.181 . . . . 3.3799999999999999 107.811 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 p 43.18 35.75 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.769 1.628 . . . . 2.0299999999999998 113.447 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.3 p -75.97 -46.27 30.54 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.468 -0.938 . . . . 2.46 108.468 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.9 m -51.53 -46.63 36.76 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 CA-C-O 118.86 -0.59 . . . . 2.7400000000000002 110.318 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.8 -46.76 5.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.796 0.838 . . . . 0.66000000000000003 112.569 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -61.95 -53.38 56.52 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 121.704 -0.622 . . . . 1.0600000000000001 110.624 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.16 -56.31 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.909 0.884 . . . . 1.9199999999999999 108.64 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -46.05 -54.29 8.73 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.289 1.436 . . . . 2.3799999999999999 111.744 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -61.85 -11.69 13.96 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.402 0.519 . . . . 4.0800000000000001 112.402 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.404 HD22 HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -92.38 -50.4 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.764 1.625 . . . . 3.25 107.434 172.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -69.22 -11.35 60.73 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 125.3 1.44 . . . . 1.99 114.583 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -31.72 -33.51 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.623 2.369 . . . . 8.5399999999999991 116.362 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -169.61 -40.33 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.7 2.0 . . . . 6.7199999999999998 108.796 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER 48.17 -134.39 1.21 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.708 0.803 . . . . 2.6400000000000001 109.866 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -116.18 53.86 0.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.649 1.18 . . . . 4.4100000000000001 109.776 170.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.9 -15.39 0.8 Allowed Glycine 0 C--N 1.341 0.812 0 N-CA-C 115.395 0.918 . . . . 0.94999999999999996 115.395 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 HD23 ' A' ' 25' ' ' LEU . 59.2 mt -84.09 157.86 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.057 -1.09 . . . . 2.1499999999999999 108.057 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -129.32 -20.33 3.36 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.431 1.092 . . . . 2.4399999999999999 112.96 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 t -156.29 150.57 25.47 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.7 -1.222 . . . . 0.77000000000000002 107.7 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.38 162.14 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.09 1.356 . . . . 3.2000000000000002 112.132 -174.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.616 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 3.5 pp -87.14 122.85 31.52 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.579 1.552 . . . . 2.0099999999999998 111.842 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.29 90.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.592 0.757 . . . . 0.80000000000000004 109.721 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.02 45.18 1.78 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.507 164.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.18 -30.22 61.94 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.564 1.545 . . . . 1.28 110.162 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -28.48 0.8 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 125.915 1.686 . . . . 4.4000000000000004 114.087 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.01 -48.17 1.62 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.025 0.53 . . . . 0.80000000000000004 110.417 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.27 50.34 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.228 0.918 . . . . 0.68999999999999995 110.993 172.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.81 179.44 6.37 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.105 0.962 . . . . 2.96 109.783 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.9 114.12 5.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.798 1.239 . . . . 0.68000000000000005 109.72 -163.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -114.62 67.12 0.68 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.262 0.838 . . . . 3.3199999999999998 113.262 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.6 p -81.86 139.85 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 121.735 -0.603 . . . . 1.6499999999999999 109.435 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -99.0 127.85 45.01 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.438 -0.949 . . . . 3.9300000000000002 108.438 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -131.68 -172.58 2.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.236 1.414 . . . . 1.8200000000000001 110.297 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.15 124.69 8.4 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.149 0.58 . . . . 2.8399999999999999 111.588 170.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.6 72.07 6.56 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.971 1.781 . . . . 1.1399999999999999 110.586 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.64 -71.16 0.43 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.017 -0.735 . . . . 1.3700000000000001 109.017 167.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.3 t -88.83 -48.08 14.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 122.641 0.376 . . . . 1.6399999999999999 110.276 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -79.42 -45.39 23.66 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 CA-C-O 119.229 -0.415 . . . . 1.8500000000000001 110.539 -166.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 81.33 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.773 2.029 . . . . 2.79 113.25 173.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.72 -36.95 90.22 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.896 3.064 . . . . 0.92000000000000004 115.988 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.84 -28.52 50.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 CA-C-N 122.637 1.977 . . . . 1.04 111.082 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -47.95 56.68 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.085 -0.709 . . . . 4.2300000000000004 109.085 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.625 HG23 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -51.21 -51.34 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.306 0.957 . . . . 1.8999999999999999 111.056 175.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.43 -63.41 1.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.457 -0.306 . . . . 0.71999999999999997 110.544 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.25 -52.2 22.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.64 0.776 . . . . 2.1400000000000001 112.408 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.86 -50.39 4.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.836 1.255 . . . . 2.1899999999999999 110.39 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.88 -31.1 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.747 -0.595 . . . . 0.73999999999999999 109.514 -175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.1 mmm-85 -70.53 -11.76 61.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.422 -1.275 . . . . 3.3300000000000001 112.795 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -56.47 -31.11 63.7 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 121.023 1.738 . . . . 3.9399999999999999 110.56 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.17 -4.2 58.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.596 1.558 . . . . 1.74 112.062 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.84 15.81 69.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.976 0.798 . . . . 0.77000000000000002 113.25 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -82.11 169.97 16.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.598 1.199 . . . . 2.8500000000000001 110.619 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -107.1 83.15 0.33 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.181 1.372 . . . . 1.02 109.954 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.79 27.91 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.494 -0.558 . . . . 0.93000000000000005 109.494 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.8 p -137.62 102.57 4.79 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.257 -1.386 . . . . 2.7799999999999998 107.257 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.91 121.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.116 1.366 . . . . 0.71999999999999997 110.043 -169.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.9 pt -136.97 172.39 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.794 0.837 . . . . 1.5700000000000001 111.221 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 67.48 -67.17 0.18 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.209 2.203 . . . . 8.5299999999999994 112.011 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 58.02 23.71 10.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 8.5500000000000007 112.731 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 pt -64.88 133.32 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 O-C-N 121.783 -0.573 . . . . 5.4500000000000002 112.405 -166.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -90.05 4.24 50.85 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.922 1.289 . . . . 5.2199999999999998 113.484 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.14 129.59 2.34 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.982 -2.047 . . . . 5.9800000000000004 107.982 -173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.377 0 N-CA-C 104.888 -2.264 . . . . 12.16 104.888 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 108.028 -1.101 . . . . 3.71 108.028 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -170.04 151.14 3.93 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.552 -1.277 . . . . 2.2599999999999998 107.552 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 p -152.15 171.49 17.82 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.41 0.684 . . . . 2.0099999999999998 109.44 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -91.3 114.72 27.33 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 106.878 -1.527 . . . . 3.9500000000000002 106.878 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 0.7 OUTLIER -87.37 114.21 23.77 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.908 -1.145 . . . . 1.6100000000000001 107.908 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -96.36 112.26 24.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.98 -1.489 . . . . 2.6899999999999999 106.98 -171.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 mt -117.62 142.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.31 -1.737 . . . . 0.72999999999999998 106.31 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -116.93 153.34 32.75 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.615 -1.254 . . . . 2.25 107.615 166.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.94 164.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 126.91 2.084 . . . . 2.3199999999999998 105.649 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -130.98 123.52 28.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.352 0.661 . . . . 2.1299999999999999 109.274 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.89 33.7 3.99 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 124.929 1.252 . . . . 1.5900000000000001 110.017 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -44.66 93.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 117.009 0.405 . . . . 5.71 110.517 -177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 m -70.14 59.56 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.347 1.859 . . . . 5.8499999999999996 110.494 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -110.38 170.4 8.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.333 1.453 . . . . 2.21 109.366 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.75 77.22 0.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.743 0.817 . . . . 4.0999999999999996 110.742 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m 70.1 46.71 0.61 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.568 1.547 . . . . 2.0499999999999998 113.159 169.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -76.18 -54.62 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.323 -0.236 . . . . 3.1699999999999999 110.392 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.04 81.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 O-C-N 121.746 -0.596 . . . . 1.8700000000000001 110.531 -168.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -36.66 -48.27 0.7 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.078 1.351 . . . . 1.28 111.846 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -68.77 -53.54 21.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.811 -0.555 . . . . 1.1799999999999999 110.318 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mt -48.81 -47.26 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.977 0.911 . . . . 1.9099999999999999 110.57 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 34' ' ' ILE . 50.1 mt-10 -50.13 -62.34 1.63 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.76 0.824 . . . . 2.1600000000000001 109.983 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -64.26 -25.82 68.22 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.962 -0.542 . . . . 6.3200000000000003 112.319 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.89 -64.92 0.79 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.164 0.893 . . . . 3.0499999999999998 110.17 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' A' ' 34' ' ' ILE . 9.3 mp -87.3 -7.33 57.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.103 0.961 . . . . 2.5499999999999998 113.408 -165.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -21.45 -50.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.156 2.583 . . . . 6.1699999999999999 115.31 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -128.6 -45.68 1.32 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.914 2.086 . . . . 5.5300000000000002 110.204 176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 52.19 -145.3 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.705 -0.664 . . . . 2.5600000000000001 109.989 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -109.38 54.55 0.66 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.063 0.945 . . . . 3.4700000000000002 109.718 170.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.81 34.34 0.48 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.408 0.528 . . . . 0.94999999999999996 113.366 169.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mt -107.78 145.05 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.653 1.181 . . . . 1.6299999999999999 107.843 169.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -116.74 -22.49 8.56 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.948 1.299 . . . . 2.1099999999999999 112.112 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.5 t -155.7 160.28 40.22 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.455 -0.942 . . . . 1.29 108.455 165.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.6 tp -118.83 170.93 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.564 1.546 . . . . 5.6699999999999999 111.664 -170.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.551 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -78.74 123.2 26.93 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 124.644 1.178 . . . . 1.95 112.027 -163.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 13.9 p -150.26 73.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.968 -1.469 . . . . 0.68999999999999995 110.841 -174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.29 40.96 2.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 121.19 -0.944 . . . . 0.46000000000000002 109.573 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -54.66 -34.19 61.86 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.862 1.265 . . . . 1.25 109.755 170.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 17.3 ptm -39.84 -35.64 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.316 1.447 . . . . 3.5800000000000001 113.628 172.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.64 -42.79 2.83 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.723 0.809 . . . . 1.1100000000000001 111.188 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.48 52.26 0.17 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.355 -1.498 . . . . 0.97999999999999998 109.355 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -147.47 175.8 10.54 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.145 1.378 . . . . 3.1600000000000001 109.294 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -150.1 120.08 7.17 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.44 0.696 . . . . 0.72999999999999998 111.329 -168.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -122.07 97.53 5.52 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.092 -0.707 . . . . 2.8999999999999999 109.092 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.0 t -93.74 164.15 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.589 -1.263 . . . . 2.4300000000000002 107.589 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -143.44 124.33 14.3 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.675 -1.232 . . . . 3.2200000000000002 107.675 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -150.45 -167.7 2.89 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.572 1.149 . . . . 1.9199999999999999 110.821 -158.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -142.06 102.78 5.7 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.179 0.992 . . . . 1.8799999999999999 110.919 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.59 77.11 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.365 2.043 . . . . 0.81000000000000005 110.674 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.56 -56.95 0.4 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.409 1.484 . . . . 1.0900000000000001 108.799 175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.55 -58.01 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 123.975 0.91 . . . . 1.3100000000000001 109.449 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 HD11 HG13 ' A' ' 57' ' ' ILE . 11.3 tt -61.79 -37.75 78.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.559 0.744 . . . . 1.25 112.238 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 70.35 118.2 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 127.107 2.163 . . . . 3.2999999999999998 113.165 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.82 -41.12 77.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.522 2.148 . . . . 1.03 114.815 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.75 -11.33 26.1 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.589 1.603 . . . . 1.8500000000000001 112.546 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.1 mtp -107.58 -36.12 6.54 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.488 1.04 . . . . 3.2200000000000002 111.788 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 52' ' ' ILE . 6.2 tt -46.6 -51.28 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 119.566 1.075 . . . . 2.8999999999999999 111.666 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.17 -53.9 37.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.006 0.522 . . . . 0.65000000000000002 111.149 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -54.94 -46.47 74.95 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 119.114 0.87 . . . . 2.5299999999999998 112.324 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -39.9 8.54 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 112.501 0.556 . . . . 2.2400000000000002 112.501 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -74.99 -45.3 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.581 0.705 . . . . 0.79000000000000004 110.178 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.65 -9.38 26.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.091 -0.957 . . . . 2.3500000000000001 112.37 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -44.56 -34.6 2.19 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.405 1.002 . . . . 4.7199999999999998 111.017 167.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.59 -18.88 46.87 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.486 1.115 . . . . 1.1899999999999999 112.4 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 16.54 60.88 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.414 1.007 . . . . 0.81000000000000005 113.25 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -83.43 150.82 25.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.703 1.251 . . . . 2.2999999999999998 110.988 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 71.07 3.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.098 -1.201 . . . . 0.77000000000000002 110.098 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.58 145.05 29.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.183 0.593 . . . . 0.84999999999999998 110.206 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.0 p -137.98 93.69 2.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.082 -1.821 . . . . 2.0299999999999998 106.082 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.8 134.45 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.425 0.69 . . . . 0.83999999999999997 110.181 -175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.5 pt -141.6 171.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.743 1.217 . . . . 1.8200000000000001 108.312 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -142.75 106.43 4.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.014 -1.846 . . . . 6.3399999999999999 106.014 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -74.73 -54.25 7.72 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 109.732 -0.47 . . . . 5.54 109.732 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 pt -149.27 159.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 126.274 1.83 . . . . 4.7999999999999998 106.237 178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -103.85 167.21 9.92 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.539 1.136 . . . . 4.3200000000000003 109.815 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.44 -67.34 2.54 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.642 0.639 . . . . 6.6399999999999997 111.75 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.361 -1.304 . . . . 11.18 108.912 175.701 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 104.521 -2.4 . . . . 4.5 104.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -48.14 154.41 0.58 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.4 -1.273 . . . . 1.97 111.124 142.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 p -136.23 173.03 12.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.97 2.508 . . . . 1.8300000000000001 107.044 173.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -78.49 142.66 37.29 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.819 -1.178 . . . . 2.8900000000000001 107.819 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.15 117.65 32.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.907 -1.146 . . . . 1.6200000000000001 107.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.33 131.29 45.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.345 -1.354 . . . . 3.3599999999999999 107.345 174.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.1 mt -132.96 150.72 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.545 -2.02 . . . . 0.87 105.545 170.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -123.8 158.48 31.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.899 -0.778 . . . . 2.54 108.899 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 m -130.55 168.63 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 125.956 1.702 . . . . 2.7200000000000002 108.364 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -139.78 55.01 1.66 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.558 1.17 . . . . 2.71 110.468 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.8 36.09 0.07 OUTLIER Glycine 0 CA--C 1.524 0.595 0 CA-C-N 115.261 -0.881 . . . . 1.5600000000000001 111.389 169.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -29.13 70.17 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.56 -0.965 . . . . 6.9199999999999999 111.594 -173.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.4 t -51.34 -15.22 0.36 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.037 1.335 . . . . 6.6200000000000001 112.287 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -40.69 -36.67 0.63 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.174 0.99 . . . . 2.8500000000000001 113.272 165.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 66.08 87.16 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.44 0.696 . . . . 3.3700000000000001 112.101 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 p 79.83 115.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.953 2.101 . . . . 2.9100000000000001 109.333 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 168.97 -55.86 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.834 -1.913 . . . . 2.5499999999999998 105.834 -170.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.45 -48.33 9.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.666 -0.683 . . . . 1.9299999999999999 111.269 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.83 -29.97 3.65 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.241 0.83 . . . . 0.93000000000000005 113.241 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -69.23 -60.99 1.98 Allowed 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 121.41 -0.806 . . . . 2.5099999999999998 110.34 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.601 HD11 HD21 ' A' ' 64' ' ' LEU . 15.4 mm -49.27 -38.64 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.499 0.72 . . . . 3.2200000000000002 110.363 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -46.32 -66.01 0.47 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.931 0.892 . . . . 2.2400000000000002 109.371 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -49.86 -53.2 27.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.678 1.591 . . . . 6.7000000000000002 111.749 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -50.26 -47.43 55.23 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.266 -0.642 . . . . 2.7000000000000002 109.266 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.77 HD23 HG11 ' A' ' 45' ' ' VAL . 5.2 mp -66.13 -52.15 51.17 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.456 1.102 . . . . 1.8300000000000001 111.244 175.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.78 -37.98 1.96 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.756 2.023 . . . . 7.7400000000000002 112.897 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -98.01 -13.62 20.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.849 1.659 . . . . 7.0899999999999999 112.516 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.37 144.39 49.88 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.005 0.922 . . . . 3.0 109.392 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -79.6 74.84 6.26 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.423 1.089 . . . . 3.3700000000000001 111.035 -158.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.17 -13.52 1.66 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.859 1.218 . . . . 0.88 112.269 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 mm -65.11 144.41 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 118.741 1.27 . . . . 1.6799999999999999 108.605 167.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -103.5 -58.82 1.81 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.231 1.012 . . . . 2.0699999999999998 108.99 167.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 t -122.32 149.16 44.13 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.852 0.861 . . . . 0.75 109.284 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.58 168.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 126.124 1.769 . . . . 3.3700000000000001 111.013 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -83.74 148.63 26.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.727 0.811 . . . . 3.2599999999999998 110.72 170.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.2 p -159.06 88.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 117.97 0.35 . . . . 0.67000000000000004 111.572 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.8 42.57 0.62 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.106 -0.997 . . . . 0.95999999999999996 109.676 167.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -26.93 65.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.54 0.736 . . . . 2.3999999999999999 109.734 167.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.95 -30.75 10.95 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.556 1.142 . . . . 3.8900000000000001 113.51 172.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.95 -43.92 2.08 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.653 0.781 . . . . 1.21 111.507 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.4 51.49 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 125.261 1.41 . . . . 0.77000000000000002 109.92 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -147.59 175.73 10.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.682 1.193 . . . . 4.8099999999999996 108.678 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -154.18 131.3 11.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.238 1.015 . . . . 0.58999999999999997 109.06 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.03 72.16 1.47 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.583 0.706 . . . . 3.2799999999999998 111.155 -170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.77 HG11 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -81.35 172.99 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 122.057 0.932 . . . . 2.23 108.856 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -135.9 134.84 39.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.2 -1.037 . . . . 3.6499999999999999 108.2 166.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -148.44 -165.42 2.27 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 123.952 0.783 . . . . 2.52 110.312 -171.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -148.55 93.2 4.35 Favored Pre-proline 0 N--CA 1.452 -0.365 0 C-N-CA 124.143 0.977 . . . . 1.98 111.16 -172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.87 70.55 4.35 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.534 2.823 . . . . 1.1299999999999999 109.302 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -148.56 -43.46 0.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.321 2.648 . . . . 1.46 107.202 -168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.06 -61.08 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.455 1.102 . . . . 1.5 110.614 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 57' ' ' ILE . 3.7 tt -54.33 -46.46 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.437 1.095 . . . . 1.3400000000000001 113.658 -166.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 84.09 122.98 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 126.548 1.939 . . . . 2.7400000000000002 111.78 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -53.24 -46.91 30.45 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.72 2.28 . . . . 1.26 115.004 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -61.48 -29.72 85.46 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 120.736 1.298 . . . . 1.29 111.031 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.5 ttm -68.54 -50.13 54.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.815 1.189 . . . . 3.1899999999999999 109.11 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 1.5 pt -59.5 -45.35 93.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.875 1.216 . . . . 2.3700000000000001 111.954 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.05 -54.52 34.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.285 -0.566 . . . . 0.62 111.385 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -54.11 -48.35 70.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.114 0.966 . . . . 2.5600000000000001 111.543 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -40.61 -48.76 2.94 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 123.912 0.885 . . . . 2.3399999999999999 110.153 171.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.34 -28.89 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.548 -0.72 . . . . 0.92000000000000004 110.252 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.16 -4.49 33.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 117.185 -1.388 . . . . 3.79 114.049 170.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.636 ' HG2' HD23 ' A' ' 64' ' ' LEU . 14.2 pt-20 -51.92 -37.97 54.58 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.252 1.842 . . . . 4.8799999999999999 111.378 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.636 HD23 ' HG2' ' A' ' 63' ' ' GLU . 0.5 OUTLIER -99.29 12.53 35.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.942 1.297 . . . . 2.3900000000000001 113.184 175.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.91 35.39 35.37 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.273 0.939 . . . . 0.69999999999999996 114.498 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -84.74 153.24 23.17 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.402 1.101 . . . . 2.8999999999999999 112.726 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.06 69.41 3.35 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 109.763 -1.335 . . . . 0.68000000000000005 109.763 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.35 169.31 15.77 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 117.252 0.526 . . . . 0.68999999999999995 110.165 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -156.79 113.07 3.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.315 -1.735 . . . . 1.48 106.315 174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.16 135.62 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 107.438 -1.319 . . . . 0.88 107.438 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.81 147.92 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.623 -0.88 . . . . 2.1000000000000001 108.623 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -165.25 -168.73 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.086 1.354 . . . . 6.5599999999999996 107.459 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -130.51 164.42 24.88 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.945 -1.502 . . . . 5.4199999999999999 106.945 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 pt -61.36 143.9 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.621 -0.511 . . . . 10.5 109.621 173.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -159.57 176.32 12.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.364 1.466 . . . . 7.1699999999999999 107.231 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.73 46.9 6.14 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.616 -0.547 . . . . 10.369999999999999 111.877 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.603 1.961 . . . . 17.699999999999999 108.844 -173.3 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 119.161 -0.447 . . . . 4.3099999999999996 110.097 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -72.77 110.85 7.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.125 -0.941 . . . . 3.1200000000000001 109.092 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -133.88 154.68 50.89 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.527 -0.916 . . . . 1.8500000000000001 108.527 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.99 151.73 23.01 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 117.934 0.334 . . . . 5.9800000000000004 110.489 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 p -112.11 105.6 14.01 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.048 -1.464 . . . . 2.8300000000000001 107.048 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.51 121.26 26.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.708 -1.96 . . . . 2.6699999999999999 105.708 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 mt -124.98 154.1 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.642 -1.614 . . . . 0.88 106.642 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -130.84 155.04 47.39 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.469 -0.77 . . . . 2.8199999999999998 109.15 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -130.98 126.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 125.454 1.502 . . . . 2.54 108.401 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 m -74.3 114.76 13.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.67 -0.644 . . . . 2.1600000000000001 109.588 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.71 41.09 6.93 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.245 -1.142 . . . . 2.4300000000000002 110.245 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 35.1 mtt 58.86 -158.45 0.3 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.129 0.966 . . . . 7.6900000000000004 110.248 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.775 HG21 ' HB ' ' A' ' 18' ' ' VAL . 11.4 t -103.65 35.45 2.61 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.966 1.707 . . . . 7.7300000000000004 107.953 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 t 64.19 -68.82 0.09 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.602 1.561 . . . . 3.0099999999999998 113.535 -175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.48 -124.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.324 1.45 . . . . 3.4900000000000002 107.603 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -71.2 30.55 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.945 -1.097 . . . . 2.25 113.894 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.0 t -74.11 -43.38 57.78 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.837 -1.171 . . . . 2.7200000000000002 107.837 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.775 ' HB ' HG21 ' A' ' 13' ' ' THR . 0.4 OUTLIER -49.4 -44.92 18.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 123.169 0.588 . . . . 2.27 111.164 -178.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.2 -42.89 14.74 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.518 0.727 . . . . 1.1899999999999999 111.459 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -69.97 -54.72 12.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.206 -0.308 . . . . 1.6699999999999999 110.221 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mp -51.28 -53.92 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.261 -0.876 . . . . 2.21 110.446 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -42.22 -58.55 2.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.99 1.716 . . . . 1.9399999999999999 110.919 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -63.02 -14.12 43.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.13 1.159 . . . . 5.0599999999999996 114.13 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.42 -36.31 14.65 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.395 0.998 . . . . 2.6200000000000001 108.658 173.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD13 HG11 ' A' ' 45' ' ' VAL . 76.8 mt -83.53 -31.86 26.19 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 124.752 1.221 . . . . 2.5600000000000001 113.433 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.867 2.067 . . . . 8.3000000000000007 115.019 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -114.47 -34.65 5.18 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.435 1.494 . . . . 9.3599999999999994 111.26 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.21 -137.14 1.23 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.766 0.826 . . . . 2.73 109.185 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -122.74 49.83 1.58 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.549 1.14 . . . . 5.7699999999999996 108.003 167.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.7 11.81 0.1 OUTLIER Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.138 -1.368 . . . . 1.72 116.464 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.9 mt -110.59 156.64 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 120.065 1.932 . . . . 1.72 110.031 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -125.99 -28.31 3.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.79 1.636 . . . . 2.48 113.126 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -140.59 146.68 38.32 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.343 -1.354 . . . . 0.84999999999999998 107.343 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.5 155.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.66 1.984 . . . . 3.3199999999999998 110.537 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -81.32 141.49 33.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.741 0.816 . . . . 1.6599999999999999 111.473 175.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.0 p -159.28 101.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.54 -0.754 . . . . 0.72999999999999998 110.436 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.68 45.36 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.794 162.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.482 ' HG ' HG22 ' A' ' 13' ' ' THR . 1.9 tt -54.61 -34.34 61.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.906 1.283 . . . . 1.8200000000000001 109.889 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptp -37.25 -35.65 0.12 Allowed 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.616 1.566 . . . . 3.8300000000000001 113.643 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.92 -46.46 2.63 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.123 0.969 . . . . 1.05 110.603 173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.04 47.8 0.16 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.525 1.536 . . . . 1.0600000000000001 109.425 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -132.9 177.24 7.8 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.033 1.333 . . . . 2.7000000000000002 109.328 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -145.57 138.39 25.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.286 1.435 . . . . 0.48999999999999999 109.13 -173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -133.84 82.1 1.96 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.876 -0.787 . . . . 2.79 108.876 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -89.12 160.76 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.199 -1.037 . . . . 2.5499999999999998 108.199 176.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -122.28 135.32 54.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 118.496 -0.764 . . . . 4.0 110.798 174.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -146.07 -156.83 0.74 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.071 0.548 . . . . 2.3999999999999999 111.18 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.58 101.89 3.48 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 123.991 0.917 . . . . 2.6699999999999999 109.833 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.3 69.74 3.26 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.507 2.138 . . . . 1.1699999999999999 110.646 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -177.86 -49.84 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.158 1.783 . . . . 1.78 108.97 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 -45.88 83.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.741 -0.837 . . . . 3.29 108.741 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.669 HD12 HG23 ' A' ' 57' ' ' ILE 0.271 0.0 OUTLIER -112.54 -93.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 124.471 1.108 . . . . 3.1299999999999999 108.065 -172.17 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 52' ' ' ILE . 2.1 mm-40 162.82 127.24 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.236 1.815 . . . . 3.2400000000000002 110.017 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.62 -35.92 97.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.192 2.595 . . . . 1.1899999999999999 116.414 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -68.12 -41.64 7.01 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 CA-C-N 122.588 1.96 . . . . 1.29 110.779 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -48.33 82.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.539 0.336 . . . . 2.6200000000000001 110.678 -169.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.669 HG23 HD12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.27 -54.83 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 120.896 -0.322 . . . . 2.5499999999999998 111.015 176.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.61 -51.67 66.37 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.721 -0.612 . . . . 1.3899999999999999 110.871 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.36 -41.76 69.51 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.939 -0.553 . . . . 2.96 111.813 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.24 -37.51 4.72 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.401 1.081 . . . . 2.1499999999999999 112.908 171.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.66 -46.71 53.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 108.486 -0.931 . . . . 1.23 108.486 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -65.85 -14.32 61.23 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.185 -0.912 . . . . 2.8599999999999999 113.068 -174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -46.08 -30.08 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.385 0.993 . . . . 4.8300000000000001 111.839 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.5 -6.66 59.45 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.561 0.745 . . . . 1.3 111.973 -177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.94 73.26 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.493 1.044 . . . . 0.76000000000000001 112.087 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.07 149.85 25.95 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.866 0.833 . . . . 2.5600000000000001 110.199 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.61 71.6 2.91 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.947 -1.661 . . . . 0.75 108.947 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.02 151.21 28.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.858 -0.793 . . . . 0.57999999999999996 108.858 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.9 t -148.82 127.18 12.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.7 -1.963 . . . . 1.3600000000000001 105.7 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -109.09 132.9 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.498 1.119 . . . . 0.80000000000000004 109.232 -171.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.86 -165.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.916 1.286 . . . . 1.6899999999999999 108.305 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 41.4 73.11 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.175 1.39 . . . . 8.7799999999999994 112.972 171.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -152.0 72.14 1.0 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.958 1.303 . . . . 8.0 107.96 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.8 mt -106.94 4.53 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 122.54 1.162 . . . . 7.4900000000000002 112.144 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -98.41 121.95 40.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.203 2.201 . . . . 7.7400000000000002 110.325 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.15 73.43 1.21 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.446 -1.862 . . . . 9.6799999999999997 108.446 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 . . . . . 0 C--O 1.253 1.266 0 CA-C-O 116.667 -1.635 . . . . 16.539999999999999 110.299 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 107.587 -1.264 . . . . 5.1399999999999997 107.587 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m 65.86 56.51 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.197 0.999 . . . . 3.6499999999999999 113.085 171.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 p -99.77 175.62 5.74 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.481 2.312 . . . . 1.8100000000000001 112.51 -172.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -83.31 138.51 33.52 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.07 -1.456 . . . . 3.3700000000000001 107.07 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.92 119.85 35.14 Favored 'General case' 0 CA--C 1.523 -0.085 0 N-CA-C 106.268 -1.753 . . . . 1.6200000000000001 106.268 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.49 124.33 37.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.306 -1.738 . . . . 2.4199999999999999 106.306 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 70' ' ' VAL . 2.6 mt -130.93 150.83 35.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.337 -1.357 . . . . 0.73999999999999999 107.337 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -131.3 154.07 48.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.648 -1.242 . . . . 2.6400000000000001 107.648 171.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.4 t -130.91 131.02 64.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.254 0.622 . . . . 1.8500000000000001 109.58 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -73.54 110.11 7.58 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 120.674 0.273 . . . . 2.0899999999999999 110.322 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.45 35.08 12.42 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.863 -0.895 . . . . 2.6099999999999999 110.863 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.6 mpp? 52.93 -150.53 0.35 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.223 1.009 . . . . 7.0800000000000001 110.197 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -105.32 30.82 5.34 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.655 0.782 . . . . 7.5700000000000003 109.095 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 56.5 -162.22 0.18 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.794 -0.566 . . . . 2.2400000000000002 111.884 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.7 89.85 6.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.088 -1.079 . . . . 3.6699999999999999 108.088 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m 75.95 74.77 0.09 Allowed 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 125.498 1.519 . . . . 2.4500000000000002 112.555 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -123.34 -36.72 2.77 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 119.151 -0.452 . . . . 2.7400000000000002 111.664 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.08 -51.61 21.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 CA-C-N 118.37 0.532 . . . . 2.0 110.839 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.12 -44.37 3.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.109 1.364 . . . . 0.68000000000000005 112.124 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.07 -54.8 28.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.031 -0.359 . . . . 1.25 110.031 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.2 mt -51.48 -45.5 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.994 -0.527 . . . . 1.79 109.992 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -52.02 -59.65 4.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.473 0.578 . . . . 2.0699999999999998 110.806 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.97 -38.09 89.74 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 119.237 -0.985 . . . . 6.5300000000000002 112.401 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.58 -58.84 6.77 Favored 'General case' 0 CA--C 1.524 -0.044 0 CA-C-O 121.763 0.792 . . . . 3.3500000000000001 109.279 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' HD13 ' A' ' 34' ' ' ILE . 10.1 mp -84.8 -3.83 58.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.624 1.169 . . . . 2.6899999999999999 111.882 -172.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -37.02 -43.58 0.47 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.53 1.308 . . . . 7.0800000000000001 114.53 -171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -131.26 -48.35 1.0 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.093 1.757 . . . . 9.0700000000000003 109.919 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.09 -162.99 0.12 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.538 0.154 . . . . 3.7999999999999998 111.177 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -91.2 53.77 2.42 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.998 -1.064 . . . . 4.6699999999999999 112.146 170.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.22 31.51 0.48 Allowed Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.667 -0.646 . . . . 0.98999999999999999 114.14 169.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.54 147.06 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.772 1.229 . . . . 1.8300000000000001 108.132 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -116.92 -29.88 5.88 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.276 1.031 . . . . 2.3999999999999999 112.244 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -151.3 161.45 42.69 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.225 -2.139 . . . . 0.96999999999999997 105.225 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 25' ' ' LEU . 4.1 tp -123.8 171.78 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.43 0.692 . . . . 5.5199999999999996 110.142 -173.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.649 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -80.36 117.04 20.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 126.047 1.739 . . . . 1.98 112.19 -165.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.34 82.21 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.77000000000000002 109.889 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.48 36.97 0.82 Allowed 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.244 -0.91 . . . . 0.5 109.11 164.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 tp -49.37 -38.02 27.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.77 1.628 . . . . 2.5299999999999998 109.267 164.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.5 tpp -38.99 -38.33 0.44 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.687 1.595 . . . . 5.2699999999999996 112.795 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.18 -39.03 2.62 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.725 0.81 . . . . 1.28 112.728 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.84 43.18 0.22 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.742 1.639 . . . . 0.80000000000000004 112.309 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -134.41 179.48 6.25 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.1 1.36 . . . . 3.4700000000000002 109.526 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.46 114.87 5.53 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.368 1.067 . . . . 0.47999999999999998 110.339 -168.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -115.63 68.47 0.72 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.269 1.028 . . . . 3.71 112.103 -168.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -84.48 153.08 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.461 0.704 . . . . 1.6399999999999999 109.707 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -125.3 133.83 52.48 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.638 1.175 . . . . 4.1799999999999997 109.164 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -142.31 -166.98 2.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.751 0.657 . . . . 1.8100000000000001 111.309 -163.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -143.76 91.37 6.71 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 118.32 -0.848 . . . . 1.76 110.553 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.8 72.62 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.096 2.53 . . . . 0.89000000000000001 111.502 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.79 -45.41 0.1 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.858 1.663 . . . . 1.02 108.944 -173.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.0 t -109.76 -61.16 2.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 C-N-CA 123.907 0.883 . . . . 1.3100000000000001 110.005 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.38 -37.15 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.981 0.734 . . . . 1.24 112.981 -166.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 75.97 117.76 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.651 2.38 . . . . 3.04 113.268 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.75 -47.44 20.99 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.878 2.385 . . . . 0.80000000000000004 114.42 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.29 -29.31 85.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 120.8 1.321 . . . . 0.97999999999999998 112.663 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 28.5 mtt -76.63 -40.25 49.83 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.416 1.007 . . . . 3.0699999999999998 111.43 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.4 mt -40.73 -59.35 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 118.896 0.771 . . . . 1.96 111.941 172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -44.0 -64.09 0.74 Allowed 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 119.085 -0.483 . . . . 0.89000000000000001 111.884 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -48.61 -53.84 16.91 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.564 0.62 . . . . 3.02 112.343 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.83 -45.74 10.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.317 1.047 . . . . 1.97 112.172 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -71.1 -38.05 69.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.517 -0.739 . . . . 0.68000000000000005 109.986 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -67.4 -5.02 12.79 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 117.764 -1.112 . . . . 2.3900000000000001 112.547 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -43.62 -36.56 2.18 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 120.202 1.365 . . . . 4.96 111.184 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.2 mt -84.1 -17.81 38.95 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.881 1.272 . . . . 1.29 112.883 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.35 29.45 40.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.307 0.956 . . . . 0.68999999999999995 112.813 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -84.21 153.65 23.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.889 0.845 . . . . 2.5600000000000001 112.123 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.24 68.43 3.56 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 108.561 -1.816 . . . . 1.05 108.561 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.7 162.47 19.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.208 1.003 . . . . 0.90000000000000002 109.38 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 t -153.72 119.2 5.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.838 -1.912 . . . . 1.2 105.838 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 7' ' ' ILE . 12.7 p -104.1 135.47 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 125.003 1.321 . . . . 0.72999999999999998 108.283 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.66 161.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.284 1.034 . . . . 2.3399999999999999 108.299 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.34 -162.37 0.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.008 1.323 . . . . 6.3399999999999999 109.499 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -155.37 -85.73 0.05 Allowed 'General case' 0 CA--C 1.527 0.096 0 O-C-N 121.369 -0.832 . . . . 5.7699999999999996 109.284 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.03 10.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 122.499 1.142 . . . . 4.7800000000000002 112.239 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -162.6 176.25 10.58 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.097 2.159 . . . . 6.5499999999999998 107.595 172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.92 91.99 1.41 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.835 -1.706 . . . . 11.65 108.835 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.187 -1.387 . . . . 20.280000000000001 109.109 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 108.082 -1.081 . . . . 4.1600000000000001 108.082 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -147.17 133.84 19.94 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.738 -0.838 . . . . 2.9300000000000002 108.738 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -102.06 168.41 9.4 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.19 1.396 . . . . 2.0 109.425 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -99.19 133.75 43.03 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 118.397 0.544 . . . . 3.29 110.068 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.3 p -109.04 125.08 51.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.281 -1.748 . . . . 2.3599999999999999 106.281 169.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.96 122.46 36.48 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 103.757 -2.683 . . . . 3.7000000000000002 103.757 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG12 HG23 ' A' ' 70' ' ' VAL . 2.8 mt -118.45 144.75 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.519 -1.66 . . . . 0.92000000000000004 106.519 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -127.68 162.07 27.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.122 -0.696 . . . . 3.73 109.122 173.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 p -159.0 147.24 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.873 -1.058 . . . . 2.5099999999999998 108.221 -170.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.5 p -104.33 72.55 1.07 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.5 -0.555 . . . . 1.73 109.5 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.09 49.05 0.05 OUTLIER Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.455 1.026 . . . . 1.5700000000000001 111.884 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -31.76 62.3 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.921 -0.752 . . . . 6.5300000000000002 110.561 176.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 t -73.21 59.11 0.54 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.471 1.108 . . . . 5.5999999999999996 109.803 175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.87 171.42 7.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.091 1.356 . . . . 2.1099999999999999 108.325 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 83.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.252 1.021 . . . . 3.5899999999999999 112.409 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 m 63.18 29.56 16.04 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.459 1.503 . . . . 2.1800000000000002 111.764 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 t -68.81 -50.19 52.18 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 122.141 -0.349 . . . . 2.1400000000000001 110.371 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.1 -54.85 4.64 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 123.361 0.664 . . . . 2.1899999999999999 109.941 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.32 -45.43 4.24 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.944 1.297 . . . . 0.88 112.728 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -64.69 -49.75 69.7 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.722 -0.611 . . . . 1.1100000000000001 110.086 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.6 mp -55.89 -52.15 52.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-O 117.802 -1.094 . . . . 1.74 109.073 176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -47.55 -48.51 27.7 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 124.963 1.305 . . . . 1.8200000000000001 111.244 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -64.81 -29.92 70.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.974 2.11 . . . . 5.4900000000000002 112.511 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -50.51 11.73 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.126 -1.435 . . . . 3.2799999999999998 107.126 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 HG11 ' A' ' 45' ' ' VAL . 18.1 mt -59.65 -43.39 93.91 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.26 1.824 . . . . 2.77 110.457 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -57.97 -28.93 64.82 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.629 -0.67 . . . . 5.5199999999999996 110.677 -169.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -97.66 -24.93 15.29 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.541 1.536 . . . . 6.3499999999999996 113.859 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.89 130.42 2.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.565 1.075 . . . . 3.9199999999999999 111.399 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.69 72.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.125 1.37 . . . . 4.5300000000000002 111.045 -167.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 149.63 -22.8 1.18 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.669 1.128 . . . . 0.83999999999999997 112.512 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.07 147.35 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.798 1.299 . . . . 1.5600000000000001 109.882 171.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -112.97 -36.97 4.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.077 1.751 . . . . 2.5299999999999998 111.578 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' HG12 ' A' ' 45' ' ' VAL . 15.9 t -144.97 147.29 32.51 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 118.606 0.639 . . . . 0.76000000000000001 109.833 -174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.83 163.74 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 127.009 2.124 . . . . 3.5499999999999998 112.431 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.727 HD22 ' HB1' ' A' ' 43' ' ' ALA . 4.1 pp -93.51 135.09 35.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.366 1.866 . . . . 1.6799999999999999 113.359 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -158.17 92.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 123.568 0.747 . . . . 0.85999999999999999 110.788 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.54 46.0 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.061 -1.024 . . . . 0.54000000000000004 109.492 163.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.65 -33.47 64.1 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.297 1.439 . . . . 1.52 110.321 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -31.39 -47.24 0.11 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 127.162 2.185 . . . . 5.71 112.142 171.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.02 -38.31 3.91 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.642 0.777 . . . . 0.95999999999999996 111.972 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.97 49.33 0.23 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.134 1.349 . . . . 0.75 110.694 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -135.23 -179.69 5.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.41 1.084 . . . . 3.0299999999999998 109.262 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' HD22 ' A' ' 35' ' ' LEU . . . -148.42 132.62 17.39 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 125.818 1.647 . . . . 0.53000000000000003 108.825 -168.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -126.72 98.85 5.53 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.642 -0.873 . . . . 3.29 108.642 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.898 HG11 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -104.98 154.62 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.199 0.523 . . . . 2.46 109.702 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -111.78 132.6 54.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.79 -0.819 . . . . 3.7200000000000002 108.79 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.33 -168.64 2.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.543 1.937 . . . . 1.98 109.862 -173.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -151.42 102.87 2.92 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 108.129 -1.063 . . . . 1.8700000000000001 108.129 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.08 72.67 3.3 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.993 2.462 . . . . 0.82999999999999996 110.735 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.56 -66.03 0.58 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.771 1.628 . . . . 0.98999999999999999 106.869 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.16 -54.51 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.286 1.034 . . . . 1.28 110.544 -174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.79 -35.05 38.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 C-N-CA 123.641 0.776 . . . . 1.28 112.948 -170.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 71.96 117.64 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 127.787 2.435 . . . . 2.1800000000000002 113.128 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -48.77 -45.98 26.18 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.605 2.203 . . . . 1.3200000000000001 114.691 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.41 -34.67 98.91 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.543 1.587 . . . . 1.3100000000000001 112.23 175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.6 mtt -72.72 -43.56 62.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.427 -0.797 . . . . 2.6899999999999999 111.407 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.2 mt -40.42 -65.81 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 119.289 0.95 . . . . 2.1600000000000001 111.608 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -43.82 -55.48 4.47 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.878 -0.514 . . . . 0.84999999999999998 111.648 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -52.6 -51.65 58.97 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.53 0.605 . . . . 3.0600000000000001 112.577 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.97 -39.54 19.7 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.354 0.662 . . . . 2.4199999999999999 112.114 174.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.25 -46.11 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 109.575 -0.528 . . . . 1.3999999999999999 109.575 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -63.39 -17.32 62.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 117.583 -1.199 . . . . 2.7799999999999998 112.795 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -42.4 -29.58 0.28 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.783 1.174 . . . . 4.1500000000000004 113.259 173.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 21' ' ' ILE . 17.4 mt -80.44 -29.17 37.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.493 -0.755 . . . . 1.04 111.443 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.12 74.82 1.29 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.564 1.078 . . . . 1.3700000000000001 111.56 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -155.89 -176.36 5.92 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.887 0.844 . . . . 6.1600000000000001 110.171 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.7 81.15 1.76 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.866 -1.293 . . . . 0.94999999999999996 109.866 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.4 152.48 27.42 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.538 -0.912 . . . . 1.05 108.538 172.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.7 t -152.19 109.73 3.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.719 -1.215 . . . . 1.3500000000000001 107.719 171.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG23 HG12 ' A' ' 7' ' ' ILE . 9.8 p -89.67 118.64 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.446 -1.687 . . . . 0.75 106.446 175.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -120.12 154.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 124.796 1.238 . . . . 1.8700000000000001 107.938 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -103.27 169.64 8.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.404 -0.962 . . . . 5.5 108.404 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.98 -64.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.447 -1.686 . . . . 6.0300000000000002 106.447 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -165.23 178.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.004 -1.48 . . . . 4.71 107.004 175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -68.16 169.94 9.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.371 1.068 . . . . 5.4800000000000004 111.319 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.5 -66.45 2.58 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.829 -0.544 . . . . 6.5099999999999998 111.771 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 N-CA-C 103.019 -2.956 . . . . 13.869999999999999 103.019 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 115.721 -2.085 . . . . 4.3399999999999999 105.822 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m 80.93 82.55 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 121.234 1.834 . . . . 3.0299999999999998 114.322 167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 p -99.18 175.37 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.17 1.788 . . . . 1.8 112.253 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -101.89 121.67 42.55 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.324 1.049 . . . . 4.3700000000000001 109.632 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HG13 ' A' ' 45' ' ' VAL . 8.7 p -94.38 124.33 38.34 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 107.947 -1.131 . . . . 1.9099999999999999 107.947 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -98.9 119.44 37.67 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.193 -1.78 . . . . 3.29 106.193 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.567 HG12 HG23 ' A' ' 70' ' ' VAL . 3.4 mt -118.69 152.8 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.882 -1.896 . . . . 0.77000000000000002 105.882 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -127.5 154.66 44.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.501 -1.296 . . . . 2.9100000000000001 107.501 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.95 138.92 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.728 -1.582 . . . . 1.8500000000000001 106.728 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -94.85 67.16 3.16 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.265 -0.643 . . . . 2.4399999999999999 109.265 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.13 36.32 0.12 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.44 0.543 . . . . 1.6399999999999999 112.832 170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -42.14 93.83 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.535 0.668 . . . . 4.96 111.054 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -70.63 61.15 0.23 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.747 2.019 . . . . 5.5300000000000002 111.008 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -113.26 -167.99 1.27 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.963 1.305 . . . . 2.1899999999999999 108.066 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.2 76.97 0.36 Allowed 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.983 -1.073 . . . . 3.4300000000000002 110.801 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m 61.67 39.2 14.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.27 1.428 . . . . 1.8600000000000001 112.39 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.97 -56.04 13.71 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.027 -0.42 . . . . 2.1899999999999999 110.15 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.05 -43.73 26.78 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 122.576 0.35 . . . . 1.7 110.692 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.88 8.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.996 1.318 . . . . 0.73999999999999999 112.777 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -65.96 -55.91 14.4 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.19 -0.67 . . . . 1.25 109.19 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.401 HG12 HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.1 -39.93 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 123.7 0.8 . . . . 3.6499999999999999 111.458 179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 34' ' ' ILE . 10.4 mt-10 -49.94 -79.41 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 123.986 0.915 . . . . 2.5899999999999999 109.127 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -37.94 -45.74 0.9 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.423 1.089 . . . . 5.1500000000000004 112.873 174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.39 84.62 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 118.706 -0.664 . . . . 3.0299999999999998 112.377 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 88.6 mt -99.64 -29.28 12.77 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.773 0.715 . . . . 2.8300000000000001 112.231 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -48.91 -36.97 18.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 8.4700000000000006 109.452 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -82.68 -17.83 43.1 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.198 1.799 . . . . 9.1600000000000001 114.849 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -65.49 132.4 48.82 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.296 1.407 . . . . 2.3799999999999999 111.598 -170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.96 79.02 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.498 1.519 . . . . 4.3200000000000003 111.103 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.52 -24.48 1.52 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.319 0.962 . . . . 1.1499999999999999 111.394 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.3 mm -70.26 129.67 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.515 -0.92 . . . . 1.3999999999999999 108.515 169.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.92 -26.39 13.76 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.485 0.714 . . . . 2.3199999999999998 111.183 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -157.65 150.88 23.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 106.744 -1.576 . . . . 1.0600000000000001 106.744 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.876 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -110.25 166.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 118.733 0.697 . . . . 4.8300000000000001 111.717 -175.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.876 ' H ' HD13 ' A' ' 34' ' ' ILE . 1.5 pp -79.22 127.19 31.73 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.059 1.744 . . . . 1.8999999999999999 112.901 -174.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 p -157.25 92.23 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 114.241 -1.345 . . . . 0.65000000000000002 109.164 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.63 43.1 1.61 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 120.933 -1.104 . . . . 0.70999999999999996 109.418 163.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -32.52 59.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.863 1.665 . . . . 1.5600000000000001 110.702 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 mtt -36.86 -44.69 0.51 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 126.585 1.954 . . . . 4.6900000000000004 112.237 172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -121.32 -46.25 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.603 0.761 . . . . 1.0700000000000001 110.977 -177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.25 55.06 0.1 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.205 0.907 . . . . 0.94999999999999996 111.528 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -134.42 178.33 7.07 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.205 1.402 . . . . 3.3599999999999999 107.923 170.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 35' ' ' LEU . . . -148.64 111.12 4.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.409 1.084 . . . . 0.57999999999999996 108.896 -168.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -118.88 88.05 2.85 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.751 -0.593 . . . . 2.5 110.182 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG13 ' SG ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -104.1 152.62 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.244 1.018 . . . . 1.76 109.421 -173.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -119.45 130.24 55.15 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.987 1.315 . . . . 3.8399999999999999 109.472 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.8 -169.97 2.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 109.622 -166.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -153.05 91.62 3.39 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.476 0.71 . . . . 1.76 109.601 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -72.27 73.46 2.68 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.72 2.28 . . . . 1.4199999999999999 110.116 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.82 -47.95 0.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 128.056 2.542 . . . . 1.8 107.496 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.6 t -118.1 -62.54 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.478 1.111 . . . . 1.6100000000000001 110.467 174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 tt -59.7 -51.11 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.706 0.803 . . . . 1.3400000000000001 112.239 -166.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 78.43 131.29 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 128.965 2.906 . . . . 2.3500000000000001 114.817 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.49 -46.68 25.88 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 125.119 3.879 . . . . 0.94999999999999996 115.33 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -61.5 -32.33 88.24 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.51 1.575 . . . . 0.97999999999999998 111.025 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmm? -64.83 -53.15 51.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.426 -0.583 . . . . 4.0899999999999999 109.426 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.84 -59.36 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-O 118.79 -0.624 . . . . 1.98 112.203 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -38.71 -59.07 0.98 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.984 0.811 . . . . 0.92000000000000004 111.759 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -58.46 -51.4 70.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.106 0.41 . . . . 2.5299999999999998 112.106 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -41.83 -51.12 4.33 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.311 0.644 . . . . 2.4900000000000002 110.708 171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -64.93 -40.3 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.939 -0.763 . . . . 0.92000000000000004 108.939 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -65.86 -6.58 12.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.237 -1.363 . . . . 3.1299999999999999 113.383 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -50.23 -31.08 13.06 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 121.256 1.844 . . . . 4.0099999999999998 111.207 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 21' ' ' ILE . 14.4 mt -81.96 -15.31 54.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.699 1.2 . . . . 1.1299999999999999 111.474 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.37 23.21 74.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.485 0.564 . . . . 0.72999999999999998 112.434 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -82.4 155.03 24.9 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.072 0.936 . . . . 2.2999999999999998 110.679 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.42 71.18 2.97 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 108.614 -1.794 . . . . 0.77000000000000002 108.614 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.16 152.61 25.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.01 0.924 . . . . 0.63 109.075 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t -150.69 117.78 5.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.558 -1.645 . . . . 1.22 106.558 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.567 HG23 HG12 ' A' ' 7' ' ' ILE . 11.1 p -104.6 134.79 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.929 1.292 . . . . 0.75 108.453 -172.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.93 159.07 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 123.53 0.732 . . . . 1.6699999999999999 109.983 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.74 168.91 8.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.595 -0.729 . . . . 6.5700000000000003 109.314 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -169.91 -176.68 2.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.634 -1.247 . . . . 6.0099999999999998 107.634 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 pt -52.18 109.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.855 0.36 . . . . 7.29 111.525 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -71.28 172.43 9.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.093 0.557 . . . . 5.0499999999999998 110.563 172.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -51.87 -52.19 35.93 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.873 0.749 . . . . 6.4199999999999999 111.377 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 116.441 -1.742 . . . . 10.449999999999999 109.992 -176.138 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.8 p30 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 117.484 -1.246 . . . . 4.1500000000000004 108.524 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -59.28 143.27 49.79 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.609 1.095 . . . . 2.2599999999999998 112.225 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -155.49 164.8 38.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.677 -0.639 . . . . 1.79 109.895 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' NZ ' ' OE1' ' A' ' 44' ' ' GLU . 35.6 mttm -81.05 146.3 30.7 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.443 -1.317 . . . . 2.96 107.443 168.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.2 t -127.66 121.3 30.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.356 -1.35 . . . . 1.54 107.356 174.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -94.32 127.36 40.15 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.067 -1.827 . . . . 2.4300000000000002 106.067 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.15 150.31 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.464 -2.05 . . . . 0.73999999999999999 105.464 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -128.74 146.08 51.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.157 -1.053 . . . . 2.3199999999999998 108.157 170.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.5 t -144.59 134.47 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 C-N-CA 125.991 1.717 . . . . 2.1499999999999999 106.995 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -89.23 80.5 6.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.148 -0.686 . . . . 2.54 109.148 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.44 56.84 0.04 OUTLIER Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.112 -0.795 . . . . 1.74 111.112 172.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.0 mmt -79.11 -44.09 22.75 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 122.939 0.496 . . . . 6.1799999999999997 110.323 173.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -74.83 61.64 1.03 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.657 1.183 . . . . 5.9100000000000001 110.334 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 m -117.4 151.92 36.03 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.678 1.591 . . . . 2.71 108.17 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 77.23 0.74 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.642 0.777 . . . . 3.9399999999999999 110.926 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.6 m 79.6 123.61 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 127.31 2.244 . . . . 3.2200000000000002 110.248 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.18 -62.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.948 -1.871 . . . . 2.2200000000000002 105.948 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.4 t -57.95 -40.01 74.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.465 0 CA-C-N 114.947 -1.024 . . . . 1.8899999999999999 109.965 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.48 -39.68 7.5 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.303 1.041 . . . . 1.02 113.15 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -71.94 -54.59 9.52 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.783 -0.573 . . . . 1.21 109.915 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -46.92 -49.11 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.053 0.941 . . . . 1.95 110.043 176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HA ' HG21 ' A' ' 34' ' ' ILE . 13.1 mt-10 -42.28 -73.13 0.05 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.994 1.717 . . . . 2.3599999999999999 109.882 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -49.24 -47.17 46.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.884 2.074 . . . . 3.96 111.849 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -56.98 -61.59 2.34 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.0 -0.741 . . . . 2.8300000000000001 109.0 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' CB ' HD13 ' A' ' 34' ' ' ILE . 9.7 mp -79.34 -24.04 43.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 119.014 -0.517 . . . . 2.2000000000000002 110.316 -173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 -50.07 -28.67 7.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.396 0.998 . . . . 8.1500000000000004 110.852 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -97.0 -7.91 31.83 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.166 1.387 . . . . 6.4699999999999998 113.452 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -67.41 127.17 31.68 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 120.481 1.492 . . . . 2.5699999999999998 110.6 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -62.89 80.64 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.777 1.231 . . . . 4.8600000000000003 110.467 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.78 1.13 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.174 -0.792 . . . . 1.1599999999999999 112.689 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.0 mm -87.06 123.79 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.419 -0.956 . . . . 1.5600000000000001 108.419 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -95.81 -27.07 15.4 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 124.022 0.929 . . . . 2.1000000000000001 110.42 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.41 141.05 17.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.225 -1.028 . . . . 0.81000000000000005 108.225 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' HA ' ' A' ' 22' ' ' GLU . 2.0 tp -99.25 175.52 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.552 1.141 . . . . 5.71 112.248 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.515 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -80.65 129.97 34.83 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.261 1.824 . . . . 1.95 112.346 -169.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -157.99 71.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.765 -1.107 . . . . 0.69999999999999996 111.716 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.9 41.95 3.41 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.768 -1.208 . . . . 0.48999999999999999 109.894 164.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.48 -35.7 30.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.147 1.379 . . . . 1.3600000000000001 109.589 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.8 ptp -34.3 -42.04 0.13 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.571 1.948 . . . . 4.0800000000000001 113.319 173.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.58 -40.68 2.87 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.068 0.947 . . . . 1.1699999999999999 111.471 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 127.02 50.69 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.696 -1.361 . . . . 1.01 109.696 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.81 176.41 9.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.035 1.334 . . . . 5.4400000000000004 110.114 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -144.08 131.39 20.83 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.937 1.695 . . . . 0.93000000000000005 107.653 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 9.7 pt-20 -132.85 103.62 6.18 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.24 0.543 . . . . 2.3500000000000001 110.715 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.52 161.26 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.245 -1.02 . . . . 2.3999999999999999 108.245 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -132.44 107.99 8.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.879 -1.526 . . . . 4.0800000000000001 106.879 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.23 -162.36 0.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 126.091 1.757 . . . . 2.0099999999999998 109.691 -168.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -146.9 112.42 4.18 Favored Pre-proline 0 N--CA 1.45 -0.452 0 C-N-CA 123.249 0.62 . . . . 3.1299999999999999 109.504 168.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.33 90.64 0.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 121.766 1.666 . . . . 1.0900000000000001 108.848 169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.72 -67.47 0.13 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.252 1.421 . . . . 1.1299999999999999 108.539 168.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -91.12 -53.35 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.401 0.62 . . . . 1.26 110.314 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.425 ' H ' HG22 ' A' ' 52' ' ' ILE . 4.5 tt -67.01 -31.17 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.781 1.232 . . . . 1.3799999999999999 112.779 -165.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 71.51 115.7 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.28 1.832 . . . . 2.6099999999999999 113.079 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -47.56 -41.64 29.83 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.282 2.655 . . . . 1.23 115.164 168.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.28 -11.12 31.01 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 121.256 1.484 . . . . 1.6899999999999999 113.082 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.6 ttt -112.19 -36.9 5.19 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 120.106 1.321 . . . . 3.2999999999999998 112.06 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 57' ' ' ILE . 7.0 tt -42.65 -51.23 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 120.016 1.28 . . . . 3.1200000000000001 111.685 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.31 -57.54 7.66 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.002 0.921 . . . . 0.71999999999999997 111.573 171.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -48.87 -52.1 26.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.708 0.686 . . . . 2.6899999999999999 111.252 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.26 -39.36 6.39 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.336 0.865 . . . . 2.0499999999999998 113.336 174.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.27 -47.17 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.591 -0.693 . . . . 0.65000000000000002 109.441 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -64.26 -12.6 42.84 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.198 0.999 . . . . 2.52 112.847 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -39.71 -35.08 0.29 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.526 1.13 . . . . 4.46 111.595 162.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.64 -17.71 40.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.822 0.849 . . . . 1.0700000000000001 112.876 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.06 23.28 49.63 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.754 1.169 . . . . 0.68000000000000005 112.911 -177.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -84.54 150.58 25.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.335 1.067 . . . . 2.73 111.271 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.23 70.88 3.07 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 108.602 -1.799 . . . . 0.68999999999999995 108.602 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.73 159.31 22.58 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.889 0.475 . . . . 0.53000000000000003 109.944 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -147.74 117.68 7.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.193 -2.151 . . . . 1.8500000000000001 105.193 173.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.59 136.63 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.943 1.297 . . . . 0.80000000000000004 108.093 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 pt -143.28 159.11 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 124.467 1.107 . . . . 1.8 108.807 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.14 -68.59 0.87 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.828 -1.545 . . . . 6.1500000000000004 106.828 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 66.13 31.48 8.79 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.218 0.533 . . . . 6.5 110.899 172.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.8 pt -149.66 167.7 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 126.85 2.06 . . . . 6.2699999999999996 106.473 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.86 166.84 21.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.156 -0.683 . . . . 7.0700000000000003 109.156 169.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.93 51.84 0.18 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.562 -1.415 . . . . 9.4100000000000001 109.562 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.428 1.491 . . . . 15.529999999999999 107.385 -179.033 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 117.961 -1.018 . . . . 4.1100000000000003 108.7 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -144.11 149.45 36.57 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.55 1.14 . . . . 3.4300000000000002 108.575 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 m -101.37 170.57 8.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.42 1.488 . . . . 1.8200000000000001 109.509 -171.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -113.02 115.94 29.15 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.269 0.94 . . . . 2.75 109.179 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 1.5 t -101.67 137.25 40.23 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.855 0.862 . . . . 2.2599999999999998 109.989 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.01 106.84 17.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.505 -1.665 . . . . 2.5800000000000001 106.505 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -103.6 145.61 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.754 -1.943 . . . . 1.53 105.754 179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -124.76 152.86 43.29 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.321 -1.362 . . . . 2.8999999999999999 107.321 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -141.44 132.23 26.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.815 -1.18 . . . . 2.02 107.815 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.5 p -81.56 69.9 8.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 110.037 -0.357 . . . . 1.8500000000000001 110.037 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.07 48.74 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.679 1.133 . . . . 1.4099999999999999 111.075 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.476 ' CE ' ' HB2' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -60.95 -36.79 80.28 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.173 -0.604 . . . . 6.5 112.192 177.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 38' ' ' LEU . 2.7 p -67.0 25.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.327 1.851 . . . . 5.4199999999999999 113.256 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 m -80.75 70.53 7.53 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.099 -1.001 . . . . 2.4900000000000002 109.563 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.89 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.266 1.827 . . . . 3.3300000000000001 112.579 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -155.01 35.21 0.39 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.847 1.259 . . . . 2.0800000000000001 110.309 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -58.8 7.0 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.525 -0.546 . . . . 2.5 109.525 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -46.17 -47.77 6.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 C-N-CA 125.475 1.51 . . . . 2.04 111.377 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.11 -43.17 4.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.229 1.412 . . . . 0.87 112.84 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.57 -44.5 93.93 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.439 -0.788 . . . . 1.3999999999999999 110.652 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.1 -49.58 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 117.679 -1.153 . . . . 2.0800000000000001 108.26 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -45.68 -54.45 7.78 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.756 1.222 . . . . 2.4900000000000002 110.722 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -56.5 -26.47 54.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 112.533 0.568 . . . . 4.9199999999999999 112.533 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -50.42 8.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.228 -1.397 . . . . 3.1400000000000001 107.228 177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 35' ' ' LEU . 3.0 mp -59.63 -20.15 54.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.7 2.8 . . . . 1.9399999999999999 113.975 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -36.31 -42.98 0.35 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.939 1.295 . . . . 7.6399999999999997 114.155 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -147.06 -46.86 0.18 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.924 2.89 . . . . 6.4299999999999997 108.98 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.24 -136.01 0.95 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 118.238 -0.887 . . . . 2.8300000000000001 108.832 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -119.45 23.79 11.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.516 0.726 . . . . 4.3600000000000003 111.11 171.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.63 39.08 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 113.204 170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.8 mt -125.28 151.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 117.472 0.636 . . . . 1.73 109.458 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -118.17 -21.46 8.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.021 0.928 . . . . 2.3300000000000001 111.838 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 t -157.95 159.65 36.72 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-N 119.378 0.99 . . . . 0.78000000000000003 109.99 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -105.06 157.11 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 115.147 1.536 . . . . 3.1000000000000001 115.147 -163.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.849 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -83.0 80.24 9.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.982 1.713 . . . . 2.6800000000000002 113.745 -168.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.47 116.21 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.794 -1.191 . . . . 0.95999999999999996 112.567 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' LYS . . . -157.56 47.99 0.4 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.697 -0.853 . . . . 0.52000000000000002 108.697 162.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 13' ' ' THR . 11.3 tp -56.09 -28.64 58.52 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 1.79 110.594 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptp -38.73 -35.98 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.433 1.893 . . . . 3.9900000000000002 113.01 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.53 -43.68 1.01 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.038 0.935 . . . . 0.87 111.42 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.96 49.8 0.12 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.483 1.039 . . . . 0.69999999999999996 110.608 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 26.3 mtmt -135.19 177.12 8.06 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.42 -1.326 . . . . 3.0699999999999998 107.42 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.849 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -143.53 138.57 29.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.756 1.222 . . . . 0.48999999999999999 109.149 -170.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -134.55 91.59 2.8 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 109.117 -0.697 . . . . 3.1899999999999999 109.117 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.79 132.89 46.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.928 -0.767 . . . . 1.6000000000000001 108.928 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -83.67 85.38 7.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.178 -1.045 . . . . 3.79 108.178 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.617 ' HB2' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -83.41 158.09 22.24 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.36 -1.291 . . . . 2.3999999999999999 111.149 -176.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.27 89.93 40.95 Favored Pre-proline 0 C--O 1.235 0.339 0 O-C-N 121.947 -0.47 . . . . 2.3500000000000001 111.735 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.01 59.67 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.142 2.561 . . . . 1.4199999999999999 110.471 -173.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.04 -48.62 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.961 1.304 . . . . 1.5700000000000001 109.484 -172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.28 -42.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.594 -0.891 . . . . 3.5600000000000001 108.594 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -104.21 -80.01 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.616 0.766 . . . . 3.3100000000000001 109.879 -179.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.9 mm-40 161.34 123.3 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 127.206 2.203 . . . . 2.8799999999999999 108.716 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -50.7 -49.22 17.41 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.581 2.188 . . . . 1.8400000000000001 114.647 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.6 -41.22 49.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.247 1.481 . . . . 1.24 111.285 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 75.9 mtp -64.54 -39.78 94.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.643 -0.694 . . . . 2.75 110.573 -174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.617 HD13 ' HB2' ' A' ' 47' ' ' TYR . 5.5 mt -47.6 -67.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.626 0.648 . . . . 2.6800000000000002 111.567 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.09 -51.53 52.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.163 -0.96 . . . . 1.0 111.47 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -58.98 -37.42 76.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.628 0.973 . . . . 2.8199999999999998 113.628 -175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.78 -46.0 15.03 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 118.55 0.613 . . . . 2.2200000000000002 110.414 168.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.79 -38.48 72.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.691 -0.855 . . . . 0.68999999999999995 108.691 -178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -64.97 -7.0 9.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 117.325 -1.322 . . . . 2.7400000000000002 113.027 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.73 -31.36 11.14 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 121.012 1.733 . . . . 4.1799999999999997 111.621 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.85 -19.32 44.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.599 1.16 . . . . 1.26 111.049 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.3 56.58 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.745 0.688 . . . . 1.1000000000000001 111.888 -173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -82.44 157.51 23.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 117.664 0.732 . . . . 2.6299999999999999 110.82 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.18 69.01 3.41 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.956 -1.658 . . . . 0.62 108.956 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.06 150.57 27.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.101 -0.703 . . . . 0.55000000000000004 109.101 176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.0 t -147.01 122.3 10.25 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.611 -1.996 . . . . 1.3799999999999999 105.611 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.33 119.21 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.98 -1.118 . . . . 0.96999999999999997 107.98 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.39 168.08 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.461 1.104 . . . . 2.23 109.21 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 54.89 -179.82 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.355 0.597 . . . . 9.6999999999999993 111.056 -167.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 169.56 91.17 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 126.805 2.042 . . . . 7.0599999999999996 107.606 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 pt -137.36 157.61 34.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.526 0.679 . . . . 5.1900000000000004 109.68 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -73.92 165.81 24.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.566 -0.743 . . . . 6.1799999999999997 109.589 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.62 95.22 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.609 -0.996 . . . . 7.7000000000000002 110.609 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.834 1.254 . . . . 11.77 109.407 -167.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 106.726 -1.583 . . . . 3.9300000000000002 106.726 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -165.28 158.13 16.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.78 -1.193 . . . . 2.0800000000000001 107.78 -168.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -143.35 165.76 26.63 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.637 0.775 . . . . 1.8799999999999999 109.522 -170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -87.87 119.82 28.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.066 -1.087 . . . . 3.8500000000000001 108.066 169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 47' ' ' TYR . 4.9 t -84.67 121.26 27.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.455 -1.683 . . . . 1.75 106.455 170.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.67 118.46 32.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.706 -1.961 . . . . 3.3500000000000001 105.706 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.89 142.9 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.483 -2.043 . . . . 1.23 105.483 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -119.14 151.43 38.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.834 -1.173 . . . . 2.4300000000000002 107.834 165.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -142.45 142.89 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 106.716 -1.587 . . . . 1.8899999999999999 106.716 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.4 m -103.4 88.93 3.23 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.277 -0.638 . . . . 2.5299999999999998 109.277 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.63 36.85 0.34 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.104 0.859 . . . . 1.46 112.006 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.0 tpp -75.03 -37.95 61.59 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 121.976 -0.72 . . . . 6.29 111.004 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -72.4 61.67 0.49 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.709 1.204 . . . . 5.9800000000000004 110.476 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.18 -58.73 1.85 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.151 0.981 . . . . 3.3900000000000001 110.182 -169.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.13 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.637 1.575 . . . . 3.2200000000000002 107.324 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -131.78 25.28 4.69 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.099 0.96 . . . . 1.98 110.865 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 p -59.66 -46.19 89.77 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.622 -0.51 . . . . 3.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.86 -46.71 91.05 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 N-CA-C 110.016 -0.364 . . . . 1.8400000000000001 110.016 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.54 11.23 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.313 1.045 . . . . 0.70999999999999996 113.188 -176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.85 -49.42 77.82 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.743 0.782 . . . . 1.1799999999999999 109.874 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.54 -42.59 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 117.249 -1.358 . . . . 2.04 108.633 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.94 -53.93 28.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.938 1.699 . . . . 2.1000000000000001 109.983 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -60.66 -23.31 64.69 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.615 0.598 . . . . 5.9500000000000002 112.615 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.467 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -78.6 -62.54 1.65 Allowed 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.56 -1.338 . . . . 3.1299999999999999 107.685 172.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.916 ' HG ' HD13 ' A' ' 31' ' ' ILE . 1.1 tp -69.89 -9.21 54.08 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.885 1.674 . . . . 2.0600000000000001 113.635 -170.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -31.39 -45.31 0.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.3 1.84 . . . . 8.4100000000000001 114.362 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -158.4 -4.52 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 114.788 1.403 . . . . 7.0499999999999998 114.788 -171.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.28 145.03 22.89 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 120.206 1.367 . . . . 7.3300000000000001 108.508 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 50.67 -153.42 0.16 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.213 0.53 . . . . 6.1100000000000003 110.303 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.88 45.88 3.03 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 120.757 -1.214 . . . . 1.24 112.63 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 25' ' ' LEU . 48.1 mt -92.87 137.91 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 118.962 1.381 . . . . 2.5299999999999998 109.638 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -109.35 -31.16 7.65 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.55 1.14 . . . . 2.3300000000000001 112.683 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.6 t -153.8 155.17 35.34 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.431 -0.952 . . . . 1.0700000000000001 108.431 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -89.45 169.74 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.583 1.553 . . . . 2.9399999999999999 111.604 -175.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.672 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -84.91 121.84 28.33 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 125.652 1.581 . . . . 2.29 111.453 172.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.12 105.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 122.894 0.478 . . . . 1.1399999999999999 109.908 172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.64 53.63 1.41 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.489 -0.93 . . . . 0.51000000000000001 108.489 163.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.28 -26.17 60.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.139 1.376 . . . . 1.75 110.914 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 21.7 ptm -38.11 -34.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.195 1.798 . . . . 4.4000000000000004 113.06 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.07 -46.06 0.71 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 1.05 111.165 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 130.03 54.57 0.1 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.11 -1.196 . . . . 0.70999999999999996 110.11 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -134.17 -179.81 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.064 0.945 . . . . 3.1000000000000001 109.033 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -149.71 125.51 10.47 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.092 1.357 . . . . 0.5 109.493 -164.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.35 74.8 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.414 0.626 . . . . 3.5099999999999998 111.705 -170.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.44 145.15 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.159 -1.052 . . . . 1.6499999999999999 108.159 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -104.25 127.92 51.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.739 -0.837 . . . . 3.8700000000000001 108.739 176.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 3.1 p90 -132.52 173.21 11.55 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.22 1.008 . . . . 2.2400000000000002 111.812 -172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -125.0 95.72 41.45 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 125.222 1.409 . . . . 1.74 109.166 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.16 79.04 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.517 2.145 . . . . 1.3400000000000001 109.987 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.73 -53.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.935 1.294 . . . . 1.21 108.399 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.31 -52.17 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.356 1.063 . . . . 1.3799999999999999 110.182 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.53 -41.42 36.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 C-N-CA 123.596 0.758 . . . . 1.25 112.494 -168.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 78.18 116.12 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.415 1.886 . . . . 3.2999999999999998 110.845 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -46.94 -46.28 19.0 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.886 2.39 . . . . 1.1200000000000001 115.239 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.76 -38.31 93.42 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.461 1.557 . . . . 1.05 112.151 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.1 mtt -65.53 -44.28 87.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 117.997 -1.002 . . . . 3.1099999999999999 110.033 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.2 mt -44.02 -58.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 119.239 0.927 . . . . 1.9399999999999999 110.713 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB2' HG11 ' A' ' 70' ' ' VAL . . . -47.7 -61.21 2.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.329 0.652 . . . . 0.93999999999999995 111.159 174.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.59 -46.39 80.85 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.948 -0.47 . . . . 2.8999999999999999 112.263 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -44.34 -41.16 5.86 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 125.547 1.539 . . . . 2.6699999999999999 111.874 170.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.7 mt -75.9 -47.37 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.568 0.699 . . . . 0.81999999999999995 109.318 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -69.57 -9.26 53.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 117.901 -1.047 . . . . 2.4500000000000002 113.217 -174.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -44.19 -32.87 1.36 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.567 1.076 . . . . 4.3700000000000001 111.849 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.67 -28.34 45.29 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.582 1.153 . . . . 1.1899999999999999 111.13 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.23 23.72 31.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.573 1.083 . . . . 0.77000000000000002 112.94 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -84.87 160.74 20.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.311 1.055 . . . . 2.6099999999999999 111.058 174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.06 70.84 3.06 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.273 -1.531 . . . . 0.57999999999999996 109.273 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.93 142.39 31.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.393 0.677 . . . . 0.51000000000000001 109.263 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.7 p -138.92 106.79 5.66 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.611 -1.996 . . . . 2.46 105.611 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 58' ' ' ALA . 14.6 p -94.95 134.38 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.811 1.244 . . . . 0.78000000000000003 109.563 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.2 pp -147.96 169.0 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.953 1.701 . . . . 1.6799999999999999 107.48 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -172.21 -168.54 0.56 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.71 -1.589 . . . . 5.6200000000000001 106.71 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -131.04 -58.87 1.0 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.526 0.73 . . . . 5.0800000000000001 110.062 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -146.31 156.22 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.781 0.832 . . . . 4.8200000000000003 109.259 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.72 166.98 14.87 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.581 1.152 . . . . 6.2300000000000004 110.477 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.23 55.29 4.81 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.404 -1.22 . . . . 6.8200000000000003 113.837 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 128.35 2.66 . . . . 13.140000000000001 115.395 174.245 . . . . . . . . 0 0 . 1 stop_ save_